From 6919e2734b2e8192641e6c657e263c499f8950b5 Mon Sep 17 00:00:00 2001 From: github-actions <41898282+github-actions[bot]@users.noreply.github.com> Date: Mon, 9 Jun 2025 01:59:20 +0000 Subject: [PATCH] [automated] update diyhrt.market --- diyhrt.market/about.html | 2 +- diyhrt.market/data-privacy.html | 2 +- diyhrt.market/index.html | 609 ++++--- diyhrt.market/login.html | 4 +- .../media/images/products/57OMhi8L.png | Bin 52299 -> 0 bytes .../media/images/products/yxRBcIHr.png | Bin 52299 -> 0 bytes diyhrt.market/meds/groups/bicalutamide.html | 8 +- .../meds/groups/combination-minoxidil.html | 16 +- diyhrt.market/meds/groups/cyproterone.html | 28 +- diyhrt.market/meds/groups/dutasteride.html | 34 +- .../meds/groups/estradiol-droppers.html | 14 +- diyhrt.market/meds/groups/estradiol-gels.html | 98 +- .../meds/groups/estradiol-injections.html | 323 +--- .../meds/groups/estradiol-patches.html | 2 +- .../meds/groups/estradiol-pills.html | 14 +- .../meds/groups/estradiol-sprays.html | 4 +- diyhrt.market/meds/groups/finasteride.html | 22 +- diyhrt.market/meds/groups/gnrh-agonists.html | 4 +- diyhrt.market/meds/groups/minoxidil-10.html | 6 +- diyhrt.market/meds/groups/minoxidil-2.html | 14 +- diyhrt.market/meds/groups/minoxidil-5.html | 10 +- diyhrt.market/meds/groups/progesterone.html | 16 +- diyhrt.market/meds/groups/spironolactone.html | 10 +- .../astrovials-estradiol-enanthate.html | 104 +- .../astrovials-estradiol-undecylate.html | 104 +- .../astrovials-estradiol-valerate.html | 104 +- .../bicalutamide-binarex-50mg-x28.html | 104 +- .../bicalutamide-calutide-50mg-x10.html | 508 +++--- .../bicalutamide-casodex-50mg-x28.html | 102 +- .../bicalutamide-castramid-50mg-x10.html | 104 +- .../bicalutamide-procalut-50mg-x28.html | 304 ++-- .../meds/products/climara-100mcg-x4.html | 604 +++---- .../meds/products/climara-50mcg-x4.html | 604 +++---- ...il-finasteride-3-solution-morr-f-60ml.html | 306 ++-- ...-finasteride-brintop-f-solution-100ml.html | 104 +- .../cyproterone-androcur-50mg-x50.html | 304 ++-- .../products/cyproterone-procur-50mg-x50.html | 304 ++-- .../cyproterone-siterone-100mg-x50.html | 122 +- .../cyproterone-siterone-50mg-x50.html | 536 +++--- .../dutasteride-avodart-0-5mg-x30.html | 406 ++--- .../dutasteride-duprost-0-5mg-x10.html | 636 +++---- .../dutasteride-dutagen-0-5mg-x10.html | 508 +++--- .../dutasteride-dutagen-0-5mg-x30.html | 106 +- .../dutasteride-dutaheal-0-5mg-x10.html | 104 +- .../dutasteride-dutanol-0-5mg-x5.html | 104 +- .../products/dutasteride-dutas-0-5mg-x30.html | 506 +++--- .../dutasteride-dutas-0-5mg-x300.html | 106 +- .../dutasteride-veltride-0-5mg-x10.html | 408 ++--- .../products/estogel-estradiol-0-06-gel.html | 104 +- .../meds/products/estova-2mg-x84.html | 104 +- .../meds/products/estrabet-2mg-x28.html | 104 +- .../estradiol-epic-pharma-usa-2mg-x100.html | 104 +- .../meds/products/estradot-100mcg-x8.html | 404 ++--- .../meds/products/estradot-50mcg-x8.html | 404 ++--- .../meds/products/estradot-75mcg-x8.html | 102 +- .../meds/products/estraheal-2mg-x28.html | 204 +-- .../products/estreva-estradiol-0-1-gel.html | 120 +- .../meds/products/estrofem-2mg-x28.html | 508 +++--- .../products/finasteride-finalo-1mg-x10.html | 408 ++--- .../products/finasteride-finalo-1mg-x100.html | 104 +- .../products/finasteride-finast-5mg-x30.html | 608 +++---- .../products/finasteride-finast-5mg-x300.html | 104 +- .../products/finasteride-finax-1mg-x30.html | 408 ++--- .../products/finasteride-fincar-5mg-x10.html | 508 +++--- .../finasteride-finpecia-1mg-x10.html | 308 ++-- .../finasteride-finpecia-1mg-x15.html | 104 +- .../finasteride-finpecia-1mg-x150.html | 104 +- .../finasteride-healpecia-1mg-x10.html | 104 +- .../finasteride-healpecia-5mg-x10.html | 204 +-- .../finasteride-proscalpin-1mg-x100.html | 104 +- .../finasteride-proscare-5mg-x100.html | 104 +- .../finasteride-prosteride-5mg-x10.html | 104 +- .../meds/products/finasteride-ricit-x100.html | 104 +- .../fiolelabs-estradiol-enanthate.html | 1314 -------------- .../fiolelabs-estradiol-undecylate.html | 1346 -------------- .../meds/products/gynokadin-dosiergel.html | 104 +- .../minoxidil-10-solution-hair4u-10-60ml.html | 306 ++-- .../minoxidil-10-solution-tugain-10-60ml.html | 506 +++--- .../minoxidil-2-solution-hair4u-2-60ml.html | 310 ++-- .../minoxidil-2-solution-regaine-2-60ml.html | 310 ++-- .../minoxidil-5-solution-hair4u-5-60ml.html | 306 ++-- ...oxidil-5-solution-mintop-forte-5-60ml.html | 408 ++--- .../minoxidil-5-solution-regaine-5-60ml.html | 404 ++--- .../minoxidil-5-solution-tugain-5-60ml.html | 506 +++--- .../open-gate-labs-bicalutamide-x100.html | 55 +- ...s-combination-minoxidil-finasteride-5.html | 83 +- .../open-gate-labs-estradiol-cypionate.html | 55 +- .../open-gate-labs-estradiol-dropper.html | 83 +- .../open-gate-labs-estradiol-enanthate.html | 55 +- .../open-gate-labs-estradiol-spray.html | 75 +- .../open-gate-labs-estradiol-undecylate.html | 83 +- .../open-gate-labs-estradiol-valerate.html | 55 +- ...bs-progesterone-suppository-200mg-x60.html | 55 +- .../open-gate-labs-relugolix-x100.html | 55 +- ...noko-estradiol-cypionate-10ml-40mg-ml.html | 104 +- ...noko-estradiol-enanthate-10ml-40mg-ml.html | 104 +- .../otokonoko-estradiol-gel-55ml.html | 104 +- ...onoko-estradiol-valerate-10ml-40mg-ml.html | 104 +- .../panacea-pharma-estradiol-enanthate.html | 104 +- .../panacea-pharma-estradiol-undecylate.html | 104 +- .../panacea-pharma-estradiol-valerate.html | 104 +- .../progesterone-endogest-100mg-x10.html | 304 ++-- .../progesterone-endogest-200mg-x10.html | 204 +-- .../progesterone-gestheal-200mg-x10.html | 104 +- .../progesterone-microgest-100mg-x50.html | 408 ++--- .../progesterone-microgest-200mg-x50.html | 306 ++-- .../progesterone-progestan-100mg-x30.html | 206 +-- .../progesterone-progestan-200mg-x30.html | 220 +-- .../progesterone-utrogestan-100mg-x30.html | 104 +- .../products/progynova-1mg-3-pack-x72.html | 306 ++-- .../meds/products/progynova-1mg-x28.html | 306 ++-- .../products/progynova-2mg-3-pack-x72.html | 204 +-- .../meds/products/progynova-2mg-x28.html | 606 +++---- .../products/sandrena-gel-sachets-x28.html | 104 +- .../spironolactone-aldactone-100mg-x15.html | 506 +++--- .../spironolactone-aldactone-100mg-x300.html | 104 +- .../spironolactone-aldactone-25mg-x15.html | 306 ++-- .../spironolactone-aldactone-25mg-x450.html | 104 +- .../spironolactone-aldactone-50mg-x15.html | 204 +-- .../spironolactone-aldactone-50mg-x450.html | 104 +- .../spironolactone-spiractin-100mg-x100.html | 406 ++--- .../spironolactone-spiractin-25mg-x100.html | 306 ++-- .../teahrt-bicalutamide-50mg-x100.html | 102 +- .../teahrt-cyproterone-12-5mg-x100.html | 102 +- .../teahrt-estradiol-cypionate-10ml.html | 102 +- .../products/teahrt-estradiol-dropper.html | 102 +- .../teahrt-estradiol-enanthate-10ml.html | 102 +- .../meds/products/teahrt-estradiol-spray.html | 102 +- .../teahrt-estradiol-undecylate-5ml.html | 102 +- .../teahrt-estradiol-valerate-10ml.html | 102 +- ...rt-progesterone-suppository-200mg-x60.html | 102 +- ...arma-estradiol-cypionate-10ml-40mg-ml.html | 102 +- ...arma-estradiol-enanthate-10ml-40mg-ml.html | 102 +- .../vannapharma-estradiol-gel-110ml.html | 102 +- .../vannapharma-estradiol-gel-55ml.html | 102 +- ...rma-estradiol-undecylate-10ml-40mg-ml.html | 102 +- ...harma-estradiol-valerate-10ml-40mg-ml.html | 102 +- ...eleste-estradiol-enanthate-400mg-10ml.html | 104 +- ...eleste-estradiol-enanthate-500mg-10ml.html | 104 +- ...-estradiol-enanthate-in-grapeseed-oil.html | 104 +- ...leste-estradiol-undecylate-500mg-10ml.html | 104 +- ...eleste-estradiol-undecylate-500mg-5ml.html | 104 +- diyhrt.market/profile.html | 4 +- diyhrt.market/qr-codes.html | 2 +- diyhrt.market/register.html | 4 +- diyhrt.market/resources.html | 2 +- diyhrt.market/stores/4nrx-pharmacy-uk.html | 6 +- .../stores/4nrx-pharmacy-uk/reviews.html | 4 +- diyhrt.market/stores/aipctshop.html | 6 +- diyhrt.market/stores/aipctshop/reviews.html | 4 +- diyhrt.market/stores/astrovials.html | 2 +- diyhrt.market/stores/astrovials/reviews.html | 4 +- diyhrt.market/stores/dashpct.html | 6 +- diyhrt.market/stores/dashpct/reviews.html | 46 +- diyhrt.market/stores/felicitas.html | 2 +- diyhrt.market/stores/felicitas/reviews.html | 4 +- diyhrt.market/stores/fiolelabs.html | 413 ----- diyhrt.market/stores/fiolelabs/reviews.html | 1575 ----------------- diyhrt.market/stores/girlpotion.html | 2 +- diyhrt.market/stores/girlpotion/reviews.html | 4 +- diyhrt.market/stores/inhouse-pharmacy.html | 42 +- .../stores/inhouse-pharmacy/reviews.html | 4 +- diyhrt.market/stores/open-gate-labs.html | 46 +- .../stores/open-gate-labs/reviews.html | 44 +- diyhrt.market/stores/otokonoko-pharmacy.html | 10 +- .../stores/otokonoko-pharmacy/reviews.html | 4 +- diyhrt.market/stores/panacea-pharma.html | 2 +- .../stores/panacea-pharma/reviews.html | 4 +- diyhrt.market/stores/rxaisle.html | 2 +- diyhrt.market/stores/rxaisle/reviews.html | 4 +- diyhrt.market/stores/silhouette-beauty.html | 6 +- .../stores/silhouette-beauty/reviews.html | 4 +- diyhrt.market/stores/tea-hrt.html | 2 +- diyhrt.market/stores/tea-hrt/reviews.html | 4 +- .../stores/united-pharmacies-nl.html | 28 +- .../stores/united-pharmacies-nl/reviews.html | 4 +- .../stores/united-pharmacies-uk.html | 6 +- .../stores/united-pharmacies-uk/reviews.html | 4 +- .../stores/united-pharmacies-us.html | 70 +- .../stores/united-pharmacies-us/reviews.html | 45 +- diyhrt.market/stores/vanna-pharma.html | 2 +- .../stores/vanna-pharma/reviews.html | 4 +- diyhrt.market/stores/voix-celeste.html | 4 +- .../stores/voix-celeste/reviews.html | 187 +- diyhrt.market/transfem-hrt-guide.html | 2 +- 185 files changed, 13656 insertions(+), 17622 deletions(-) delete mode 100644 diyhrt.market/media/images/products/57OMhi8L.png delete mode 100644 diyhrt.market/media/images/products/yxRBcIHr.png delete mode 100644 diyhrt.market/meds/products/fiolelabs-estradiol-enanthate.html delete mode 100644 diyhrt.market/meds/products/fiolelabs-estradiol-undecylate.html delete mode 100644 diyhrt.market/stores/fiolelabs.html delete mode 100644 diyhrt.market/stores/fiolelabs/reviews.html diff --git a/diyhrt.market/about.html b/diyhrt.market/about.html index 2f6c2acf8..c9b3bd739 100644 --- a/diyhrt.market/about.html +++ b/diyhrt.market/about.html @@ -141,5 +141,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/data-privacy.html b/diyhrt.market/data-privacy.html index 1b6ce95d4..dc7662590 100644 --- a/diyhrt.market/data-privacy.html +++ b/diyhrt.market/data-privacy.html @@ -146,5 +146,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/index.html b/diyhrt.market/index.html index 5a27c5be7..10fa865fe 100644 --- a/diyhrt.market/index.html +++ b/diyhrt.market/index.html @@ -98,6 +98,11 @@
+ +
@@ -256,6 +261,84 @@
+
+

+ +

+ +
+
+
    + + + + + +
  • +
    + + + Removed + Fiolelabs + + + + + + + + 21:48 + +
    +
    • + + + + + + +
  • +
    + + + + Fiolelabs + + + Service status updated from Active to Closed + + + + + + 21:46 + +
    +
    • + + + +
+
+
+
+
@@ -899,68 +982,6 @@
- -
-
-
Fiolelabs
-

A relatively new UK-based homebrewer

-

- - Active - - - -

-
- -
-

- Ships from: United Kingdom -

-

- Ships to: UK + EU -

-

- - - - - - - - - - - - - - - - - -

-
-
- -
@@ -1424,6 +1445,237 @@
+ +
+
+ Open Gate Labs Estradiol Spray
+ Open Gate Labs + Open Gate Labs +
+ +
+ $75.00
+ $0.12 per mg +
+ +
+ Out of Stock
 + 08/06/25 22:10 +
Out of Stock +
+
+ + + +
+
+ Open Gate Labs Estradiol Undecylate
+ Open Gate Labs + Open Gate Labs +
+ +
+ $100.00
+ $0.12 per mg +
+ +
+ In Stock
 + 07/06/25 06:59 +
In Stock +
+
+ + + +
+
+ Open Gate Labs Estradiol Spray
+ Open Gate Labs + Open Gate Labs +
+ +
+ $75.00
+ $0.12 per mg +
+ +
+ In Stock
 + 07/06/25 06:59 +
In Stock +
+
+ + + +
+
+ Open Gate Labs Estradiol Dropper
+ Open Gate Labs + Open Gate Labs +
+ +
+ $95.00
+ $0.16 per mg +
+ +
+ In Stock
 + 07/06/25 06:59 +
In Stock +
+
+ + + +
+
+ Open Gate Labs Combination Minoxidil/Finasteride 5%
+ Open Gate Labs + Open Gate Labs +
+ +
+ $35.00
+ $0.01 per mg +
+ +
+ In Stock
 + 07/06/25 06:59 +
In Stock +
+
+ + + +
+
+ Cyproterone (Siterone) 100mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $105.00
+ $2.10 per pill +
+ +
+ Out of Stock
 + 07/06/25 06:57 +
Out of Stock +
+
+ + + +
+
+ Dutasteride (Duprost) 0.5mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $15.80
+ $1.58 per pill +
+ +
+ In Stock
 + 05/06/25 03:31 +
In Stock +
+
+ + + +
+
+ Estreva (Estradiol 0.1%) Gel
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $43.50
+ $0.87 per mg +
+ +
+ Out of Stock
 + 03/06/25 22:48 +
Out of Stock +
+
+ + + +
+
+ Cyproterone (Siterone) 50mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $48.00
+ $0.96 per pill +
+ +
+ In Stock
 + 03/06/25 21:11 +
In Stock +
+
+ + + +
+
+ Cyproterone (Siterone) 100mg
+ Inhouse Pharmacy + Inhouse Pharmacy +
+ +
+ $52.50
+ $1.05 per pill +
+ +
+ In Stock
 + 03/06/25 21:11 +
In Stock +
+
+ + + +
+
+ Progesterone (Progestan) 200mg
+ Silhouette Beauty + Silhouette Beauty +
+ +
+ €35.00
+ €1.17 per pill +
+ +
+ In Stock
 + 03/06/25 18:47 +
In Stock +
+
+ +
@@ -1508,237 +1760,6 @@
- -
-
- Minoxidil 2% Solution (Hair4U 2%) 60mL
- United Pharmacies UK - United Pharmacies UK -
- -
- £9.90
- £0.01 per mg -
- -
- Out of Stock
 - 30/05/25 02:40 -
Out of Stock -
-
- - - -
-
- Minoxidil 2% Solution (Hair4U 2%) 60mL
- 4NRX Pharmacy UK - 4NRX Pharmacy UK -
- -
- £9.90
- £0.01 per mg -
- -
- Out of Stock
 - 30/05/25 02:40 -
Out of Stock -
-
- - - -
-
- Bicalutamide (Binarex) 50mg
- Inhouse Pharmacy - Inhouse Pharmacy -
- -
- $47.60
- $1.70 per pill -
- -
- Out of Stock
 - 29/05/25 17:15 -
Out of Stock -
-
- - - -
-
- Open Gate Labs Relugolix
- Open Gate Labs - Open Gate Labs -
- -
- $125.00
- $1.25 per pill -
- -
- Out of Stock
 - 29/05/25 09:32 -
Out of Stock -
-
- - - -
-
- Open Gate Labs Relugolix
- Open Gate Labs - Open Gate Labs -
- -
- $125.00
- $1.25 per pill -
- -
- In Stock
 - 29/05/25 07:47 -
In Stock -
-
- - - -
-
- Open Gate Labs Relugolix
- Open Gate Labs - Open Gate Labs -
- -
- $125.00
- $1.25 per pill -
- -
- Out of Stock
 - 29/05/25 03:47 -
Out of Stock -
-
- - - -
-
- Spironolactone (Spiractin) 25mg
- Inhouse Pharmacy - Inhouse Pharmacy -
- -
- $18.00
- $0.18 per pill -
- -
- In Stock
 - 29/05/25 00:59 -
In Stock -
-
- - - -
-
- Open Gate Labs Relugolix
- Open Gate Labs - Open Gate Labs -
- -
- $125.00
- $1.25 per pill -
- -
- In Stock
 - 28/05/25 16:05 -
In Stock -
-
- - - -
-
- Otokonoko Estradiol Cypionate
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $85.00
- $0.21 per mg -
- -
- Out of Stock
 - 28/05/25 11:04 -
Out of Stock -
-
- - - -
-
- Otokonoko Estradiol Cypionate
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $85.00
- $0.21 per mg -
- -
- In Stock
 - 28/05/25 08:43 -
In Stock -
-
- - - -
-
- Otokonoko Estradiol Cypionate
- Otokonoko Pharmacy - Otokonoko Pharmacy -
- -
- $85.00
- $0.21 per mg -
- -
- Out of Stock
 - 28/05/25 02:43 -
Out of Stock -
-
- -
@@ -1783,5 +1804,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/login.html b/diyhrt.market/login.html index 58f303026..1bb364dc7 100644 --- a/diyhrt.market/login.html +++ b/diyhrt.market/login.html @@ -95,7 +95,7 @@
- +
@@ -142,5 +142,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/media/images/products/57OMhi8L.png b/diyhrt.market/media/images/products/57OMhi8L.png deleted file mode 100644 index ec9e0d9b59374dbe7f2e4941354ad4af8eeb552a..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 52299 zcmV*9Kybf_P)004&% z004{+008|`004nN004b?008NW002DY000@xb3BE200034X+uL$Nkc;*P;zf(X>4Tx z04UF6U|^D900Jff28P_clA<7YCxwW}Cf`zJpiUm;Y z<+b;UVsD6o3JTa2lwv^;73oEK?;S!2A-zv;cgp|yu6@_c%@Fi`f94|mKd#BnId`Ak z*R$7JyPSROzw}?)Qj{rNpZ9d++rOSED=)LHw%W=ztly9s9vRM-m6caiRFsbl4G#7H z=Et8NDg^!iB^`P6hcc?HWilD7tgNv9fgUR>E3-eG`;(DEkpI$u>A&<}`Y-*L{!9O* z|I&Zyzw}@FFa4MPOaG<+(tqjy7xW*Sv^@Gf$CGzWCX=boShib5DIXXZC>M2IaOQE( zIsy5Kubh*aI(2I0J@?#`85tQFmdpR?*Pr{3PTaljEuYC$RAyUMp?cN9@*>q|U0Ej6 zUzsVlY__7RtgO8M_h)_QS$*J^5N?Cdj+f5A;gmK;p)c;8pIuP84+ zq@k&~wJg`v)YaKl-`m$Wp{H+Xdu2ac4OliZQZ`~EmdRCDt3a9Fme$ra;zw6cPtVBk z@UWM$wzgJG$yVg^1JfHD8*A6BUSqX&wZrxG^}RhkooiYrwA@=!QSs!EB5d5SVfygU z(5%W_?x%x8BUf~Fb+s#>q3Y_Ymj1rJZI$J&{r&wD1;k#3o3G?2t1L@Yhz>p5SXEWA zdLTd0t)#N~{9tW)S$RWeXZw^{)2FmP{q)nhsZ*!4tX#1+H#|Jjq%u|2)m2YizhP~Y z%3d)vG-xV=sm?>HQ}^(IN-#29rDr`#zbji=xw@vNc4bvnRmb4qptZEL;3}S8^3)FN z)~%bnV4H157C-gW5Zz?*`9{09F(3$||$j=7z?G-sQ{I zWJiX}Muvt)mW|kO*GQ(X!>sIy{NV5{72jbH|K^MufM*lt9!<~|L0xy=SwfQ70cIIe!y(FOu#8qi16%BTIn~{Ra-+-&bm4~th+O#GGwhuv4fK1R2j$nDA5k9Vsz;aFq(=1{QGTiJUT^YO8w?0w>SQ+1 zFR%>`sBXgsAP4(;MyhKoGCe(QYQtgc?rFEGYFl@}0WVu!l^I-g(^Z!q^Xt>UrVRgm zDjAsG{r=-?dIm>s?HRV6BmwN*?|GNq@zA5z+C0T>z2$COyRlo1AfPx22v+WQfQ0Z~ zGF=c^k_^re0YMFjugl>YE= zpFi{RseqKJsi{f8>sRhHBGYn?|oDXp;nDup+*{3133)5 z$01!<&~-os>9(?}(wRj_dSnp2k_L21rEnuACYzoUy-+)zZ@>Na*3;8vy}iBG+tX_s zHgu`MD;11L0;?%c{*+8tf2Y0b)d$q=na+w=vqtW6S*I+P1Yly_ht?^4sHlYk|)@6U6&oNTXZtIn3oFRL~kvT4mj z)=*n#Pb^$5sjrUJyTR%!2H*FtBX<9lH`KpLg+9FHX{TKeC?6cke5|aZP94A2GL?0< zdR4o1v~@cZ=^?12VTt;@z@cV!#tf=)`v>z9=R@k@Qh9~zfc$#<`>aO>YQNOLKwjb0 zqx<{wu3`rAg9s6S(L8+gfe%%iVaAq4ewu!Oj*48&*17dJL`6+Dw zh~kL7{Ud{lGhnl~o^N;D{h$qJ>-2lrD(mVkQzeF}q_VD6R;fLcY7`JhlpX-eNYV@e zZX}+rLsYQ5O81o#zLi#%tF(reX59lWbpTxfYU{*FCi};>nY)!up4edRU7faO-9~Gf z&}{R!nP6+zblQyRGZCzkRwFiPO06~2R9S0_RBC;VO_?~sGHS<(t@Tzf+tQ_^@@~+x zib}QLP`C1^weG$VYisYdnOjY=uJ$gQK6AF+a_ik^-gf059(AVun^ZC|?Y8GZ3wrwo z-)GtCOi$mSGZb4Il|(PnNJq}Bxv9}=>l;i)x%(sbL-Nq`Pz{K7>?E$JC9Zh^Wl#Vj zEDk%1o(bss)LZic7OIe*tBbXFbV@2zic!6KK4`rH$gsrFpdJE7(vXSa*M3RS%BmV$ zxq6)>ON9U|NnG%-J@ zSIirfM8OZ+1r?F(q2y3gam7I+X^^*xzdQLM$pBme-&p((0eVmps2?E84ne(Y6ojFw z=P5qvj$of;tF5g~Mz6AA^aRNJ)U&(0Fsdby0DVD{s?=yo%gctM?B!Bx5MYYDD`gWQ z!0^)u(1!B;He<##H@s)f+DeisW0PbCJaFGbHf8z@Yi(^6u-dJw138%0h_B9`UcS-F zq_!3>U7_-nNpe1HOIK--Fi>Srtyn9NXJm_ZTDGR%I=XuWc1ghUT1ig8t`60S!O!5K z$0oNl*s7H)k#N^uasE#q@B;svlxn?&sVrN$V7S8GURkH!y=JWqs0$B?Np5VaVPSF@ z+8VZNbk`^GGhpRXG3w;WNQ5n71Y!l)s98Kb%n6W;cW$IBe7U0H%J36N%Sc0RSS^}Y zuN(x}D$}rEm7bmr0A?XaC6jc~aAzYx!Y~K0<<{RfWF74tUL^7dL>j*N+S8S7vi!sFY=Sro zO5_BjtW>xJ zs3*~&G;XLf?x6~yC99GEq%!q()SqG?e&A%XaRV%J&?W#X^7n88M+JsFyjDtX;JQ<3 z^c-*rr7Dxs(BB|wNo>%ARXBBqtR$&WgeXz(E)yuqu!%em;!;l3G|#vyt{7S_@S)0w zRA1pHNnA;uC|{Y<>+S8cDO09ecW++CbgxR0m1>e&Rypr`e2JCSHQM48vX>NQ)rMYM zu|cX!h$yRRvTo_Gywt0VFI)8VT5Ibrv-JwoE!72pJ9_&3+9!37y6#b4*phkKjk4|K zKV)6<>yheTzP4SGOrycRp^09hEkGp!Q?{~V2)#TsBzr?cZJ17PhPa|OxQ3Kr6vGvp zhoO7;L&1o|$n=|@9(7a$uH7`O&tH%Cz}rW;1fBj(3_lp`Dz<-lGG|Hv1L{6iWs zuS6K?7;%~9&i9Ylx^-OwVznetm#e9+0Wn?DVnb)Y-TA;mTielN_dmAC7A;$4YukHl z+3JnfA&K(D(sd?{Wlt_&XKNL9gCx>AMv5Gz@R<|QOV-Q4{*fqc%BGm59&9zRNkMB zIwXtaUYhGkaUq^XnnCWTKU8N%;geGw<>P(|Q>LFu6()cbgO&Jk9dojgWXKOmU6z+? zm@a8VvGJ$;FcKP&G|6T$wyVTUjTFV$cB#v{28|A-A~Eh63D(rNNOA}OvJVD^$}J~J z)X+T1YU-L~jbNjjg-w+T77+^Y_lrMDlcJ1F101~ zpiRnUKOjl5w=!1YX|#2=?|t|&U)dr!C<&M<%d1+ud-^KUFuBs%UV$zv5ETpQ1V!Vg zo;wx}O8kVGN=3{bVtnB`mC$F&1b(U7wWdG zEIV3m@32y)bV8mpbKajBwCaYMhTh(u)KLE>l>|)X6=jnL^Z5+D03a|MoPaXM-01ny z`)Pb^si=4mjSo{JPD&@Gfg?N=*YG2)pyF^rf}>wOeVjlg;o`(-3nE|Ap==>(f{0I1 z%GBFo5VOjT#G-VGhoj^4^z`~P1+(9z#iSxqir+&5@$%)%T_r&*^s@ZIOgC$HlzsK; zRlYt+nHU*1H8y$tNFP7atgovpv^OcGwk&RE(tx4wq{ znEGH6tMpQ?R5}_tz!Lz0s3D>Q^NObx`0x`PQn!aH~flbA_zNUI1Reo*99 zoF{jo=Exg$Kzz~!6xec1oB)%mY?W16>`0#l?-5{FU#t*d znYs3Qr~pk(4PIWahd{~iA*uK3>M92xAYxuhQpB%=l0fzKb&_C!C@rUuRKBlO`0^x>gsdW*i>V+b(J!lyRE)jAY~?9rJX)~s<$7i zG+U|mlW^raT6Pt!tgK3%g(jA|%PT+Hxw4_Jv%f5f#D9}Y0;blMmU2`Dc1lJKM{kqr zQ)S9WRmUhJ#7ypS#G!#9egnRA9Rp=h#7XxljbbW(p1{NJlnzw>!=?ODXE2&{P*25aB1s5?AJ1^aXAW-Fs#R(evyB@!dRU%8 z#9`EiN*oX{moH!GaiWd5@;k~4gRGJDW5bB5iqk)5p8wT%qR(u~+{F??$YA~e{V2&_e4jQ?LisMtJ z_ziFpyOf^l#yk`tCCx|!+lNj8!&xrjcXxNU>MFxpc1?hld%_Wq-}nPWrW07`G}Kl~l}`2m z|0b0LOzYOKaf(CNTUZ4pI<}ZNA?D@ zt0P6Kl&Ooz2LeQZr$NA2*S^uJ8|$q?whtYMbO8*D$yIeVuJ&qW`yg?Mhcv>z#3-lC zEQ9oG$cSoeYF0YgjJ0=2N>x?Zr0G+vUn;AvQRP)iWz<2}0Y<4=ft$fW0Z|)rf&Oaj1sujA2CWaxB^}^%7{;zDRDGUtO@1(M z3zw96{>#&!FdyIP)z5yk9M_bTLNIRcEr9E{&I5?z%W5-%A z@V`kV0aJB#u2H2|MPNR*4wc~wbJEpo=8hupJPlRZ2p7OfKukk(9QQOvx=#!xYyc+i z!_k1Fy|QqRR7lUp{Ja#p$5j{9P)Z{)HPR+L_s*CC1&HvAa^gs1^{Umb$^Z|loxHgs zfdCQ!iF9$OF~S2ZBvqA0YJdxHBeB}s+CAMEz>p3^SnA;_PZ0E#1Ob%tb0ux=2?LPu zqto;&UQc(=pwiwVIM^aX!tr$QD_*x;kQpi)8JMd+aJ`N6Nhjy4k^xM`k^(~_jHsfO z6;)Qro*#j3Sn8uJtKOVduaa64?-U*bRjQ-{>4AD-{sfgJX~(^IOPZ)lMo-D1#^l2W zI3+@UTq|p8t(V3IL=z(2@uIY)|Xs*2#`a}JnK2XS>EtDE&fPS z5!2jJn$to~F;B%X-2nv{)XK!?zOlL0y8Bq5W%(u}ASJ1Xs_E`aYLY}4NU+cgWw4|8 zt#D*XIfw&sj})kqI?80zXsb>(lG;PvP4*jePL<`>-P7rkYVF#M8u~YT9oRxVeM*zm z*&3H_lO}Ja=WCT_x%Du$Pyn#Hq|#0ET8#b6R5vC(k?b{P`JrrW?)+R`?w;K6U}tr< z;_14Y+&x{ZpKN*Xj+@q8c=Vq`K3 z0DxdfVjGZk>mj0gFh3*_u3jav4x`yM8EOS_uXa>?8Sm=-eR)9*W&*yEtN@l6r(_*K z2{ha#>Ss%Vt5kt*NI+BCguzcR)jcdi)+H6!+|ptz+d4dtP<5mS1Itt&mq?_qf7mWO z_lL#zlIpQO4aaG8@^E{oASu|tgnV-5C_UoH+VRoX)TvV)#FUR^4D1@p z$y+X&Dy37Ia~r0jvcl?`8Z_#w^Kv6a01}`FPYl!ZD#zprEmq}k&0yG9D($@L)n)5s zMCWR%y(6%-W#fAGrVn`DeN4!TC@!Jw>%GU$WJ#nUj4cTn)uM2|$907>+Zh zPxo2gjty&U>C&a%kh~Q_SQaG#5K;^VcXoEG;K@km)gy-T7^yImFi0;PmIKW7xh(Z^ zR|x_xwiZ(o0Hv#|R}61(=C`&?@ExH5gEYJQdtJTx0 zPMBaTSFKfEX-f}ZGVP6j7{3ww&jgOEh2hvqdR(Y=5|I)uX! zpY%q7q_9JS$w20JId8Wxf|0GkC`lHHH$K@64hWjMM-Q;O5_?EVp-bH^@n`J11e40A zTwvi7J;+^9+qF7>Ls=m3-{BO@Cr$bD6XBy6r)^%zqA6*iFX_4ns^Z*F8@#AmW8 zYeg=vbSebEocwzQjuES8LXvVwJ)#cDlQJb+OruA24)&L0Be9KvjfR!%(hz7-^D5od zLqo&Itz5DG!L4UaN>k`1ppt{>3&(x+K!NG1`sOBen>5QCjgItzXl#CakCXMmeXO8E z017bS514dOn;~Tq=y=9Gjm&exb1z}zM7(k_wnCDCJnL#3B;BMo>uP;g7=WRE+dDdx zyGB|HM|!-Dm6uvXG7cjJ0cL_|!hpP(^lS+G&q=n|h(@ZaLyzjd zcJ)T9P-NPB{rU|WVo*m|jlBLR!E? z>=`!I^PBs=o^Bs9)97hZGfA5fF%`)L^9KQ6!A=28ewCx4u_drQV0uqChI<;qV<|zD zfuMc8{caa^Nis4mkZc;37%HWvD#ct$#0u#PF&uDWI5VG3i|sHHX@umU=R>TdV{m%I3UGrmU;!W_CwG8M&j1tz zaClXl9gTpAks$fNBf$xeFPIQwoxq;*mf#gf{Mc!Kn1gs1fwC+3^jEu-WsZx3s0!$TZazsXTmER8y5BS@#4Ek$x zS*xk7)~E@PRa#4HqpvR#rn$L+#ZqgT&?F{SOKKt6%537K7LBGdHe*VwO=zleLbpCkfmHt*nRZfUS;0R-1CL%FkaqczIjDXSP# z9U26zDyx+(Rjc^w7KL6bAh^OE2P8RUE6tOB@m!bmpW025J3nj#8uoYe4A@fw&${-0 z8yL~3vQwr)w%YfJGe;*a=ljmt2bCmbVQENeyQ`vF9s6Ruw>8DO$seItIe3q?U(CT zJ8kS9unnDglQ|@Vzd^QMztp%K@3zynN+hfL@@}96lG<7-t}wV5l-WRjym8#8j!`Nq zDVW6M#Yz3BFBa??#BLbP*hfqautb1gh-I!05;Z`81+g8HD1a9BS23{Cj?UzuxF`Ma z^YRqjroYq3kFYQx%Fge8F%CbBa2SJqN0|T|>8@F`#yWTfJp+KUGVs|^nXw)X)w|h3 zBG~w!(n~NJBmDiUOP`vlS77Mu8?x1HJ+`)^*V=mr{k8T4?snfF&V9E4m8MoGM_Ry5 z?Sie8+L-pCyeW@NzwQ$wN;i;@X&_y=e> z^Jx8sjY&$#k1O?I%WYR@+IPfTzB$=^NTu4EI^$iq#ZRtO2kDSB>9P)`(<{l_r}(_q zM45Q$b3g#YAuU*V-XM_h@?@VROSe>7_W%cKD4ZlEF01;J2YDf_m4w$Bz*Aj1A@#{i z@_0RIf0Z@bya4>p>n{6idRPJ~DVQ`$+LsMls%B!ah>FG4d%PG!g(0q}6Rs{z)UcIV zskMS*L{(X-YdPy%0IS;Xt14?14{23r6;graIbMyH3X(CMk?Lbo5yu8I-`obUly~Hr z@mG;luF*y1R7Tz_L(Sx2C?FbSbD7kj9&>QT+BF-!93Ac5R#)3(U0nj8;?}pcSdVO$ zPDu`FD1l_y*0y(AyXxA(s7n&8Q)zTadUOgf-Gh>z)%7-zskAPs*G{Q43~Ll{UZRS< z+8ymI5lI>;4@?9APlroeab!>Bdwi!s+Uw5Cma?V9-H^t--qhQZuYAR8-kKV_1XNnd zG&Hn^UKC(~=s`4u5Aj_JB(>&}LeF7jfQfZ5m|mO)e)KZLIoEJ*SLsU6jc3F|{c(kg z)m#v>%H&P@i8)Di5*9Vgk`M7wFZ@Quv~6s2e}0QiE-`rS@s!Tmwd)k0X@n7LZ|fEF z8EPOIQEnjX!;GxFKU zdvt~NAs%6h+noAQuFlTR8r6O5!4{^Hf=LCx1K_|68UnFf@b?M=ln}`f1|xnEhkJm* z7FI-hfCC^x^(?@ukw_bH&rvnp2apnYlHC<5f!~A)B9ACfVpNirDgU(GgCB7K5NnEV z)aE4_`V;tgeF-(WX3bh_liEu_?3HB2*k_0i|FV)~9DE^zopU;d%KbTj!T~sbQ$7yX zpjq;gV${91rpnsdc#EY>086v)OsaYwDr4I5S?T4Zy`oMy5~9OkMogbJ?WQX)`rQlD zW)ee&kwgsfQ4eL6GNxItD)bG2z}u>bbIzoZ=^{-d12(JCp8VP8R900ZRh3hG)Rsnu zdS2VqYPF3mR*|c*tZb(G)@Cc0N~@}sbgHfQI74FMNI7b*TCT>*r2?(I&d<`6PEo$e zP#)H(2Lfn=vSGUV^L}DTkL(tQY!{z_IlJn+$Lb%~{B`Yyv#M zq~7eDL=ACb9a9QTO?3*-iFJU-ToM7wG_#&0BoeD%(uz}80Fu9TnROT`P5J!h39m?zzn@ka?VOb??X{@`@D_bHeDVS<&YaiXPVMD(g*J2jE z7)KpL3M8p8>^;sOh%l(#@Kys79!B$s9vLDWMq`-!d6W9>l0{*YBuXzhvRE4N+4;y) ziZ7EC@*!{H#+5RVZ^R)D0D)=?2}u}K2`@uVnKD`T{k{;3UweC-t8Jc<38O4Vc-`H7 zwr1@HTfcszt3=`;RTAjfv(;-Gr8;R3R43;v0I;5(Zq+eO%!VItuHc8EO*||<(jhLA zAAjoOri8+$bb44e8hZNaC3mHomxf9TCiSKVRH>WUHZrK5O0S~F7BdhBKxi;}wKKlp zAA}#wBn~|k`-rgoW(Onp_{9V#j_^p8NSBc!Ai7Yn+Sh4>McG`Z(> zZ0{7h@9FN5f1N%3^ilyujOyxkZ~)|W>()DS86g6sxU%5O;w|yp+Pi%Iis3z*0*S{u zAL#%#9QEOMN*jQsEi;`OMRLj>G2(tE*MH6-yEVKrn5A6ktyi2TE}8=!k&9T4P3fyied7(de(gx7!-(Gy)ZXS1es- zS;eL9Ln=4Vm}T$j>a+n#85X&RCE11*Z{zxP>Hw;h0G@XhoiNi6@L(-GO z%*YS&HjqYhOl4rpX<#Eq+HD)x`F7wHE0@ViD9HkGNS89E9*<;_ zF)J|l5B5t9W_91~b7hFG!9%;8}xBDTb+LSh`mk!4c ziH#dK{^9D&E?(@6DFM+*N=~Pr_VX7#wQR-p*~+SHNE%d0%v?kG0UR7XKhzxz#!Z!p@vPn+#=VMvz%0dTh2 zW*e!or$@_28obxW6o5=)8yv~|GY0*P!Wc<%_BMHw7P~E3kz*7|JqR0}148m)TvKnr zOS#A+$_D`4yz@?wMx>-o7>GD=AN3|Kb{=7A55iMVwj-F@gWA-Kd8?O3@hv7Q2h4z+ zVM-e#A5agCC=HdDvU}1ZjQcbPM1AzTjOmC3X39l?H$&)c@hL8#A0&l#A0 z`ecso<{F!zBu*CG7feAY4 z#8Vojeoj(PJXDpPsRs5h89_7(4H%8aeGvD!XgnxD0r8AD;UX=-M0e*t{32fXDQ8K$ z3C;w!vod3&%}D>*h;R_$BJUuN>&r9AkGyaJ9H=<`;{3Q$J^(^k;zb<4BGq)EJqXKE zlG<`eo#j%2|5v)d_PfV_DZSnB98xObb4;K3_-AS5gVivvR?pl`5^8U`3aPjZJvd2- zL?bGp*d)~;se*b^10rFfCpu_E_;Vj1afTFLo8k{1V03kk8~RZE0HhrOv`5!eX}(&H*AfT2Y=W9^sfK@WF*f zqoMYROnARnm|Sf&?X+CwzqX^j`+jwVzbci-fB5}xMT*ZkrP}`o>Es`rmJv8+uUfTg zk^pjq?4ZxdD0M@9q$1fh-mBHn47(vDNc38W2Ie=t9wK}IA_xN<-a*oQ3Y(-Gwp(9+ zmoJm>$`#CW<5xfe*yIro!hcheza&uP72zm9+kyKvYJ(^r<$}hiN9Q1Zq)q)O2YbJI zy7|t_29HlTp4HW}TcT=EZMN$l&-u+m9_e{NsYcHe`r{w|oVo0>%kJ56#~pXUC~cWC z$?m=PUT6Bm<`(N{Yqzbp-r5^>*|KFWNt|f{PB0&aVe2p=!{Ej7T+orENcIWeZsDaz z!Z4fM)7xPS7A)}J9IlmK3{7eYyDpd?QX-h27%m%bAgLwF0<*d2nnyax0ZyJpSt$c9 z^5CBINt66A{sA{jD@;-Xrs>nCd%myRk-uJ$b z+%a$7{5_e2Y3u5=4I4K)c$n&|P{TVz)aa8ZPqs!iIzw-c>4O2N27s_$jlXQ^GP~oB zJJK7m{AHwG$_k^oyco$A76A#h)6v;xGq>8x8NKj{g+9b*v=wjv2AEJov6#&03cxUG zWC{Qv0|x!`D`oN5B6MZc1-S|z%zOGQ_0ah2v+@z4%0W0@H77oK^U@`AXXH0~_H54| zFx4>$Dj{~)U3X8v;E!jo@Wh`7^t=Mo`4?VR{*P;~T{vULj5$aN=8*suy&s}cVIZTK z;Y?c52WW(4GLv4;ybVlaz6Cpo=>y_qu|rhd!f3}GQwB^E02F?6g}9Ozk^qWl#g4oZ zc+#lO(<@wgj?|J8H4f^)-<|wJ@sd7ekF@yhX;lg2l1}{AqXbsn%$h#KhVz5g-P2X!`=wO55~e!T*@mk7#9o5^^2=El2s0 zs?>#(=C~hwUX%Qhz=ibqO<4gg?)gN|H!zipN%g@L8V$AO43OlZA;TX(7zG7GAsQG- z70eFXggCfhdc^T~0tX|d@E?1g!m?Yz!BMy-SM9%f$&#H5&U}F&zysjI{^2+NNKbYc zaHI|(A};Z$7tc7LgLDH-{I0L7_cBDj+{Y(DqW;epdfwSgZ+hGNZrW|P-S&f-E7z_u zzGDm3sFz~L02D@bd}t^3WTWzETpBuz+yE3{a&-l`0FEdOUWjeNynxAbSx5SvCQ^L{ zUg_XZK1m{_@JKXNmXj`|<>1q^I6{Z;G5gK4>bhEbONvs6%33AqR0*_U=(D|eG!2!3 zMR8O!uYfV&;J%_fV{IE&VG~Zj@{+&)*JgS)dev*+bkXj+@BV6EnCxu#w`D_h!4w*E z2%}VBg0L?JE!ic-BQG3`bU=u>$2pT680k4_7sq4P+DB*tWrU6J#qn^FCm`mY@^L?! zRv|7lBna|_Po7f;wuTUfEi^-YX=@H)*)z{u#*k9-dLmId8w%cx- ze#13a{1;5mMn}H!ofm23^6Gi>=2>TNw=H_|Nf+-lD2#&%ye3|$-V9TCQ-nh)U`&7x z#=vZti=E_>Nfcnh1t7SOXRZn>s`V>LnurIJBRuz%gLDCEs89Su;zgPfpWlFq6Xqf; zX}H=_KD^(@UMha`jXs`xJQ?3>SFiCU9pdpy7%EUvEHm6^k3II-^vf=K{utoTJ1`yd z*7shdVgIXVX(-G#-^U+++*j}S+;dO6`|i8#WiNY~Yz7UHd(x_TLu0))Hr4y|0IC2G zz+@J9FS_XO4!8saw#qWsBzuEBN&c#Mnh1n>+(V=dVMC$)kWwLe0wla-sgOP+&*C$A zCJ-S-#ztsaf14&fm%`PsUuh^NBCMah?RkT`6s!4HF+Ye+!C zw=_1{#`PQ0)Q7;--`&Y%=JY?Fch2($OsNH)M|9x9hrLCOyA7MuP+^FEhWUU6dw~&5 zb&fNVh6-THF&peN#4sb6#oE|I4?W~+F#&;X9lV3jNw(zz-9+1JtE~jer+nnZXbRx@ z5y=7~(+Zs(Y&1*TUc>PmsmJ+Bu_YFU6CO1bYkd5!s7No50t_ZGv8DkChjy^Xi0hm= zbG+=RF#tyWr~@9bS@jRgC9hhG6@>jokps#4BqQM|%j5~IR#&6pywa!@$Q$eHtde*FF9&Djl-8t{RvFc5 zc)1~sR3|n!D_o6D6S&cyRT=?KQpahkZ;%@7mg;V@NfTSFsjlZyAv_X|&r_)L7gS!_GZptp1%4yJkQ7L@P3{mupEi2Io(J^21JlVT|M2e;<*!;O!y860>&u~{ zHEPgCNuk-ZX8Al5Bb^pkeH-k$Yj1D^768C(t}v~#w%X^RNQaZtkOs`_pniBOB!E*4 z6o}tp1Hp6{%`?D2TG&f`f5pKh05Cm~_N1#^BZN=K7-C?PK7#`Q0>Jpd4kyO(f2Z}%yk%FQPJQw7*dHr13S#>Tt|1GZL{rmz8xbmMs|jJ{6h~uU;`Q@(ZfS6!C>Od z-+m{lxB;JD=-AjM+o;dB-+p^niHjF6_OQH3!U=Gs2?5}cZ~!Y@QfItzlD46cANR4Y zMtNLnWpi%dVchSw>mCl?E3drT!?Vpr7n?J8mhwn%=RWboB3u0AQcs7xXU(4G(vXfp zJ3y3;Lqvn5Y0Hd!ei7L@{^03poa^b!tIWi*&$dxxq^ z99J!p7+iV9h?7GAV1NY2J(7vC@Ege$R|ky9~7;%v|ucM>pxZkk8!?sli*m>t2 z?ZF2hQv5QFA}7fnnj!mY&{nQoX)BhmlpWNqdu+tefDD?ESo-K<|&O$wI9z_i%BCeIn6lJSP=Ie z8o~9b$FuX23B6tciWeZ81u9;4BrJ1IfP@WY^m@)Kz~J_Yz>V!1Jr$NL3c#U<4i|PiagM&^$3Gfdq4C;E}SVejpljJi$C((`LSha4}JcTA=Z9 zG&t#HDyn?q6JwZ{Dq&*mrzUOG1~>x^RgOZl^0$w0!&t(Kmu*jGYjM( zp|N8GCWgTzY#W#XSm>!ph1!ND-*Cp)BWZ9L>#9WrGl>gmAbFl)=-->BdayMXMJw&+_|m}IjEvhqphZ< zW)F)50|>kBwwv2s*f9VEfARoe*dZ9djG$O9%SNSt1ai058!CNSDM=6(a$y#X4OIykkYpikQX0u%2PEW+ zI*YQCPSgP@0b}vQ;m4INGn5TUf_2B16w(a9ge&$7qD=Tl8L9=y@~U*K5K@#Ypd}8+ z7pW64q4~LEk3II}LK4pjJ!fG0@sEEzO%?r%q{d#=73?k?Tc(IB4%^__36P8xIyEq( ztaSC?Fs#tr39AdU*S;bz#)Mjf@%)BD<>C){`l0|4We1QEkLMAG z`(aLS)0J?EI8*JG!-5zsVDcx@gg&zI*S!>xdto zdfHVU@j0O9M9rOi^2rt5ZELTYI8p;a zGjG<66tIJTF_4Ip%8@AUi?0q$m4iu74FRN~aO7JF+E_qlBRuCeNx>BgzxWN|7p|E6H^Jlr zXyfA+-;by9>2V?pXD~6@S)Qx&O?o8W?_YT^msSFPog~%)vLCOw_10V4Qq0m($-(rs zuYK(hRqX6+Ma5mJ{0gqR+Q&;ZeXQBX20XYRAIdckLP~uhc z@HE_sah@pmVV8_OgIU;BT=`9!ai7vj%QdJyo&~6iff3hGb0Mi9uDD`QM4a)2f8@=z z_&(C(cT#~Gh345OmFBQoo13Ki#!lQ*oGBVC>^g1QwBNEEQ%c$t?pv5nKjnKeg7WX3 z*xFQ8QJ$%*tg33R%w`)ZDzdfZWdan9L}P_Ia_FSqTHMUo8V-&CiGIT@cj(39-*V3g zlYWl+kESE?ycj*gEKFn43xBSKd!EBQR2|ny$HU2a9R4e0#&(zDXAt)e1_hz+<0<7= zNUIPp>Jau9{s5XKn@WvbIa{+z#Tn}Fv4NfrPOuy4?(Q1s?(W{$*Vp^BY^wZ(2@_t@ z+}ymsCs0Bvsbt!BpS_NpG;zY0E3*~657#N_R9l&?Y%0%I4|aD|&7etNq^siZn3t^BAVskHQ^hqSLeMP0CY9 z?-?Y|NX4&(-=h!k2S9~3ap~=j-((>>Y={$u5 zLAAbI(~XBqUWIGHB`UfbyB+oQJPPEoM^qj$9+#fryScygJURV&-edlW#(u}$=x@Ro z;>556~T#wr1o1Wc!%dTMp9I=2rD ziWy~99Q7u=6aWNh;_3}ka4wa&Pi)amfeHL9{7&o``yJusoEZhjZ+Fft@=4c7-^0)Z z9!|GKH16kSDWx1P{rR0P{;QBja`H?6x!dGffJ0XYk&o2)R&dVv&fF-F0!)QAOzE(D zA?>+}$yD}1B|r^Tu(k*f7>(v~)syP$>ZhoXB_Wk)%aaQK8a2p7Y?ByDs{v#WCJ_zu zQ$x_OV?b~h%q=j(ulgH(E;ky!h+&?l$1TLiU%%bO?@e3^JNit2$tdS%N_#wQ-e)Xq zN-F)1e0UW1qpko1&wmpjA;AS4fywPj+D-mGIB^gafTZvtogyy?Kn0K-OhZFuciet^ z#&>FFtE{}NDm!)R%&k0d35e2caq8>qn_FF-quC0LAt#YDT6u2(?hDLxrgKe=;^eo4 z(@o*to&QcQ#T~mJ@AO~6rF=Y3m4)B7omTV}Da5uy=xvE@-*Xw!11r;b>>{^Jh#i=A^b@;g}22lc8v2+@B z3d`Br7^*%3mCrLA|Bcev51&EuB>1mzmGe9cAQ}adR8`nLW3FHiRiM_&3+WU&ei!GB zw>(DMtk`(aFatS@5O{F1*t{1JPG~NkVd>8&ni3j60xZ{ z0z5D*D$U6x!Nfwt5V*MgAXeN*8#kPOj{&vtyWltKU*y8yorlMpXNBlN#rH*}QSnB9 zrBaGEi8q!$_u-v%%RIWwrJgQsxBO#w*E=z1eXJ9%5tIN=K9x~1^j z8=fZAHN5dFxO5r&?asp%|Ayk4C}kgi<9<8i5{+IxE!`B{c=Z=~MOhMHxGy|&O67%8 zJEXk0ru)5E_dVy6l}!k4qlDy!Y8 z2YQWRgI5&r&>&m^kwC@09(o$jAa8eX`9gz1qc;Ug&q-m-@w*T&T!EqCQkX=1Zw{AY z7pJqSFUcuIN5I3gpQL6`m#L7qv;j;YXYJGqn>y!X`>>hJPU!uHl^0eR;)* z)abDF_4jz#7aW*^IJTH!E^d@*UdJS^iyO=vrqHr+Ev5vd0{{I!SmGX=iSd7+qU4Y$ z?zm50n4kWd&(MDK!_ef7~C!(X{r*!8QA@(QkSpZG^ZrN-hnt}r5$OCWFt6ewZk z*#UxoFf`)*Gcb*(v78d6-^KrrQE?uA_4`8J0z=q5p~{{CAl;9t{X||r>K>p$+84|R zj`Ly3#g|biP+%iG>wNOjB8|Gq{4kMz((54EjZx2_Q| zA(^^5yRmD_Xsl%J($JD%YPfWt8k{W^9B~sAAOT3Jp$p+)g4}r8oF8$EDbm0{?t{o9 zDB^7{O(>pk4w$TmMY<`E6fSj!6rOpdKupw=uwFN{i+uDr4Id(o=c!wsImNyIOz{C7 zetr2NTef_;zeo7u{a$LVtrKm-`nGGPZ#D5?kGqAbP@*kQk38~NTU%RuBlqkGWaS!0 zZQQWYdb>MyUF*G#Ude2*?^{;S%8M0(Fzf}IH<2?QF46D>h8BY%s2EJe z491^$#c|?3F@6k85wDmcKF=cmAixCiEWpS$*^f}hIE3Eg73#|^e!i~eaR3zgj-~A% z?(wiHn;!967pe_Sz=x&z_%(TQO3IvV7TC;LbCqY6p7q#3|FG58<*u1LvG#=prU&kS zw5_jquo33)+A>!*$^k4k^jBol!X}c7w_~xbICykuq}vk+yY~$l_U;Mn700M{CL!rJmm;UewZ~FpN z;v`nlp$Nv&)fnZpPc6q+H#XXoDN}9ww5>G!Z}jvwboE+SFR!eZS-nPb91Lrj!D}Yg zRlTslbla_WwP_^VNDqw$gHhgSG70%)JHX-@py0{`=Sblz-+Vil@PG|sI9zB?_a_dG z&+#;XiN@wPVB$W0$9*vcbIG$9NYHpNMHcb16#A|tht&7 z|2_-x@uOWUvcoStFkODx)ol|eOl^$yw;*pkA5nz(Pp=K7Mocrc00p20qd7NnaF|!X z6C(-F)nAC@pi+U8cnpd0BVI7X87Vs@%8-W5s3-k^u}X_a0S2U@f0IS&`ACys`lG2( zJ$&K3cutH9M+%~PAo60w29Zu7suS_N6Ud{YEFI862db&9Nkx@QT5-bK2mFG9i=IYE=qlSZ`cfwr2K~F>t64oV~KsAu>8?`@3GkqB#z3WdhZc~WH z(l0O*kYprf%9*y{EnG%b3ajU7G?f5@oklrefP=b15=P}=L>AAZyyTA`fC6Nc0qK*g zsE}!NGWj+(;?n`}ge>f6!H} zB!p}`3}wJfdK{cVI@AMl){@C^I=PMvN1rJ?`BEM}!jr465}5T&Vdyk`;-i*>Daxrk z;6b%g&!iGbrntSh$3K1-6Mo_CS567e*)=V>iWe4`&O7hCwq17Gr?I0W9iU%aVHyA? z(V!3vDJFjNoN$BzAkbKYDZHc$&vAs0dyc(fDk6+);&4r1BRy;sfkeHTIUD@)1M#M< z($_!EL2#9(YowE_tF<1fRMc+}Oy`ms9O3MH-1Wx?n^DoIJ5GfIWgLlEp)&Xu z9Xg5f1+>Ja9%YK}TmfG^E2wDN0muD#igp}NG}ma8K>|}vP3D@$s`8S6Dd~a|5F@mT zEImWLxh#F|0fq&rkP-ooVxR>u@S~CNkA@tJk7%L+VVao5Mx?@hQ{x1`4(0*Lh<`L0 zu#EVzBjrh@Np%1!K%nHTx`uD&mRW6m*0MEXbbY1ebYE5_$sku=Eh*)afd&6Hj-A zGNiIaogj)>4Ei*Z4aq}!qTDHdD&yuHw5cCP{(pi>1}46YqZ`MIx;zlV82eYIt1$!gvNo*r0e8Wo63< zOGE&Pdd0%DLXNuP^dNrwuG0eWpp->~rwqvvCP}xka4Al5MMc|$@OGD?m4r$LCMu3< zV8lXYqmgLzU3Ihd$36EcKnnB~k6jS(djdF2KOiK5}k1~WG z6zSrM<3ofk{+-fGfK7%k;r)^O>7U{tZIj(cT+$Dh!j8hgU5XdK6Q%GeVXpeQ2~h=) zA{zf}OHv8JG-5ry-DysUT{WsrFco3tTVrX&f&>ZXZ0bg=wl-(qJ@EvAif|aW0-Rh; zP0s4-`S6WY1!E+Qm`EN5(zxTnQk*V+!8m?LxgyS(9L6~`y1%sfmijFl#T7F23g#2FUL(0HVmQ?t>RuGL&Pv%25{5o|E^(7xg5=8BvO4tddP%! z#uskW{0q`2&0D43%N2a00#A9(HkN6$wg)~fI0W2LN)tUN5=LrXS`3iAT zJony&R6?J!$o`8D9sN60QZVrmzfdDViRmd@!T^Nv*9b$y*4EbeeQMN1{6?yemm(0L5MO6Jb@#n zNB$`uQZ=3zC0R&6QcUS{9dpIB>F>ykjy*82X`5_GDjAp{n3ftm8exn9UR{5*X)l9l zI8+$JWkxHsBOlh8IB|mUZCj)X_b?fC3IKzdi6L2kM+|AQIYP?u4jNhV_D94GqAW0= zxLhiQU&*r=P{hUI@4xj&9ImPC$+3Haau&A*Qa8o(hHyV-!Bc(wr)cb1B0!$*(zW<` z+!ubU9H`pLET7@$J29(m-MS6wSqZ45l4)pA>ZqL6aztxXSUp9zENl+ZGYd=#8fA)F zs=TUN>P}Lorq(XF@Gth`AOFN|y6Gl+?6JrE!#M15BA-cB<%7 z_0Nd>aO2DRY?Kk^a}^`DXyL>DRR{($Pd>T0@N~=5|E?DQ4|Mj~XSYeqG#-4=p|)W? z^G)>F)PpnZMb;G+7`;500Y!rmmXX(k4?bXzKk|_ENv#1SzA=YHLRw)!ha|#}jr5Ba zEwY!t{1Dq=`(308d!GS}iIZCG;~)R1z4fhc_0OL6_oZ*8IM51Voyq>ysPv3&w*H=9 zAxwk|sTlDGRmXVFGtxor4(74_lCfVLpLoPierY#CTC*EVGl<_ogkiEX-KX>-tr*#r zX9m@ohwSRcGthY0p|7^~w!Tp?dBYXJ1P}sD zP*QD4jlcx%am*`KV6{ta@J(HqLoZvihL1w`_(zlZA`@R?;*($8A9KtbZRS>UrP9XK z7+2EeGpAqt;^*y6Z+er>nKO5EKT|P7JgjUCjA-ryOz}Lz7c-lC;_#e%%E`TtIyJ(` z<;K2INBl9OdbH*e9$UYz z-8OFMvUO|Q)OzJsThnOUZM&nr?4<|U(MKI)pZe6N>>JzUFi~L}} zmo0S~I+Ikg+Dfp~?|#3stvKZ&;Aj+9oh!F&xdt?uZd>x?16Er->>bR@sCLR~2w7jP zGFy+HKWNLBK4Jg3`Z~M*`kQR}^hvh$yjiw>{kly$@0O;Lfr&<^14ZL|ql_aAVV)N= zkb4@R_v@KptF5VawZ;y{^zp#-aX`d;TF*k&r2W*qQnhyNI{)SxBfZTr+!-r>jQF5n z`ZGw;0XASO23&Ev#rLBU!~a)Zq*^E!X|RWTY?z;(2T2C{|2Y3EghRRvj|`~u_38J3 zee)aNw0rNp&u+g%lBT-S8tSuFRmqo~NU+aN|MBVeg)e-`{{Hui?XgD}`kpe{h`ebt zUPPEZyJSaNmJUovmg?#n>+MUgDit$>dzi=XVu=)#dTdfjs43J%vLnVAM)*hv=l*hO z;WVj|2ovEUm7|6^f-vdqe5d$8k0=) zV6HTT{}#g%uy~WCPa`iectnlCFh!30FzVgbP!^~y)F1o2`4vQ%aNv^n%JPGJlXvq{ zDaynEfcYrC3EWg)V=WD}*44h=?!Mzzd+@%yt);QnrN>Y~J!PbBM$0JUJtxMW^P98n zj$3cB8mVklQjJvBp()UaPJwxAT7g zNBiN)r`Sb*yF{beUsz`+OG|Z9UpLxz+s(87e3#pfeZBoQXZBpT8)*nS)zw#DWyHS|)!cx#UoKgG0Q<(l3u^f{8FN0sp)2zT3X~)vwwQzW+T9 zuQPV>-!HNgjz8XR7dXy2>$mpQ;zcS~wK`6v0L_lfers&36Vuzo>l}DcIjny#;?z`TW`5j`CMxE-E+U)eB({Z zx59SaWoN0hoCBg)z(M7&Ub9kCXn$*IX;G)6-Wh+JmoGgrs{Q=uKVxrr!|ODHo8*9F z2gJIyYYMg8@>DV~!4Q~@N^u4jfC9m!09f4P2!n)Sn2#y}h=_a`d%PI=-te$zjEm^X}dNi8jIcjyngjSm}Wr}~ek90_zJfH-$lqXV>aB))t?dm^pK%edQ}(c8RrU(UU6Mx9wZsI$qZk{QkrfPqH8W@JA}|i7sVH zi+QoM|9aRixZnc+1pPbT`A&PyYhLZo_t|G}JLHf9Y~kYzWhk%rc&s2$#={RkR3L2d zQ7WB=wgE7-6Xl@;@gCiF+ih#FfBkE1`|TIli(a&+I$oaBzkT-4tByLD{-PB2w?HgbHvJI*O?6v#ucGT-$tI;CTGo9F$ zR%YlpWp>bk2aT40>#gSrXzfZ9$z1M6@-DmVWFP9ug-LI)9kQ>RXKP%*#7@A|rWm06?CT(vbz#q{^|*{m5eW$$Rvpuc6yR(csGPo8S! zWtFla`>ZOLlT>=UpAFE})nikqOqZIw->$#z77gR4+h6~Bk=sZ80@lk9dAU{R>aAtM zWIO5m-?4YU=k0dDK?g_@HQQ@n`x@JRhaIiESLVdPkoC#Y0r*5d@9C}7wZ5^QA*>Ck zt?M-y=;>o*SQ;uBnEZ?&7%BeHvl#Bu_{9`V3*t9+5sX93<46O?Og3tdSEsQTaM%G% z8^kmK>gb?@4w9&Uy{jVpgJ|Rc7JH>gn_UATfgsWdgP*XJn>;bX3ByTj3l=PJHT0z~ zecAn3!XXa8BRqLB6mM*7cFEV$(&WrV4G#{cH&AZB?M}PsqKoZ_BVO%mjHssl_kXGF zz4z|wB%igDPCCI(IN=+9I0es|np#wEUXQ0u8Cue4XZ;!y9oG|G)P-l*R%_hE4`KR^b-eEcE8_{dI_Ms$e)3d|;K zrAADbU3RIMx3?Rtu~#ZU6=_HMfV5Ti*wh)*ZSLH;`aRhu2#BwG)vIh<*(nXOXI{4d z%QX6|vVC5(k4>L3!%rvK`$hW-ER!TnUo1OjJD&#wkOxV!?Dyh*ZPu(g^6ORFlWhJr z^OdnANPk{ssvEVLkevDakVdlQk~Ucl1WvK-x0`Qw-*u;e++w%hdYet2GSSYL9d_jv zSK5jdE7jf&ZZ|zFJLzRF+s{_6SfviI(RSWpTU)ha*`l+4tKnq{sB~&hjPT?23cVH} zrNbAp8WvBmMj4Q0jJyhKMj;i_NGbOJUda(Z_E?^=ft+uuffr8JT_DQOCS=&a1>BjiSjv2Ntb%GIJ3Nbt7 zlvC}TbAE4s``h2_AOE;cHdnP(Wy|fV%dVD69kzaftfQmL=FFKT!@SWRedtkpx$Lm5 zrp>UI2&Al80zy8u`tbb^Ta#4rfiK-pc4(v8y}o3UsbpY+5tJIfz(iCFqo1Gs?C18G z&m8Lw)!Er0pw#;)$+zVy!Wd{0NKkn!k)Un>h^H$D0UX@Ab!#~&!+!9CAK0fq{b`B+ zzxXV8NE)a(URQUQ$3qPP8~g)65cdHr+%?x+V}JbPAML*T?sK)#A&L3tKmVEaM@g10 z2QgcK|MaIniTVF~x6eMi+cuI` zt5>g48!&sF7l2lm#bCh_U$<( z<9SKJM8gFG*&p56*`-m+$L-i-KVx;WL(croZv~W3+wmG!Uvu@<&KQhiW{Lwie4S|B zI)=)5_ebSSojS$moqqe<-^zCRlKn>MJo@OP-nanogcH7FTWz(~s3antaDbyup!S2Y z3N~4kv6!6c^6%{Gu*lV?Y1JFYScye8;}>m9GiVgO(K#m;<6? zoqO&d1oRrI`)dT=DoM3=?^GP7F`z4;q{vJ)aJ&v5Jff`ZI2e|sL-jH<+tSi(Q>RTe znQ0!Lo})J5VDOSq$-p$MkxQxo%u2llm4XOnD*Gh|9$;Vo##iloC!b_*d(#`NW8*qI z_qS&XXrFWA8bg)Y?7BMj-sTBDI$dI~Be0SQnAV7Tv-^aD&B92%pv0A4Y1yvMA0<}T*II>4h?g9=zwNy19&&qGTgQlPztiqgp^{c*SsN6%*bbeykryDC zoPkNbVMI%DcyA9$fT2u}YnLs7nt0PO$Jp1t_En8!PIO=-ns$7Ycf7+z`wSVpEF&=DgArjWkq<7^6^{JFE(6$XF$pRL6!(PX6t{i$ z*+(kweo2w9_(%@*i2X+$P+?1#F0~mN(lcX^`oT7$9B+Bco9un>dykI>4>;gJNz}<6 zo_aH1MtPuIE^X-R>tld1C|hW@{r>mo`&7u@d+(`dvGv7#W?T5RgEeaX$VWclBf@?6 zd8v&IOO4jFs7`sMlggfE#mOP5aBh{y*lRvpm`VmFh{ahptRa!2_rqK!@c_xPWl#Gv zYzOrI%9X2JrJ>?r6b%T|ks{m7-^Nwst6%+UZ&1KPm_$kX(31nKafP_w#OaT8<5^II z=ZZtc0#x#R+gso25`yI$2;c%_z_HCX+t|}jFZIK_01?A|;!mGG!vTVk&J6YP&ANT4UuL~M19tS$NBiC=PR}*V zsto`S0|n~KC^p%8sVb?y(Yc`Vii#KBw^Pc?s=Ptb@icm>AT!4`cEx3v*pGg2lAU$N zukFO|q~(VV8`itcgKA@|FEhn31}VThZjDWi_WkdFpHJL-BjXPsaB+G_F))J26TpUZ zTTK1{(PySpt9x9^2;s-?I*rCI|NF&u)3w*zpZ<8B=f!Y*yB&A1-<*54{rrqyS@Wa` zHgEfFY_U4Vm%jcr|D43!xwE|kUGCmcCtK+)@l=gGCW+NI2;%zkYsaGdwhXl)7c%$9d&Z{ z%7!W?fj5l~NXUwyH-V{;2o__i%yYPYw?9-q4xQl;A zUANtKt6g{9^}bd$Z|en;S{>dfA5e~nD8S^b#;|}?BgHtbv{Oq^mOvWML6yO4{Gh{r=QlSYPC-X_>fyF?vA_f z@&UoN+ivTAs7~g1nwzk7Sc_XP_03BU<^GI(kVvGxbm`NQtm}PvfBPMG+2_9adHt3x zBq@gxO?=AE20q>oOl3n&2fN0~3Z+~AOLJ)uX>d;*`begH#5la}q5JOr(~I`p{f!=I z3)5JMwlMwf+&{IIl@B&HHcpW7x~SmVhSMP8XD`R zGC$%HufD!PM)c;J0fr$}gK?C{fhLA?PQrM97&tNvAjXbm#viann8aZ7=?0c&cG-1T z4OWu$;CWn0o8=cy(T(4vw>gSugyR~&;~spKWd)`xN#w51_e^STJfjeGi_+#xw*@E~ zj-kHy8QBF4W06E#&z&d6^M%YxHF8EO0sAOx?|t9-q)-N5*a?-Nf=>fqs4;hB`=iYlX4!(|orio=hvop;;Yditb#^8j7a z#`j_gyt0MT8$AgiK~a~e5A6~z!g1wyG4V4-)K!(a^hwMTP)WfAv)L6$Jz*r@MB(ba zU0H`??@@kW&>9<>-1xlr-n$isUY;7LxUm2gz(K|EcF9LR@)1`>Ojy#}Ip~5pAQ~?y z;zFcFxhRKzJ)_}^NySRrqNFPPzTgLUyxfJdB zg27C#sHwg7+FPTXYh@hQdLux@jYce%RIK`A(0}GLpYdse+ittfzV@}R*dO=u8-8V1WuhpW!be9{E7U@690*A)ZG(uCz(Ik2XnRXs7f% z(jd*4=1676Z|phg6hK_K57J}#r~4>JDX3&%LQN$`2{5WW84YWw&03rudIO9n8lM?p zR@r0KI~ppbl^6g>JUZ)I`C)6@*kSYMEwHbA`Ku19TW`J9)ggI9#Etkc1J#x!<)&qb ze1hSLDJf2*;r`UAD9z%qLHsW8&+o?=4)J6xesMj=D1{jdOBn+E&*l;pr;Fn!Yk){l zc72wLN(LrB(+E;c5aBWx9866bj`JmJB*%E7>WuKxGDl(pOs8?iH}r^Xt+d*owq>yT z&dm3$S+o2cf?~W6Tsu2_VP1|lt7q!SD+rU>K9HKJq_J(Gg*hwm<(8+Cfr(1dSbRH# zGqtJOko>maaeKQ)HWA1AaZo$Q2U2lt1U@9gq#uj9EJ^rBZDh1#`gmg$7+BmO_>)(n zWK#rS#{9mZLiEvCt5{9K7eiwrP!Y_d|{f_4WAfCniQ(|6moUuIf8m(ni zh7olPW-7Qx)n}AmMrq;HpY%Jg#0P9-u-~dHGgiyj5_09%P@A=;`mD7yR@sUbPpb22 zG|Z>vecEGFBHt)OlnDT(w}@$dI^~dc_mpgApmbnLm4XpTG)Dz}#J1<2t~x&Z*<NJvAr)Sh zx0*TurZH#D%?;kMT3eg!vdb>B6HolUAHH$L6<6D*KmB?8+uts=(@*=UmzPeEi26L! zrPs|1ZBn?VHA_7&+?R?^v%k1i_ zul7Aa7{%;CVj+`#)$FB)DM*hmfBDO{^Ugc_+TENvbF8Jg)tcmL#8?2tA~DMqyus1X zP-`Fh&*z``zz!8|~VE{KHx& zw%SWywx3;d%|Gmkg-`ey3hdYVRG}VITU}$R#iG)I2iE-(lo43J)DO5_{TqH%a$#7 zdx{;JOj5G?j&x&B()8)m1foU<8;y!I1B~VMRX*_J}p@jZFM42G3(?~XrbXERxske2jR#<&?r7d2#$R~5BPnqmt zOF^4&(Jer!myC^OI5~}3?PW`sxs!9f6k+9)J9Cb-Mk0S1Ic4d*Az^!gM9DhgDy2v@0J*E5uYK)n?QL&+n{VS~E3G$r z0YJrIa=S*i00vbOc21C&vmn7JD-w=bcECW{xIXmILq5d;z$wE*frModfXbV?0EPTm zJ^>so{Q9140f)D4-~Nub+s8ikVYN-CO`S4T@ha3|nygKAq7BYI`y4+C=bCG-waJns z?EU`02i~jl)}=y9#j2$4ko?P+FI8t;?qx13&r8Mj+uirv=AD%ClO|G|sTta{RJ8fY zm@Pm@zu~CkBmr{e73ygdrnt?-C)1x;yvUAu)6p88EVZkyy3+pgmka%b4x|9P7co|U z{_|hh%U<>}mr@wJTrZNk*=eVpoOy(WaY=d%8Q-fN%%^KtXSenC@%<7?L4zkS6-yyD ztX+BK6;dUyv)&#KuNaer#bE&(Y8UmoOg0DGP&iDCGGWh9md7-3m@G95f7fr^V6Q#u zNW1j%%d9+GVF$hZV7unJYwd2Ss#m=7P;2Yxw98fJ>#o1SLC2W^t&*T~XU`LW2W_9d z_pv>8-^*V9@|W9-_j|GJv)_ws!S>r)M|ZE)OZxivXdsycWdL4d{WfrY}!=WOiQ1Z?KD+oZa)9J-#-4Kl+c!?(t+vd1g47e zN{vz`TYsKYLYM-mw5?{$u@*)vKqnk$*jM8oKxj6wA(#Iml@!^pO&vDI2z zCaR%orPurYSiz3=ZaZNAgB)ww3PythADi7Ybcaba8t=t%{oxOP==osJa2^tqavJM+ zzA2A!;+$D*IjqDtzNT2%w4R`l(puTdP$CY%jv$mr^6?4D+Q#d z7CmVf|LtNM9_Y1m&pO+#lO46+K6@&BGU(^cpY1OyRLGpzcfWn?h$CL9PPpD~y6IMH zY;LfI)&}2vC+u3c)M{7f*eml}no0^LCdk~r@f`q(U<|$dvdb=)ZS+goLVs5;9g>0A zDkd;B&}|?2$Vb&68^k2yr8Pa?)2D~Sq&K|b4K{DyJm15_WGC}IY~pWjW_qC6jZN~| zlu&h`JAHf^5VH+}F>G2JJrbTd{Jfop#!(J~#H*V~X&=a(qofMM+)!VLdFG-}IY=hLGbI1bZ+_zqibMcJ)2Gd(-F!hYiL(fRYYaodVL;~3F5UVEK` zK#AGszwkLbPN3X<_ubs~;&rAQZ@k%F{pwd~Aab>z!35pN;a-wR)Riw*F&akwQ%A~! zqjS-zIFIUzE3UL%cHYf*OML$G$7)oWR55$XrwGV*-F2_*z8!7d`t`Q;+}YNv&RQxe znE`&(QAZtDUS5{VR_1I%>lF3Gepd&)wfm22uCcFu<14n;K6}eBe3=?zrd@i;C6Y#K zZO^^-&?twa3pMN&mjM<_0qinh(v68h*<&&~FSYHr-`+m>fe+fNk9dv1wXeTaFoAOn z1k(B2%(H%t>H-)nEdYkFVQ#rrK?{+~!93?RVZODR-QJ$0>NV ze&qCvU%a1Pd+qh=NQe1>TomW=#~1l&ECok^FpndBYFFTB++4qzrxzPJ8k9KRkl(?*@+Wd?JHmXl14=9)HAPF zL$d%&4;&DP(&3=D+;X$;qGW#RfCCQjmoSk&ETe4P&@P;m*^KEkeRQ@c z_IjBN+47v#NnNxt))@AwcKG0(&$K)^mq`LRzroo|VHL=pud=>ja|8)A zpJ!f}YhpOh#*wlz0Fk#p{^3u4ln!lj{{s)$+ur#$d)dog;^qDAZ_jmG?nN5qEnT+C zjyn2KyWxi0thITvq+72`#rCH#K@i?U}o2goim}0&8 zUMsIGw?`g(#CG0kC(CP?imj26T|hCw1uBaZ(Vlo>p`Z0g!=VPwI_oSK{pDr6>7qC; zPz4~@PN_d6FmWAwUQE8p4uFZ+V~*|h%2&QpOh+AV8kTTK7l6xXi#0)Pm_7I0(?^j9 z9&)g~Na|*iK*LP;fd?OCThHIx=196!RH_rOvM&%!MFloA`5|Du(!~O-PfV)5NEqtf z+skbIh#1}M^G7phZY5Ci`uJUT=C9ARR~~+_egC8%+RG0)P?GBS(lec|)=)o*>%_B-HZw&=-4_Vl8~Rw0$zC`s`6gAdtSjoQBZt>Xov zT6=owBKzg9erC&8EV1AJ;cVG3ueE*mdy&oEdbZ7;GuDpd+xKZz5MXQZ04N#R;K40JNhgu z@G$3#Va}#J-k_d3Wu{G@G__E>El(u_6KhJSH%4==$^S_!#1$j>6G%0Us;;+y_wxo+Is$4m{%?zwtzxsCA9aTGRRu<1Z+zp?J~4@kW~9da8j=(hMV%-k zohBp&_9D`ZPg7ie`IUaiJhbbsJG->{@|VA%!OQtBU0J*p*~l!Qt{ZwNz{bG%PH@w@h-eP85@ zyR5l!e!y>kdzLerurxU0oGAcCJpm2?5Fm=*;pp9{P$;R;O~XLM#kdE+nh@9XvL zD7(oRe|pJMm;9xol7WfOio%p&h}%#iD&EuAZyP$gtxwq6VVB+Pi(mVSo$&pW?2T`E zvm3`qCu|zxv&|JIGW$%Uht$B2=fQZcJmZ>{8YYM-G__PHtDHq|YT&A>&;fuu0i1Zn z1VaG@ODSv>Zjw>oQr~E`l{xPi?LA#qQC(&2y3x3hpZDK;&U4Q9e3;V_>#TsC-qBTdT}-te1?I@prJI%(ns}i(v46AiKY5@- zK_Ts=^xRNH$53EGRV5y_ZM`XpW=c9wl%WoLO1%_Wljb*Pn2A5gSh>#lICH_rFbe~v z;&)cU$AdVF9ciAMTJ6j>3AaZ_M@_&$@q6*NMf_{l-^87C^0N=A97g`XSOAIKzlac@ zQZkS0`R(-EFMRI-Z-)Ud8xHVrvym%3gO;gwo!Lp2O$5bK$}pineq{Bls|1-l_WED% z=01z8?8)QUre(MCcf$=dpyaLz{3~02RzxG={kP$kmaWOQnd*P9VfG9B^axg%w6Z{#FX&4d{HA*(nq8(U6oVSu z&afYdX)cQ8t!Vrz+!juj*Nh!2tvu=hxGQRYfH>Xp96B6lL;}AC2=HMB!me~&{Okbn z&dQZecsI69rs4~s+{wKTX`5dczo9-wj+<0;iDp};Wu|y+`g@L9xlaimo;+0FAGCG? z-o3wF7{6LRA8kX?j8KdHTag-~i&e;VEXFa50kCFx`c0fK2z0hVR^~sqF}-pj$zLFu zR%V8=3$ovSd!5?dhr9S&j0C)9y7wb7JdzN_KnhH(E+0A%MTz%COvRrwWaY=xd{itJ zNzL#n8_WV5+cRQhgeZ@ZALak35>d`YTOrxv`%9-_5jl{6kC_#6X=ETjI+hy zo7jK;#H1t@4_pQZ8do+}NyHmc;l_1&D z?$>+aSK%&mbG#ATo=I)?s)qxJh>LOtGiNy@4I*u#*wozmNxHOxcBewjeTkde(DuodUFJn^2Sk-bOX>m=rO zf_F+<;|HQ3a=;{#Gp*fdv3ke-iN)1A1_e%@XFIN&$4=zd z)ns5NSfa~dhlyg&F*yKV^<394x;&35|;NBFEQoYzg})|u=F8w-G_&lb1PSV^$O zUh0DeN6v{-DynmxlWdWufO8%3^zIyE@5z0S{9~u=Tb7U}ndQ0wcXM%z?dUw8-x$yH zc}5SA_ZaKG{Y0>WyGpli*Vy~^?+^ump#7u$jNyelShtGQh;y-gWKg@G!ZK}DGD(@=iW$ri2>7q`_YnY=^D=0T27jBN-I}T zj$uaSQkC{9f*s{n?fqG^+?RyuZ1LqIox7yX500%Z-Jl2VdZxJM2FgdAB=~Z-+gXQ8 zhulkQdNg?veP-Dk?Afl_an#}HB+ z_FkBeIgd{J{8xx0r;4>+lQst58t4d`$Ccg=#XPFk4Kevhlj3IS)l&>pQsQg93XMEF z(t_aJa{@X)??aY^_jSI?kw1C!=K<+%^A#%E*bl$&0a0_mxJBP*dJVWLN(hPJbNqkK zEG=faV%}Dsf8d1Q=`l-)17(Fzrd}psX2It7`hMb-`_d-&-*`}8ta7w zHchsmR7KC`UuW=Iw20pR8fb}@c=-=XKrPgt9$ z*+nrqq_eYN%so|4!jI1?iB$=hfGKiJhKWj?csLt}`wZ|6Z(s(NHh3gOFa0iZW0Xo@ z;Hw)dq^vo=F^DBmE|4mPwaxvyy#y18r{X?Fd8nv-zKOcrWqM+`#Ox6ueQ3LH`4n6B zHUjt_($11|pR&3%%*}(`u5XF%zt#G#ioIOLulk5xie++`H+0D+nRmhCH}Vz;>8e|{ zcHK7(7`-a^tV$wSt7g=z_}+83l**c}pEo6=Rj_J*FgCL#-D_qOLUt?Mt=s5J!tOv@ znc7$$Nm5+GXZP;+cRo43pLu=I?^;7*l76M|yG2@mA9~hJ<@>%+F`?a_DCTjR0lkx8 zTeGTQT&yj({qWmET(=C+56l4)!9YRWbnFRqWL1dc%?}*z%}%oM*0pr*e17aOPoBDP z7E^)c1nnWKjxWqBpUUM3#&2EY17gsnsgtzpHIe&soiDjyq~8+&2}=;ji&HXUGK@B8 zhnyrq1aTybkfKoRAf3PDiK$#K?%1Rv^fo;)e1SdXYi_@5dxdH2IUv6LCR-D~@?FQs zj^eSm<2CBbn$yU+uPIJom2MxuS7mi^yS({u)33)p=0jgD-k`l*?%Phq)^=}uCSbz~ zjB_EQYXqB`%%{OGpy+7_^~H=G#dc=GH&X3D;S)#MfEnk^6+pbaIna=NY$zDbjW8ZI zD>d{v?-uy4K8U%4k5eAqrwp|(R~P}8=24n&)>||(M8|jFMOmVy&W@2YpT>o8nV^X3 zUs)3B*_BR_P>rj#aB2iX@Qp7$Pm>wyr50;|siflC@q=49>uki;<8F_=%fUnn*-~B; zl;ZFrjm#_16*%^Gy&P@(x9gz+c&jR`*X3*6uTs7J@Y68M&XvCGg?Xqn{3mJ*&-4HB zUshr68_Wh!)6r^g{-Bw<>e2noD*U#-mB8~;Qr3d_dOmvV^}@r4{p%{MA%!};yyNvK zLkHA&5xE33CSf7rE(iXwj4mOnOFqaM%F9|%(AfQ43dQqd*VHzW{mo=N*4cKi0Q zlHK~-)<&DH5y|vyG0o6~;Pr`}Z)N^)1a;GYSJ{0Ha3!_&+_UPpe<^>xXth{pV({DQ zzKL~MMRG2EyX48_b7Sc^8ME;tXWCDe*jzBMs1>-S)KRuss&e5d*kPm~3mX`;%monm ziPmOET_R&1h`selwtLfbz_CDOnqR2U{&z0fT!5B}{~a(begCHmV|_-V7R_cxnq;=7 zxB$CCP@a^Ri<&@9X`m0xcXad0x5>S${}W6@h$7L}ec^VzFHhQ&$kCbIe-s%h(oH`q z2%9C<|AG^)x8XQ|CKid5FALHE7g1g#P^M4?YN3)d29Dr4LVZPj?RkIwn?&5x;(d3L z!PW0|l{|X_*rm4%$G*k0r~GRlV_@+b4fHq@d)db5XrilD@jFR2a;N7hzuELTKX;=E zkj*~Keqf+@lH6OK?KAjHJoI*3+S35Uz4t$Ovwm)xF0b@EE&!UOAll3rYj`#t&^IazXy(+eZYrn)ojapH*r zPh#`_YD_ zB-80)UF&(yTX{=OvGByRIa}_J2aB^D{AajagC7^LDLk zQmZVdYy6LQ-{m^zE;>)O*Z&UrJi{_7irXUey$PQDGNZjZ`1fyvbA;6FKRxr^hwPr2 zg+VHkPMwwgIIf1=mopcCGh3J8u!@SR=F+sPrjEbfGd&6NehHq$6rbt!zs9qFwiP~W z3b*TmbO)f8X#&o*Clfqq1#tL|n&xA@Ux*t^oXtTOw-GGl97XG+r$HHuw>UN&Z{UD- zl!jxXQD<>qH_Z;TRBzx4kq;DA5Ui9n6_ZmYO~0CK@XhG_f5^>!q>As{=b;UtmtfxL z`N#4a#k*&Y-^I7v&#i45Mav z&0BI?L_}d^H@sN6kUwQ25~hO#3sAW*G;9)iScys>h|P4V+xsoUrRGBSkR%$F(;MNt zuVNj*W7T(tFp@){XwSiXgOq_Zr=lOk=9fDJ6CohLH(4J-xoYXF{NgQ6cwgL-mVPRI zFO?%Q^0CW|BWUg5{BXJR01@Ff3UB;er{`bu^7bn+>dVP;&n1DjAoSH#2L*Q9nqME$ zF<=Wo@ETe7_d!=z%uZaMbm660S~CbxVoUZi$(~MW8BEn{p+3ZMF(*Qgk(i7u=b8Yd z+NK=T_>LwLk5?qUeML94P`YCf8)XTt0NANTJBuy@SnV0rB+$-qvwLIBQKm9{V z4%pf~$?A)MfzarGdoD$Shz}ufyH(FYrDrlN;&5MDY!_~}?UovmKF)#-E#4$frWfC| z6(kW_PFTL8ll#1JNa}j#3j1L&s4bj&5`>Q~@h56JE;wqu7xOhm#p_91;RG>7m*`Qgci|UzqnxTECu$%=18>jFGk%NTiUSe(I z(~bFI8NYK5P6z(nI(w&t>V9p~O}25%b?1$tLo?w0Go&=8K^i)gnzOl1_?hsI(V>V? ztR5`?lho&%5m^EL0hPB`J{D*;Fy?^p00%yBW~Gmklo_6*{y5g+_7Mbw7RLFBFl>k8 z4Djmjm$_0a@mON^nD~O}$MlpQVT8ue0_z9B6r;aL@sqHu1{L9z6gl=Rc*c-AQK?tf zCnLVUDrLQlOPY{IO|xiN(dyV7GLu_pimEHwR2g>6o_=ZvVI`-gWd8%v@`11)Gday4z0MpY^DV8x9RAW}thh#(l#LyGW`EwANs zqw=nY&2>3Q);^jGVdQoKGzeZEly2!tIF?_=(VA|_F^8ZTy32#L^k_O|*DtqDLp}tdEWClkmCR{bM19whoukuM#7Wi|!q!(B(Eu&xUbpr$>u^-&qF168^|85|O;2My zF03=#;|*@9#M{mFZe>L5P2T4nLHw+yHQ?91-<6`<_rateW+ce!0b_f|Nt#txNHV@< zB@&t=!mY*ppA`U;Dh>r+=%_8#H?K0$O*TJ;fiGIqP$4UFyq8imT|WxH9A%eDc$=RX zhKM2HRaB;vBEnH)psJqX+$$Cu@yXq)k9|v_@%KI_K29+Jb6>}bv|A8aUhRBT*CVMa z&3skZzh9xj&?}VHj2F2~`0EvL+5LR}2AoD-E(f1`V$P~Gk6!vk|9s=Kw{f2VFHTJr|bYYYfa0P2_GcSJ+c6m~#=di=K$sBu0W9EDaDg95X$lW5X+ zs}Idifz5u$6(w4#HU<0()}F&I&Pxhn($xB-RLFI_SWqub6YPn90(-#4Wp=P4r;HpQ z8r)tk$)}~iO#myf>J<3{DrRW9J&cyx5HUe!EmM)8R}xS~A)CQQsKqEqjn&!VTX_O@ zq_*>sH@B8YuJFNe^uduS(=hM&-yRRwCgFZZ(iGQRkmoCH6r8rR=zlu|Jx63wtM;4B zCUHp32x{722bpx3MQJ`R)B~-1t0GsnXI|=_#Xx9pq*1TE9Pw|Kv%7q1GvG)dQUCb8o%#8ZL5#|6;rK>Tqg182`E*&)8FlR)!1LU9J{?-D8IO%67 z@Yn5# z)D*Nh$54E|*cDvgl)co^Nhx;>1pyah+3VwonE6QO6{|n&AA+8LZqEluTg|`}I{sGf zjsJP;?ZRV~Wb5D8OzwajyR);)-6RXkbg?oP2_o{O&)*Bl1ZeUaLuv)fUx-%IoS#hG znu19_*y@whZH;AxJy-=imo&9|OEsam5s{DStH`CfHFtq}vXemd<^ClNpdgRo#~k9W zoJ0cLSc!DXIgpHqnS0g~ZP>x!J`oLxCY(C_T_nv1G$OV+R(e{3xX0acfdEi=(O~xg zXE`$H34(q_B+oS==LdC>P|-;n^wW$CSeYuVIEGH>PE7MSpE0o$gC>UF@Lhhka^aog z#~1of)(-d+L}e+@%#vni$5X^Bu1V%7b0qO%CvBTS+Z)>YldckFqc3K>EIKuH)rV8F zj_=yJ_7J6(&FJ%!-HhZz1da zMmItCi8Fr<1nc8-zwXeZ#)OXwt2pE|%uS?2Kiu2?h&CjOP9L^+CmAtfK1Nl1>f{KQ z)O9uy|CmX0a7r!Kqu%z5+l_ch{ zO&y<1z#7UnqLjH{khGry1)0N37mB+`F4QTYKP8?n&{*}#Z|~TtKEpsLwixaz)4Opw(lD#zyxVMh zK*WW%p5g%=$c}F$gP=9@5}Wf;aQiu1_3~&}uqttoGWFx>Opp>Hr(eqTL*gMlq)vla z-50~;l$yA)u#MB=@4m*h(BKJ0&fLKUI2ZY%kkEdr3{^Li&}551#tRb}gM5fT<}uty zQqs4pn639H5hF?Ok1u)DodO@p-$e|m>oqmC2+fxmvt0>)35*&O>gNN~HgAI!>m|Qvw z&9ReYq!U9ueshE|epDINxyaDz@9&hv;|a#=!WcEN{<_$Z!%Q<~|5+l}pkeY=|e&tH_b{6?zp zD|25L)|MO~YjboWNfCNJYarHMU#*%JqtTR@-=E$)w4VaT8C% z-L1obdd>|+#&lyPFlRp(S6USrng(f)?wpf9y^G=_mV0NR;Y$KixyS`l8q4(03X5LJ zk$wz0k~-<+jK{wL@3^hvK%Rt(&r!Y{U;}fnS7d9Cad^?oM7?;v2Ar_2s%U z=Fe=#2B!2sV%-UMJNe*rY5r1Phh7;#F<7}6D-AN;M>{*CMSeben2ylt`h`JoCmBVp zT<*X;p8judO?>9BdKx#>N{(tnZo0i~MdQD)AHlIn zz2VVKS0ohdbLLAKg}ys7kP92@%Cl=0w)y}ApYIc(qNxa8{w2LnUgj%bvxqPm$6yD= zo@dKTSCsjU9r(9=Llo({UtHJiJUr!0;&CW}s;*ek?j!lkRtO0Tfy50A&64WYSqC4{ zm%1b6)#YkK8kkOUpMi1h|K9banBPVlA(|UBc+ea#UwshPmHsb>xf+^|CL&h~Nd!f( zxO`esKkMC#Vc?s{KLC+h5#aQwRhJ3P(fM;?Mnziqjz2JnKh?hijCdW1ecR?hKX`7N z+%Xyb0Zcsik!)6yk)m|-dJLOnTYw-CNd`Y!Sa{vAAc0r?@PwtdPWqiq$l{pa z|6X00yNeOr7d7>3=@=Q7ZU5hMw5c)#QMlCxVNV3MShjL)Oke2x|9V*vVG?G0I`8K#}>0i@?yL*ryF|MaQu zf2*>>V3?s?+9lb?!%V0Sg9MwNUOmiVu`(S>-?$FqOh=wAQ=)*l)E6efXdsOXyZTPU z%J$M;uaJHdKTdR?kc?%h*UdnBp*ikF+{yR$iY+VQvuIZ57k^(>Im_v|Xe!My__A!^ zRxJ9`8*+bmGu>*HT)KjnX7trYySnAwYq`VjJ*{(vzNKX)r{nL}Wt3YLk+(MGRJ(y6 zEE6T%+n>aqaLW&^i~>M0u4Xmoe*=1ChVL=V!GAvl-md}UeU+zjcX)S4>-1xt$~(ln z7zJrWhbN8A(6my!woX1-enzP zyb~ES9Y^^bgae62N`=@6Vbn;79&1*mPeu$2gzEyHoH$4klKQAZ8wZFG2E0UcI^{0^ zd3s1I3_^0TA;t&!FMcio`p>dDoYDBAYz$KVF;jq31Ij_TPVp z`nMyLGdO1db@-gkMZepJ14@6N(eCG!&#UYNFIOt=mv0EV*|vly3U4dEwi#aPy?Z&= zAlilHj;%X#pHux!d;Q6DyKr*vHivKdXGw+bea37}OY%4`C`bkZm`A|2M5H*-D-3id7 zH)+HxX>pog;!vQg_Cm;hxf2pj{3Em5@I8C$H*r9DtGE&)mHr0R?lp^J{T~M?TF&dA#bUEO z;b$2&k!AZ`W3*{u(Ii5oc-W>Pllsj|YQxy*~-TRQ%fiL0N{i$1UM z_gL!~`o&gCy4xkO-<4FiAENw7GxYv8nRey>n^%YQCL5>cbCUeHGC@fTB^fX(jWmBs zPuU$bWR@+qv@Aka+UBS1(=O->Ip*QfHzPWL;d=q3QF73n{rSsRo1*M=p+CN8XDx?1 zDsk7vNRX1^>VSItu=l3>F!rWJWzs=7{u{fD{OB_<%yDpgh>~MbuqWTew;v~6#*{O_ znLK(sCV~+`!$cNY+inBmQ1RdPxzdydhv;Jp(N~o@1Kvd3DC62bxtT10eG>WHzWg(d zlNj=X2U{5-e>CL|_IarvIU5~{=E-Xx)2=l*H)hi9Jc_)j?b$vdSQy)_j6ns-xcJ?6xq60h-uXr8FcOgU~s1#c5ti)Pm^Hx zl$bXgB8w?srUiDF?WM(l2Yf^0nJG24P`@?_%Yb*PXMEG#RSl{jAFp%b-x zMsEl~_iN`>vDLEDW2BggaI9Z={Sb7Zy;a+6{e*0j0@Z!~0@o5E>-_q}cY3^@z^n@m z++0V^eMP1S5voue(OWSImZ}k#kB!~%p!V=%+aNmhE;f4TCtYr4v>6kNJO$_`s2`@( zwUiQ?2Hli9@K+x+86@b$HBrr<*FO??Fp z5u#k7O4J2JK8i@6P<|u4<7B<8kN2B6OiypyC5kQxj3%`S3mI;J?rDY4!bPr-4CyP(qX{gbw+}{!=Uh}b? zB=Y^)VD82VXC0iCI`jQgiMSG0COTI%h3TY=x>;w^W%%;Y!%{6*bYXl3G5<>-C(~n@ zOYk%Wg{~@m)Cl*4tW1sGKM3A~}{0OZGNhCon*W+&JQ^uab4s9KNV=<_7?7wGSg zNMDfd;&2*8@YsBRdsvkdzn9#q@gC0TsRM@1Vy)#bST71*AF3(mP%hO|L72Ga1*j>J zFH*sMGX2mW=#KnDsnBdG0@O6I3;Aog(&S^~zu3OHudnVe8<>kf?N3)1wysaxt$lqy zud1$`=Z7{u#0mhY8*7x7Rkhx=O|k39_-8?dr$nm#Eeo=9QRrsWr|lRI=BWwTiGcU< zt+OQ(hg5IBnSVch?AE<*$^$XL2~wo%jqiO3YivGe7Y@^?7F?xW7h2&ZyT=MZ6mfDc zoF)hc9e$f~;qwQwUWpuO4pCd8bU+Y!frJ9%c-voNj}FK3AichI-_p7U2)0?*caVxT zwjpdKfFjG$7?q3hx;K|)m~SE|Qpp5lIfk0x^@#}RYAX;^`sM!1e%&u#^b3M=z3BbM zywStI<#j6JA+q;#hjmS~S7YG!Qwo9xtdfN)f|y(1aOYe1?LRGXYh&{=^|hb%$gz)v zcT~Xr8m*wu$~$JkDo~y7(yQjDW8hvq&B-~6e95#G*ehNnTlp*XoprIn_5WFcsTyrz zFqF5Dr6qw_zYPeFzQZ_ND@+1w)*?HSGz1#0v!^=XVWcOzKww@es+ zWU3qa#oQxJZ&bxlt#fWjC=-YMpU+SIQ4#Cbb9|j6=guCS$yhNton4NZ3RuhIg_a=n z+y+10QlJ5bY+^=gNU8KH-DZ2;i3hci=ZthJyr}PZpNB67kz*$;3NaCN+b2Q?ajBcf9Y>DfuNGp6+FRs$#l7zL_XzwFFhzJi z0my0{pJpGQS$`$VIeQ1dfL>+313SLh&@B5wOBfZ6*>1NpEM~#MYe+*er-og#_6zW* z*WcrNhXL)0ePCO1Tlj8#`PzeZ2QZ7QbWAWr3S4>BB-rB`sx-WutEzbGi=p$2pA^(35WKnOew9Gx3^pr=l^<#O;dAkG*}i-GE6LILGcox+27>o&Upj+nRA`(t z;DUO3A+`y{Q!ulXshIPCrHoYgNh_beT{AyP2Eb23~sfa_@-D zUq7IR>nW*nNfm5oNar(1O*juA$_P!M9S5W2Z3piN=7vL_f;=ukMBF1oS0+5;oPnV< zsM1jqP;51Oie4*K2s9K|%?%1Vlc2;|x?@Mg7n*p{6ZPPXXK{dZ7R&BE<88bH8=okA zR${G-jIS#*b%(EGKW@?gd&w(aL^qEKW|nnk_d8b96iam~X&*d*#giE1LXjvsd#g6P z`+NclEa$dyn+WA@oGNg1aL`$ZOF2E%4z@Suus>qo7L+Ymz!(MA7{a2%O7JJgS>lQd#J68NEinI? zE@Mq-?L1E!y~S+vg?@`+_UG|Yi~djZxi;6h>a8Ya4-wo z1K>+2ndA0=IM7BRj2TN?Z%Wa(5x|7nV|_Vp{5nz7bz!aFVgDVp?$AW`+*E19Tuhzz z3=TI$iVRaH`3gpn;I!TY)$<|PtgvG4$21J%`M`4Y7|}E^X)vt+ytDD0CmnD}kH>`t zWy#F0(c-z!Zk^>n|HV=KUfJ98chhHeee0V3^zU)Yx_!R?dgdR8{*7Hvw`05^&j!nX zi*$&hgtyy!YbzryVZX^>R=pM~o^QI%J0GgKA(~7a_d%2-hFaA^v*I zZaaLNA%@s{$x1&aFHnLHf_EXeE`~lYMkLHQI?ECjxwKdO=L-H@3L3O@bU$NWq?BvbQTdt3+r-PW|Y_ zc8^Y>Uw*z^v%D4x9Iw;J55W%vC*YSU9e8*;1vv&1%q%S~+JvTz5s&kiS=NTzwx=gW z+(ykS?|)CsV)DKJE_XsX^yCuj9sA(oJj&DZk7C+WIg0>0A#_4gE7hX9CN*fV0Bw28 z^E{s|R z0?7ul8(>;-MiPeGV&XFmiw^h_hJBH2PNLucL&QC$*3u?5w7=sgg(xm-Foa7_NxAWHvTXxbtI2%?VCm9X=g0imUf{}}y8*O433G>Kor z9%VwB&i^`@1FswGUY2y?Nh%@083id=ig-2+lbnWUexb3wx@jw|r=DQsml0wAL=h$M z7#{$Cb*w$Uw`i6@PuN%;HNS)WCqax!g%@w&FIG80s~)nt%mnemv?Jy*Cc_vMoCJ05 zJ4^kHFb_btIWW=8AyYP9#UUBn_9uXuzvW=8U*oByx%xAeslKwRD3uf+JTK$MlAw{X zG5RA&MFS|uAxRR*SZr)lw3pS#Ok*~jtJ1KPVmK*#IFQG! z8OxObHQKRVb7qAA7xNb#w_U3!@;URH+p}X#rgENQ)mvdRJZKCX&kr@ri#mG70pY)$ zmM6u8w`OPgR<@RPuFn~OtjF8I{%>N6u~6f`5DRv8=~N!=;ym$D_lQMX9>suNG%Y)1 zqK1@+z|-w3>9mAv;zcgY#z-~Q^Ff1ZGG(|i?IyPwLGwkVys2T949VB@to!+I9ZPMu zuKV0P@$V;GSqEW_ooOgwkp{fPLe@$)lfGL{*?1}s5t?FDh|^`3q&qpWeg$)&N7X%U zQ~KkGaay8czDGsy4<~4*?sNvfm@9t$!Ru|-mqOKgSYGD^6}*qG{hkND(Hp1k`BnKr zUs|TrUFS-OX~2A1S1B7|q|P3+Hq%H``i%)2pO^dDwDk6}|c;&9|{`w_nzu zZ#4eku6^j!k>mBp3kmoPOuYwsGWlj~(9qnhuc=P)(&4ZDOefNRW250yBJt-$4dBf; zetXy9Ni|{~`8p3$LT99%)+Ov4`kmkpQ$;!F+j9LUMBD^C%g=#p;PluQe;uoqGGKPv zK8Ky|sZX%p^f?=ls8KWq<&XzyPKPaw!t?f%5EJGIL4y7yve0$N;|jdy|qQneCO>MoGio;2Z@9x2}#(SF2je{S0@ zQ_jZ~)2J3NzUxk8b~9+jcMZ}Py~?UF^Rp8hw&u-EzEzcDU#Np$34vp21p7;+ZNgz@u$g3p5Ep5BlQotL4t>?m>i=Lfs*T_*dPyrMUJEG7gR zT-D7@utTy@ksxAiK&&dGb8yC4Vlviyf-ap!4W;e*vG>84P*8lk> z(a`v#5f$?`7_-YxeXb^1rBCKU8Gtt7UcZZanH-~vDRFm9TMvFk^F`@@7 z2bU+AE<_xw88%zG{4R2z7n6=Z{adT7t%ephOKcj{U}qzDaBb*ElKGso7)nvGUxoK) zOkdQTnaR>=r?Ack)YWX;&0WVLoyt1&8ZGo{gi0+U-dv~nDW$!yx=CbWfSIeDR2foa)URXw#KVt4A8|lxo4X`_VY)cUH#=3Agea<*dy9z zD{)d#0orkbO`CCqOZ0I}u&y6n7DsEa+ z%;S|Wm2dzFkaT|2RBg~bfiHGn1_VNZrJvmwL$Dlk(Z+E9oGRg23%j!w-OlrZKKi@r zUOf9eSJmfl58nW-DbCYvgFH*>`sw~}(evx@@bJV~JxT`JUj+@t4;_Y=_<28P&|d-BA#2B#LSeVhf+q*?4AN=mg zAzs)?S#SgN31B3v3#~8>yftTYs=`uIQ(&+l3G7WMPfMH22}X?*bO>EZf7kGDd8pCr zSX;!kzuwbsmv1p0Qh<`rR{SWj$X%Q?S>h~_D3;Qab(!>$*%(~jx#n;`k?~jjg;(xv z4ki`IYAxXoxQXWDjSGpC9oOEYE%Eun(2T64j84xrjj>lPi+Y4#rW!u?R`Y;$M=Cn- zg$iWqLi~qDG(r|l0&ez*rvyfJsz<2&5L=-;_!G>HNMYC^D@K_Tq|g@ADJnx#JGFak z5R+twNQs0drKy)H&V?C?9dcim75J^o^07W?+JWv|?n>3F2niv_iTL7Vv2uZp1jT(j zfdXP&8poSJQCHLQNq+uTNHmO>#&8S-Da?Y}NEwM}g*rd{`^=QfluS?Izk*fUGZC$C z%FL9mIVM|%TdUO6+6)?X-R2eX>_9KKTDDi!iwVn#fG7R zW_Dp*MOf(j1?N>g@e1A6N#N6%v;Eu)3=$9MUgbVWkeCh z=)Le>8O1JodBtLjz7y?k1sGDP?D}8*4DGtj!<&jzeXT-Uj!#e3_h1vs*mbV+S<5MU zm~=L9;F&P;zHqL@Sj}Vneoq*vxeQMEFD!Q<%Uh1-go$wAUfWwq3$Kg4OSZ{-l9^Y+ zdlIQ+MwP8(@d#YPNNIJMWkmSUw?RqFMa)Z_<@=;e+K1++DCbhN?{GH1SUimCOg_j%h2?Ir|vxY z?(T6=eE-~uT14iyi##N{AK~j516p+!nVGk_Ik10?5`FMH{!X4h2mlDLw-%)>NMLk& zVoc1dVffg&`4CCH1IXG+i=@9iuY{L8o;QRr-K{=%hkQKp!=aO6FCOun6blN z5D9epIm*gv*nBxFL~I%lO4#8z#>mdjuj`6}WF)ybS?7L-EF4&7UnuvcjPaGEI_<&C zqJtv&4spyHGK}iiH=n!e`drtJ8CuKLh>!imTK8n_PpS>9AjCa(yF#&JkG|GIs=?ZWzXAdnH?#BB_ zd9cDoVJ)A0eFuruJ?AV&3zT}Gu)dju>3wTNUJP>VJo|-^O@)v}+9M|kCPm{kX$vvx zVNlB0?mhl$-qSc~EJOJ+QGHOht0f%B$a2MRyOH;7BwG4`IpoBU#)Znr8SZVtxRtNK z-S)eo!e=yIpvPpz^~nF3;w7uBeF2(|G7x%prTlQF?#TCnoQ_toZIM1PQ3_52!+p6Z&RQPf=vFzd;=EbCO zlS29P^88T-9lCX8_>aoPMIX&Gj_b|Cil=yzNQsVS!JXrV-K`o06(g^Mtl|jer5)q7 zA<{sT_I}@InmehV^;!9Glq27*5_PF}M8y-LizKC>QQxtH-x|LAu7}R=>Y6Iln$5Cx z;`XMoSGtf2rwCz_fu32n#PghK`O73@)?K}akzAm7YVv#CFA$uv^5}) zem4oJUf69+Tg-HK27wr5bT8~WQ1g>mmlW*x)19vBKp}5>hz#Dr(1(j%!3P; zieC6G&1YMR} zyFiSj3lE`aDAq(L97@$^>|r^NB=wppOH|&3$D9Zs-l(lHP%#5Ha)AZT<}PClx9*f3 z5?WzKCuvIkm}mz&Q7Vn(HFC0MUbfwJrv*mq(+oZkoq!T`!W~S4-Jgln7it*pHpE@SbJEXO10IBU0 zt9fN86<^$;Dcj=-R$X;JOL%80_wC207FzCibz?^CX1qYtG&pR+#Yh-%e^Wee#sD_j^1_1uYip0F z51x1q3UkIJZOFgH^K&wtKCpxYdpwoBi=yHWBpnPHYpSk|I$Su&W#KlJ|89crrkUFi z6h0|#4^_=xh-5s9njUW(7aJ-kS(k>5w z#j?oQQ&iw}cTsbXetL1#)Lgmj`3*{`J?0aI(CH?cE3ukC;zf)tl><%7WChGzg5<`? z-!_j98LOF)-`MKY4~b$l;&iY$8&pF)LOUBpLET0cBId3Mc|t|#1Nn1=?UAQR0uAPF zlSi#p?8T8kWhN1i4DLt*Jj%$8xl@8z11X&ZDzW{kn=d?k^g|O%;jRy ze74NASy6;3*X>_AgOoe^FYD>4A{ipHOQy z+Ax`(!zw0y+kHS&mZN&oOGaSRbP=aGH1S#KGUh!tY|qERTtL*+G%-@e_-K(LR@vxG zwhXh>5l)ihM=H$6>G46wESMrt-Uo26ER#3+cKfx!3vZ6|JFbz{kzn-9Xn?B8_m)5z z!t0VZP_RPio(Wa@M}{faq=W)zIDTyh39tdYkn0$824;x*mfvqt{(zn25w^R)X)FM0 zno*PME|)88)!EVy7(h@?ANRUrOJa`G0pIMA(#iBO~(6HqCft<`d#+bDUr>@ zS6GQEI~|8w{45@@NfGzJ6p@GDejIuj3N;QL`q+LI0>=4T+LpP5BEAMY8lkzvf4&Rf zvvVU%io0xC%gApxENb-HEY)VqP2D67bi@ZFoHc1r-+0t zL&MRK^hg?tM#mwwXl(8Y$BDOTzG|#-aSn=tLq(Qnbr0hdR{?y@jWlTR(Re%)Sg}ze zE@9Y1jh|0C%8&USWS+}Cj~if2pl~Puc-vAKlmfp-rjELt!{0?%4=(hv0=swg4_a592gHU*> zR(73?KGzSPr*J7pJIZ+ke9zuF0KJ&2fUuSuRmA~aK-G|v&%R~h?g{( zFOenc3`7+%rxYrQwI%%+WgNW`$2)kugb+R18&P3s*kTG$1f#g(ih-qz1XS8V;0wJ1 z)adI=BdEtQP(~bo6k$YhA7u#_VJR2Cp#U2liMoW^=Q&cauDR9tsI$i@OH&%GVUF5v z3K#hSD1K8u+Cu4V6kLz~;Kx4woE%g!o=P^)v^m;)@4cUDXlUqG;~lKVEMsbb&wMhv zqCv2qd~T`0cqRk+gSkG3^Z&JXZlQ4%VI0pU*<`b+CMncQ@u3QZSV$TX`cM%;`clyc zpA>vj#Dbz&iI+AhHP%aMP^k!3ibBzcpoM@Myike+w1^n!gFZz^G=$cdW;f~l!f@uyedqh1Idf*tZq#9PJZn$v<+%xa1QT=8b>K!5ZG#z+_u z!?AtA?I)S^Zzj5MIl|mNVuMeI0Ei>6IV;QjEA@Er$3;eaXdh*f$L59{*`wpN5q=Mx z#a%Brm8H+ZXsLqSf+yQSE~Yj!BtuX)>TX+BO`Tt_uPG0FuLHm=nDnJqtU2>6w&CR zqx(H0`Ij`h5$3;@E2HY%y+Nrw^$D(Qza3(AmfbQ0ao%7i2s>g((wmShulY%5VK~HM z;$a(!Hwt=^X&coP`k^9`u&lvn=fdJCjx?mDAGqa5b&aWM`=32{_&3+c zD&c#u3JeVmJ=WRT*_+EPbYGg9RDajI)#6H#m1=J+GY%ccBR@~X_~VeqSQcAkPz%Fv z`7lP@;P|Nvzgw`Bm{<|#9LH7f+NLndi08vkoC$%WIfP>KBb?Pk81cY45NB8%Si60^ z>Qa;~dJ-e}_dVm|w!=1;dSs-qB-bzt0R zZl6GY;>{Ewgje>TqvxI-k+NjU>#U*dkHKoAC^OK+6om>ny5mTHCqvyA3vieYNG4tfy-0VG*lamSN3S8Ydwnx~rS`FRL z+mTLiG7e(mXrq7`=xUfTbyK4N=cf$HibEJ9kY+|vh-bM@CD&a3G6=WwNoV3QI0swM z&15ptQ}OIVHrxN^iFd|bWQ|gjVluw@>ht=Jj*dsw*^fv}`(|cl(tM|mQAtx?XBdnv znYi>Aht*;m$xLwGSQyZqu8Dg!LZUMhe4+FOH{Tx5;2@+oT^32TQQuMg-kx+k}gy?1tcrj>0O z%#}#`5etK092|ZVh8gTicoFy`dE)|zB z(>K?O4Jjt$^m~K#jZMkDtvB9qS8F=mqbIR;8EU889WqY3Tv|#XCX8nSa|U+K8ygMq zW~K`hCJLqWX@#WXj?9lpCzdTYG!^os~lAVHxihjaa*6z}+%t5^=GrUR>Vil2~}`5*XbChu<(! z#X%&92S{s<@TiQU+!snStR&;QJ^!P)zn(bo%;l@Dn}|&*rq!GnIGkv1Zr+|srMBzV zx3f?xb~Q95x5(JHYlOKi*_dLRzDWk(s;~x)WJ?+~5)y|~i$su<Ey<5t z(D@&l&;6o&C5d)IVL!?HXYZjSzmxxZ;kpph)p)h<<%GndyJSO)M0B%+x6szs)+|x9 zNGN*9tNg2ENgX@nQo2QDHNwqk)ImsSsC4x8<10g1AP@)y0)apv5C{YUfj}S-2m}Iw sKp+qZ1OkCTAP@)y0)apv5TmZ{Kix*oUV>S&asU7T07*qoM6N<$f&l>h&Hw-a diff --git a/diyhrt.market/media/images/products/yxRBcIHr.png b/diyhrt.market/media/images/products/yxRBcIHr.png deleted file mode 100644 index ec9e0d9b59374dbe7f2e4941354ad4af8eeb552a..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 52299 zcmV*9Kybf_P)004&% z004{+008|`004nN004b?008NW002DY000@xb3BE200034X+uL$Nkc;*P;zf(X>4Tx z04UF6U|^D900Jff28P_clA<7YCxwW}Cf`zJpiUm;Y z<+b;UVsD6o3JTa2lwv^;73oEK?;S!2A-zv;cgp|yu6@_c%@Fi`f94|mKd#BnId`Ak z*R$7JyPSROzw}?)Qj{rNpZ9d++rOSED=)LHw%W=ztly9s9vRM-m6caiRFsbl4G#7H z=Et8NDg^!iB^`P6hcc?HWilD7tgNv9fgUR>E3-eG`;(DEkpI$u>A&<}`Y-*L{!9O* z|I&Zyzw}@FFa4MPOaG<+(tqjy7xW*Sv^@Gf$CGzWCX=boShib5DIXXZC>M2IaOQE( zIsy5Kubh*aI(2I0J@?#`85tQFmdpR?*Pr{3PTaljEuYC$RAyUMp?cN9@*>q|U0Ej6 zUzsVlY__7RtgO8M_h)_QS$*J^5N?Cdj+f5A;gmK;p)c;8pIuP84+ zq@k&~wJg`v)YaKl-`m$Wp{H+Xdu2ac4OliZQZ`~EmdRCDt3a9Fme$ra;zw6cPtVBk z@UWM$wzgJG$yVg^1JfHD8*A6BUSqX&wZrxG^}RhkooiYrwA@=!QSs!EB5d5SVfygU z(5%W_?x%x8BUf~Fb+s#>q3Y_Ymj1rJZI$J&{r&wD1;k#3o3G?2t1L@Yhz>p5SXEWA zdLTd0t)#N~{9tW)S$RWeXZw^{)2FmP{q)nhsZ*!4tX#1+H#|Jjq%u|2)m2YizhP~Y z%3d)vG-xV=sm?>HQ}^(IN-#29rDr`#zbji=xw@vNc4bvnRmb4qptZEL;3}S8^3)FN z)~%bnV4H157C-gW5Zz?*`9{09F(3$||$j=7z?G-sQ{I zWJiX}Muvt)mW|kO*GQ(X!>sIy{NV5{72jbH|K^MufM*lt9!<~|L0xy=SwfQ70cIIe!y(FOu#8qi16%BTIn~{Ra-+-&bm4~th+O#GGwhuv4fK1R2j$nDA5k9Vsz;aFq(=1{QGTiJUT^YO8w?0w>SQ+1 zFR%>`sBXgsAP4(;MyhKoGCe(QYQtgc?rFEGYFl@}0WVu!l^I-g(^Z!q^Xt>UrVRgm zDjAsG{r=-?dIm>s?HRV6BmwN*?|GNq@zA5z+C0T>z2$COyRlo1AfPx22v+WQfQ0Z~ zGF=c^k_^re0YMFjugl>YE= zpFi{RseqKJsi{f8>sRhHBGYn?|oDXp;nDup+*{3133)5 z$01!<&~-os>9(?}(wRj_dSnp2k_L21rEnuACYzoUy-+)zZ@>Na*3;8vy}iBG+tX_s zHgu`MD;11L0;?%c{*+8tf2Y0b)d$q=na+w=vqtW6S*I+P1Yly_ht?^4sHlYk|)@6U6&oNTXZtIn3oFRL~kvT4mj z)=*n#Pb^$5sjrUJyTR%!2H*FtBX<9lH`KpLg+9FHX{TKeC?6cke5|aZP94A2GL?0< zdR4o1v~@cZ=^?12VTt;@z@cV!#tf=)`v>z9=R@k@Qh9~zfc$#<`>aO>YQNOLKwjb0 zqx<{wu3`rAg9s6S(L8+gfe%%iVaAq4ewu!Oj*48&*17dJL`6+Dw zh~kL7{Ud{lGhnl~o^N;D{h$qJ>-2lrD(mVkQzeF}q_VD6R;fLcY7`JhlpX-eNYV@e zZX}+rLsYQ5O81o#zLi#%tF(reX59lWbpTxfYU{*FCi};>nY)!up4edRU7faO-9~Gf z&}{R!nP6+zblQyRGZCzkRwFiPO06~2R9S0_RBC;VO_?~sGHS<(t@Tzf+tQ_^@@~+x zib}QLP`C1^weG$VYisYdnOjY=uJ$gQK6AF+a_ik^-gf059(AVun^ZC|?Y8GZ3wrwo z-)GtCOi$mSGZb4Il|(PnNJq}Bxv9}=>l;i)x%(sbL-Nq`Pz{K7>?E$JC9Zh^Wl#Vj zEDk%1o(bss)LZic7OIe*tBbXFbV@2zic!6KK4`rH$gsrFpdJE7(vXSa*M3RS%BmV$ zxq6)>ON9U|NnG%-J@ zSIirfM8OZ+1r?F(q2y3gam7I+X^^*xzdQLM$pBme-&p((0eVmps2?E84ne(Y6ojFw z=P5qvj$of;tF5g~Mz6AA^aRNJ)U&(0Fsdby0DVD{s?=yo%gctM?B!Bx5MYYDD`gWQ z!0^)u(1!B;He<##H@s)f+DeisW0PbCJaFGbHf8z@Yi(^6u-dJw138%0h_B9`UcS-F zq_!3>U7_-nNpe1HOIK--Fi>Srtyn9NXJm_ZTDGR%I=XuWc1ghUT1ig8t`60S!O!5K z$0oNl*s7H)k#N^uasE#q@B;svlxn?&sVrN$V7S8GURkH!y=JWqs0$B?Np5VaVPSF@ z+8VZNbk`^GGhpRXG3w;WNQ5n71Y!l)s98Kb%n6W;cW$IBe7U0H%J36N%Sc0RSS^}Y zuN(x}D$}rEm7bmr0A?XaC6jc~aAzYx!Y~K0<<{RfWF74tUL^7dL>j*N+S8S7vi!sFY=Sro zO5_BjtW>xJ zs3*~&G;XLf?x6~yC99GEq%!q()SqG?e&A%XaRV%J&?W#X^7n88M+JsFyjDtX;JQ<3 z^c-*rr7Dxs(BB|wNo>%ARXBBqtR$&WgeXz(E)yuqu!%em;!;l3G|#vyt{7S_@S)0w zRA1pHNnA;uC|{Y<>+S8cDO09ecW++CbgxR0m1>e&Rypr`e2JCSHQM48vX>NQ)rMYM zu|cX!h$yRRvTo_Gywt0VFI)8VT5Ibrv-JwoE!72pJ9_&3+9!37y6#b4*phkKjk4|K zKV)6<>yheTzP4SGOrycRp^09hEkGp!Q?{~V2)#TsBzr?cZJ17PhPa|OxQ3Kr6vGvp zhoO7;L&1o|$n=|@9(7a$uH7`O&tH%Cz}rW;1fBj(3_lp`Dz<-lGG|Hv1L{6iWs zuS6K?7;%~9&i9Ylx^-OwVznetm#e9+0Wn?DVnb)Y-TA;mTielN_dmAC7A;$4YukHl z+3JnfA&K(D(sd?{Wlt_&XKNL9gCx>AMv5Gz@R<|QOV-Q4{*fqc%BGm59&9zRNkMB zIwXtaUYhGkaUq^XnnCWTKU8N%;geGw<>P(|Q>LFu6()cbgO&Jk9dojgWXKOmU6z+? zm@a8VvGJ$;FcKP&G|6T$wyVTUjTFV$cB#v{28|A-A~Eh63D(rNNOA}OvJVD^$}J~J z)X+T1YU-L~jbNjjg-w+T77+^Y_lrMDlcJ1F101~ zpiRnUKOjl5w=!1YX|#2=?|t|&U)dr!C<&M<%d1+ud-^KUFuBs%UV$zv5ETpQ1V!Vg zo;wx}O8kVGN=3{bVtnB`mC$F&1b(U7wWdG zEIV3m@32y)bV8mpbKajBwCaYMhTh(u)KLE>l>|)X6=jnL^Z5+D03a|MoPaXM-01ny z`)Pb^si=4mjSo{JPD&@Gfg?N=*YG2)pyF^rf}>wOeVjlg;o`(-3nE|Ap==>(f{0I1 z%GBFo5VOjT#G-VGhoj^4^z`~P1+(9z#iSxqir+&5@$%)%T_r&*^s@ZIOgC$HlzsK; zRlYt+nHU*1H8y$tNFP7atgovpv^OcGwk&RE(tx4wq{ znEGH6tMpQ?R5}_tz!Lz0s3D>Q^NObx`0x`PQn!aH~flbA_zNUI1Reo*99 zoF{jo=Exg$Kzz~!6xec1oB)%mY?W16>`0#l?-5{FU#t*d znYs3Qr~pk(4PIWahd{~iA*uK3>M92xAYxuhQpB%=l0fzKb&_C!C@rUuRKBlO`0^x>gsdW*i>V+b(J!lyRE)jAY~?9rJX)~s<$7i zG+U|mlW^raT6Pt!tgK3%g(jA|%PT+Hxw4_Jv%f5f#D9}Y0;blMmU2`Dc1lJKM{kqr zQ)S9WRmUhJ#7ypS#G!#9egnRA9Rp=h#7XxljbbW(p1{NJlnzw>!=?ODXE2&{P*25aB1s5?AJ1^aXAW-Fs#R(evyB@!dRU%8 z#9`EiN*oX{moH!GaiWd5@;k~4gRGJDW5bB5iqk)5p8wT%qR(u~+{F??$YA~e{V2&_e4jQ?LisMtJ z_ziFpyOf^l#yk`tCCx|!+lNj8!&xrjcXxNU>MFxpc1?hld%_Wq-}nPWrW07`G}Kl~l}`2m z|0b0LOzYOKaf(CNTUZ4pI<}ZNA?D@ zt0P6Kl&Ooz2LeQZr$NA2*S^uJ8|$q?whtYMbO8*D$yIeVuJ&qW`yg?Mhcv>z#3-lC zEQ9oG$cSoeYF0YgjJ0=2N>x?Zr0G+vUn;AvQRP)iWz<2}0Y<4=ft$fW0Z|)rf&Oaj1sujA2CWaxB^}^%7{;zDRDGUtO@1(M z3zw96{>#&!FdyIP)z5yk9M_bTLNIRcEr9E{&I5?z%W5-%A z@V`kV0aJB#u2H2|MPNR*4wc~wbJEpo=8hupJPlRZ2p7OfKukk(9QQOvx=#!xYyc+i z!_k1Fy|QqRR7lUp{Ja#p$5j{9P)Z{)HPR+L_s*CC1&HvAa^gs1^{Umb$^Z|loxHgs zfdCQ!iF9$OF~S2ZBvqA0YJdxHBeB}s+CAMEz>p3^SnA;_PZ0E#1Ob%tb0ux=2?LPu zqto;&UQc(=pwiwVIM^aX!tr$QD_*x;kQpi)8JMd+aJ`N6Nhjy4k^xM`k^(~_jHsfO z6;)Qro*#j3Sn8uJtKOVduaa64?-U*bRjQ-{>4AD-{sfgJX~(^IOPZ)lMo-D1#^l2W zI3+@UTq|p8t(V3IL=z(2@uIY)|Xs*2#`a}JnK2XS>EtDE&fPS z5!2jJn$to~F;B%X-2nv{)XK!?zOlL0y8Bq5W%(u}ASJ1Xs_E`aYLY}4NU+cgWw4|8 zt#D*XIfw&sj})kqI?80zXsb>(lG;PvP4*jePL<`>-P7rkYVF#M8u~YT9oRxVeM*zm z*&3H_lO}Ja=WCT_x%Du$Pyn#Hq|#0ET8#b6R5vC(k?b{P`JrrW?)+R`?w;K6U}tr< z;_14Y+&x{ZpKN*Xj+@q8c=Vq`K3 z0DxdfVjGZk>mj0gFh3*_u3jav4x`yM8EOS_uXa>?8Sm=-eR)9*W&*yEtN@l6r(_*K z2{ha#>Ss%Vt5kt*NI+BCguzcR)jcdi)+H6!+|ptz+d4dtP<5mS1Itt&mq?_qf7mWO z_lL#zlIpQO4aaG8@^E{oASu|tgnV-5C_UoH+VRoX)TvV)#FUR^4D1@p z$y+X&Dy37Ia~r0jvcl?`8Z_#w^Kv6a01}`FPYl!ZD#zprEmq}k&0yG9D($@L)n)5s zMCWR%y(6%-W#fAGrVn`DeN4!TC@!Jw>%GU$WJ#nUj4cTn)uM2|$907>+Zh zPxo2gjty&U>C&a%kh~Q_SQaG#5K;^VcXoEG;K@km)gy-T7^yImFi0;PmIKW7xh(Z^ zR|x_xwiZ(o0Hv#|R}61(=C`&?@ExH5gEYJQdtJTx0 zPMBaTSFKfEX-f}ZGVP6j7{3ww&jgOEh2hvqdR(Y=5|I)uX! zpY%q7q_9JS$w20JId8Wxf|0GkC`lHHH$K@64hWjMM-Q;O5_?EVp-bH^@n`J11e40A zTwvi7J;+^9+qF7>Ls=m3-{BO@Cr$bD6XBy6r)^%zqA6*iFX_4ns^Z*F8@#AmW8 zYeg=vbSebEocwzQjuES8LXvVwJ)#cDlQJb+OruA24)&L0Be9KvjfR!%(hz7-^D5od zLqo&Itz5DG!L4UaN>k`1ppt{>3&(x+K!NG1`sOBen>5QCjgItzXl#CakCXMmeXO8E z017bS514dOn;~Tq=y=9Gjm&exb1z}zM7(k_wnCDCJnL#3B;BMo>uP;g7=WRE+dDdx zyGB|HM|!-Dm6uvXG7cjJ0cL_|!hpP(^lS+G&q=n|h(@ZaLyzjd zcJ)T9P-NPB{rU|WVo*m|jlBLR!E? z>=`!I^PBs=o^Bs9)97hZGfA5fF%`)L^9KQ6!A=28ewCx4u_drQV0uqChI<;qV<|zD zfuMc8{caa^Nis4mkZc;37%HWvD#ct$#0u#PF&uDWI5VG3i|sHHX@umU=R>TdV{m%I3UGrmU;!W_CwG8M&j1tz zaClXl9gTpAks$fNBf$xeFPIQwoxq;*mf#gf{Mc!Kn1gs1fwC+3^jEu-WsZx3s0!$TZazsXTmER8y5BS@#4Ek$x zS*xk7)~E@PRa#4HqpvR#rn$L+#ZqgT&?F{SOKKt6%537K7LBGdHe*VwO=zleLbpCkfmHt*nRZfUS;0R-1CL%FkaqczIjDXSP# z9U26zDyx+(Rjc^w7KL6bAh^OE2P8RUE6tOB@m!bmpW025J3nj#8uoYe4A@fw&${-0 z8yL~3vQwr)w%YfJGe;*a=ljmt2bCmbVQENeyQ`vF9s6Ruw>8DO$seItIe3q?U(CT zJ8kS9unnDglQ|@Vzd^QMztp%K@3zynN+hfL@@}96lG<7-t}wV5l-WRjym8#8j!`Nq zDVW6M#Yz3BFBa??#BLbP*hfqautb1gh-I!05;Z`81+g8HD1a9BS23{Cj?UzuxF`Ma z^YRqjroYq3kFYQx%Fge8F%CbBa2SJqN0|T|>8@F`#yWTfJp+KUGVs|^nXw)X)w|h3 zBG~w!(n~NJBmDiUOP`vlS77Mu8?x1HJ+`)^*V=mr{k8T4?snfF&V9E4m8MoGM_Ry5 z?Sie8+L-pCyeW@NzwQ$wN;i;@X&_y=e> z^Jx8sjY&$#k1O?I%WYR@+IPfTzB$=^NTu4EI^$iq#ZRtO2kDSB>9P)`(<{l_r}(_q zM45Q$b3g#YAuU*V-XM_h@?@VROSe>7_W%cKD4ZlEF01;J2YDf_m4w$Bz*Aj1A@#{i z@_0RIf0Z@bya4>p>n{6idRPJ~DVQ`$+LsMls%B!ah>FG4d%PG!g(0q}6Rs{z)UcIV zskMS*L{(X-YdPy%0IS;Xt14?14{23r6;graIbMyH3X(CMk?Lbo5yu8I-`obUly~Hr z@mG;luF*y1R7Tz_L(Sx2C?FbSbD7kj9&>QT+BF-!93Ac5R#)3(U0nj8;?}pcSdVO$ zPDu`FD1l_y*0y(AyXxA(s7n&8Q)zTadUOgf-Gh>z)%7-zskAPs*G{Q43~Ll{UZRS< z+8ymI5lI>;4@?9APlroeab!>Bdwi!s+Uw5Cma?V9-H^t--qhQZuYAR8-kKV_1XNnd zG&Hn^UKC(~=s`4u5Aj_JB(>&}LeF7jfQfZ5m|mO)e)KZLIoEJ*SLsU6jc3F|{c(kg z)m#v>%H&P@i8)Di5*9Vgk`M7wFZ@Quv~6s2e}0QiE-`rS@s!Tmwd)k0X@n7LZ|fEF z8EPOIQEnjX!;GxFKU zdvt~NAs%6h+noAQuFlTR8r6O5!4{^Hf=LCx1K_|68UnFf@b?M=ln}`f1|xnEhkJm* z7FI-hfCC^x^(?@ukw_bH&rvnp2apnYlHC<5f!~A)B9ACfVpNirDgU(GgCB7K5NnEV z)aE4_`V;tgeF-(WX3bh_liEu_?3HB2*k_0i|FV)~9DE^zopU;d%KbTj!T~sbQ$7yX zpjq;gV${91rpnsdc#EY>086v)OsaYwDr4I5S?T4Zy`oMy5~9OkMogbJ?WQX)`rQlD zW)ee&kwgsfQ4eL6GNxItD)bG2z}u>bbIzoZ=^{-d12(JCp8VP8R900ZRh3hG)Rsnu zdS2VqYPF3mR*|c*tZb(G)@Cc0N~@}sbgHfQI74FMNI7b*TCT>*r2?(I&d<`6PEo$e zP#)H(2Lfn=vSGUV^L}DTkL(tQY!{z_IlJn+$Lb%~{B`Yyv#M zq~7eDL=ACb9a9QTO?3*-iFJU-ToM7wG_#&0BoeD%(uz}80Fu9TnROT`P5J!h39m?zzn@ka?VOb??X{@`@D_bHeDVS<&YaiXPVMD(g*J2jE z7)KpL3M8p8>^;sOh%l(#@Kys79!B$s9vLDWMq`-!d6W9>l0{*YBuXzhvRE4N+4;y) ziZ7EC@*!{H#+5RVZ^R)D0D)=?2}u}K2`@uVnKD`T{k{;3UweC-t8Jc<38O4Vc-`H7 zwr1@HTfcszt3=`;RTAjfv(;-Gr8;R3R43;v0I;5(Zq+eO%!VItuHc8EO*||<(jhLA zAAjoOri8+$bb44e8hZNaC3mHomxf9TCiSKVRH>WUHZrK5O0S~F7BdhBKxi;}wKKlp zAA}#wBn~|k`-rgoW(Onp_{9V#j_^p8NSBc!Ai7Yn+Sh4>McG`Z(> zZ0{7h@9FN5f1N%3^ilyujOyxkZ~)|W>()DS86g6sxU%5O;w|yp+Pi%Iis3z*0*S{u zAL#%#9QEOMN*jQsEi;`OMRLj>G2(tE*MH6-yEVKrn5A6ktyi2TE}8=!k&9T4P3fyied7(de(gx7!-(Gy)ZXS1es- zS;eL9Ln=4Vm}T$j>a+n#85X&RCE11*Z{zxP>Hw;h0G@XhoiNi6@L(-GO z%*YS&HjqYhOl4rpX<#Eq+HD)x`F7wHE0@ViD9HkGNS89E9*<;_ zF)J|l5B5t9W_91~b7hFG!9%;8}xBDTb+LSh`mk!4c ziH#dK{^9D&E?(@6DFM+*N=~Pr_VX7#wQR-p*~+SHNE%d0%v?kG0UR7XKhzxz#!Z!p@vPn+#=VMvz%0dTh2 zW*e!or$@_28obxW6o5=)8yv~|GY0*P!Wc<%_BMHw7P~E3kz*7|JqR0}148m)TvKnr zOS#A+$_D`4yz@?wMx>-o7>GD=AN3|Kb{=7A55iMVwj-F@gWA-Kd8?O3@hv7Q2h4z+ zVM-e#A5agCC=HdDvU}1ZjQcbPM1AzTjOmC3X39l?H$&)c@hL8#A0&l#A0 z`ecso<{F!zBu*CG7feAY4 z#8Vojeoj(PJXDpPsRs5h89_7(4H%8aeGvD!XgnxD0r8AD;UX=-M0e*t{32fXDQ8K$ z3C;w!vod3&%}D>*h;R_$BJUuN>&r9AkGyaJ9H=<`;{3Q$J^(^k;zb<4BGq)EJqXKE zlG<`eo#j%2|5v)d_PfV_DZSnB98xObb4;K3_-AS5gVivvR?pl`5^8U`3aPjZJvd2- zL?bGp*d)~;se*b^10rFfCpu_E_;Vj1afTFLo8k{1V03kk8~RZE0HhrOv`5!eX}(&H*AfT2Y=W9^sfK@WF*f zqoMYROnARnm|Sf&?X+CwzqX^j`+jwVzbci-fB5}xMT*ZkrP}`o>Es`rmJv8+uUfTg zk^pjq?4ZxdD0M@9q$1fh-mBHn47(vDNc38W2Ie=t9wK}IA_xN<-a*oQ3Y(-Gwp(9+ zmoJm>$`#CW<5xfe*yIro!hcheza&uP72zm9+kyKvYJ(^r<$}hiN9Q1Zq)q)O2YbJI zy7|t_29HlTp4HW}TcT=EZMN$l&-u+m9_e{NsYcHe`r{w|oVo0>%kJ56#~pXUC~cWC z$?m=PUT6Bm<`(N{Yqzbp-r5^>*|KFWNt|f{PB0&aVe2p=!{Ej7T+orENcIWeZsDaz z!Z4fM)7xPS7A)}J9IlmK3{7eYyDpd?QX-h27%m%bAgLwF0<*d2nnyax0ZyJpSt$c9 z^5CBINt66A{sA{jD@;-Xrs>nCd%myRk-uJ$b z+%a$7{5_e2Y3u5=4I4K)c$n&|P{TVz)aa8ZPqs!iIzw-c>4O2N27s_$jlXQ^GP~oB zJJK7m{AHwG$_k^oyco$A76A#h)6v;xGq>8x8NKj{g+9b*v=wjv2AEJov6#&03cxUG zWC{Qv0|x!`D`oN5B6MZc1-S|z%zOGQ_0ah2v+@z4%0W0@H77oK^U@`AXXH0~_H54| zFx4>$Dj{~)U3X8v;E!jo@Wh`7^t=Mo`4?VR{*P;~T{vULj5$aN=8*suy&s}cVIZTK z;Y?c52WW(4GLv4;ybVlaz6Cpo=>y_qu|rhd!f3}GQwB^E02F?6g}9Ozk^qWl#g4oZ zc+#lO(<@wgj?|J8H4f^)-<|wJ@sd7ekF@yhX;lg2l1}{AqXbsn%$h#KhVz5g-P2X!`=wO55~e!T*@mk7#9o5^^2=El2s0 zs?>#(=C~hwUX%Qhz=ibqO<4gg?)gN|H!zipN%g@L8V$AO43OlZA;TX(7zG7GAsQG- z70eFXggCfhdc^T~0tX|d@E?1g!m?Yz!BMy-SM9%f$&#H5&U}F&zysjI{^2+NNKbYc zaHI|(A};Z$7tc7LgLDH-{I0L7_cBDj+{Y(DqW;epdfwSgZ+hGNZrW|P-S&f-E7z_u zzGDm3sFz~L02D@bd}t^3WTWzETpBuz+yE3{a&-l`0FEdOUWjeNynxAbSx5SvCQ^L{ zUg_XZK1m{_@JKXNmXj`|<>1q^I6{Z;G5gK4>bhEbONvs6%33AqR0*_U=(D|eG!2!3 zMR8O!uYfV&;J%_fV{IE&VG~Zj@{+&)*JgS)dev*+bkXj+@BV6EnCxu#w`D_h!4w*E z2%}VBg0L?JE!ic-BQG3`bU=u>$2pT680k4_7sq4P+DB*tWrU6J#qn^FCm`mY@^L?! zRv|7lBna|_Po7f;wuTUfEi^-YX=@H)*)z{u#*k9-dLmId8w%cx- ze#13a{1;5mMn}H!ofm23^6Gi>=2>TNw=H_|Nf+-lD2#&%ye3|$-V9TCQ-nh)U`&7x z#=vZti=E_>Nfcnh1t7SOXRZn>s`V>LnurIJBRuz%gLDCEs89Su;zgPfpWlFq6Xqf; zX}H=_KD^(@UMha`jXs`xJQ?3>SFiCU9pdpy7%EUvEHm6^k3II-^vf=K{utoTJ1`yd z*7shdVgIXVX(-G#-^U+++*j}S+;dO6`|i8#WiNY~Yz7UHd(x_TLu0))Hr4y|0IC2G zz+@J9FS_XO4!8saw#qWsBzuEBN&c#Mnh1n>+(V=dVMC$)kWwLe0wla-sgOP+&*C$A zCJ-S-#ztsaf14&fm%`PsUuh^NBCMah?RkT`6s!4HF+Ye+!C zw=_1{#`PQ0)Q7;--`&Y%=JY?Fch2($OsNH)M|9x9hrLCOyA7MuP+^FEhWUU6dw~&5 zb&fNVh6-THF&peN#4sb6#oE|I4?W~+F#&;X9lV3jNw(zz-9+1JtE~jer+nnZXbRx@ z5y=7~(+Zs(Y&1*TUc>PmsmJ+Bu_YFU6CO1bYkd5!s7No50t_ZGv8DkChjy^Xi0hm= zbG+=RF#tyWr~@9bS@jRgC9hhG6@>jokps#4BqQM|%j5~IR#&6pywa!@$Q$eHtde*FF9&Djl-8t{RvFc5 zc)1~sR3|n!D_o6D6S&cyRT=?KQpahkZ;%@7mg;V@NfTSFsjlZyAv_X|&r_)L7gS!_GZptp1%4yJkQ7L@P3{mupEi2Io(J^21JlVT|M2e;<*!;O!y860>&u~{ zHEPgCNuk-ZX8Al5Bb^pkeH-k$Yj1D^768C(t}v~#w%X^RNQaZtkOs`_pniBOB!E*4 z6o}tp1Hp6{%`?D2TG&f`f5pKh05Cm~_N1#^BZN=K7-C?PK7#`Q0>Jpd4kyO(f2Z}%yk%FQPJQw7*dHr13S#>Tt|1GZL{rmz8xbmMs|jJ{6h~uU;`Q@(ZfS6!C>Od z-+m{lxB;JD=-AjM+o;dB-+p^niHjF6_OQH3!U=Gs2?5}cZ~!Y@QfItzlD46cANR4Y zMtNLnWpi%dVchSw>mCl?E3drT!?Vpr7n?J8mhwn%=RWboB3u0AQcs7xXU(4G(vXfp zJ3y3;Lqvn5Y0Hd!ei7L@{^03poa^b!tIWi*&$dxxq^ z99J!p7+iV9h?7GAV1NY2J(7vC@Ege$R|ky9~7;%v|ucM>pxZkk8!?sli*m>t2 z?ZF2hQv5QFA}7fnnj!mY&{nQoX)BhmlpWNqdu+tefDD?ESo-K<|&O$wI9z_i%BCeIn6lJSP=Ie z8o~9b$FuX23B6tciWeZ81u9;4BrJ1IfP@WY^m@)Kz~J_Yz>V!1Jr$NL3c#U<4i|PiagM&^$3Gfdq4C;E}SVejpljJi$C((`LSha4}JcTA=Z9 zG&t#HDyn?q6JwZ{Dq&*mrzUOG1~>x^RgOZl^0$w0!&t(Kmu*jGYjM( zp|N8GCWgTzY#W#XSm>!ph1!ND-*Cp)BWZ9L>#9WrGl>gmAbFl)=-->BdayMXMJw&+_|m}IjEvhqphZ< zW)F)50|>kBwwv2s*f9VEfARoe*dZ9djG$O9%SNSt1ai058!CNSDM=6(a$y#X4OIykkYpikQX0u%2PEW+ zI*YQCPSgP@0b}vQ;m4INGn5TUf_2B16w(a9ge&$7qD=Tl8L9=y@~U*K5K@#Ypd}8+ z7pW64q4~LEk3II}LK4pjJ!fG0@sEEzO%?r%q{d#=73?k?Tc(IB4%^__36P8xIyEq( ztaSC?Fs#tr39AdU*S;bz#)Mjf@%)BD<>C){`l0|4We1QEkLMAG z`(aLS)0J?EI8*JG!-5zsVDcx@gg&zI*S!>xdto zdfHVU@j0O9M9rOi^2rt5ZELTYI8p;a zGjG<66tIJTF_4Ip%8@AUi?0q$m4iu74FRN~aO7JF+E_qlBRuCeNx>BgzxWN|7p|E6H^Jlr zXyfA+-;by9>2V?pXD~6@S)Qx&O?o8W?_YT^msSFPog~%)vLCOw_10V4Qq0m($-(rs zuYK(hRqX6+Ma5mJ{0gqR+Q&;ZeXQBX20XYRAIdckLP~uhc z@HE_sah@pmVV8_OgIU;BT=`9!ai7vj%QdJyo&~6iff3hGb0Mi9uDD`QM4a)2f8@=z z_&(C(cT#~Gh345OmFBQoo13Ki#!lQ*oGBVC>^g1QwBNEEQ%c$t?pv5nKjnKeg7WX3 z*xFQ8QJ$%*tg33R%w`)ZDzdfZWdan9L}P_Ia_FSqTHMUo8V-&CiGIT@cj(39-*V3g zlYWl+kESE?ycj*gEKFn43xBSKd!EBQR2|ny$HU2a9R4e0#&(zDXAt)e1_hz+<0<7= zNUIPp>Jau9{s5XKn@WvbIa{+z#Tn}Fv4NfrPOuy4?(Q1s?(W{$*Vp^BY^wZ(2@_t@ z+}ymsCs0Bvsbt!BpS_NpG;zY0E3*~657#N_R9l&?Y%0%I4|aD|&7etNq^siZn3t^BAVskHQ^hqSLeMP0CY9 z?-?Y|NX4&(-=h!k2S9~3ap~=j-((>>Y={$u5 zLAAbI(~XBqUWIGHB`UfbyB+oQJPPEoM^qj$9+#fryScygJURV&-edlW#(u}$=x@Ro z;>556~T#wr1o1Wc!%dTMp9I=2rD ziWy~99Q7u=6aWNh;_3}ka4wa&Pi)amfeHL9{7&o``yJusoEZhjZ+Fft@=4c7-^0)Z z9!|GKH16kSDWx1P{rR0P{;QBja`H?6x!dGffJ0XYk&o2)R&dVv&fF-F0!)QAOzE(D zA?>+}$yD}1B|r^Tu(k*f7>(v~)syP$>ZhoXB_Wk)%aaQK8a2p7Y?ByDs{v#WCJ_zu zQ$x_OV?b~h%q=j(ulgH(E;ky!h+&?l$1TLiU%%bO?@e3^JNit2$tdS%N_#wQ-e)Xq zN-F)1e0UW1qpko1&wmpjA;AS4fywPj+D-mGIB^gafTZvtogyy?Kn0K-OhZFuciet^ z#&>FFtE{}NDm!)R%&k0d35e2caq8>qn_FF-quC0LAt#YDT6u2(?hDLxrgKe=;^eo4 z(@o*to&QcQ#T~mJ@AO~6rF=Y3m4)B7omTV}Da5uy=xvE@-*Xw!11r;b>>{^Jh#i=A^b@;g}22lc8v2+@B z3d`Br7^*%3mCrLA|Bcev51&EuB>1mzmGe9cAQ}adR8`nLW3FHiRiM_&3+WU&ei!GB zw>(DMtk`(aFatS@5O{F1*t{1JPG~NkVd>8&ni3j60xZ{ z0z5D*D$U6x!Nfwt5V*MgAXeN*8#kPOj{&vtyWltKU*y8yorlMpXNBlN#rH*}QSnB9 zrBaGEi8q!$_u-v%%RIWwrJgQsxBO#w*E=z1eXJ9%5tIN=K9x~1^j z8=fZAHN5dFxO5r&?asp%|Ayk4C}kgi<9<8i5{+IxE!`B{c=Z=~MOhMHxGy|&O67%8 zJEXk0ru)5E_dVy6l}!k4qlDy!Y8 z2YQWRgI5&r&>&m^kwC@09(o$jAa8eX`9gz1qc;Ug&q-m-@w*T&T!EqCQkX=1Zw{AY z7pJqSFUcuIN5I3gpQL6`m#L7qv;j;YXYJGqn>y!X`>>hJPU!uHl^0eR;)* z)abDF_4jz#7aW*^IJTH!E^d@*UdJS^iyO=vrqHr+Ev5vd0{{I!SmGX=iSd7+qU4Y$ z?zm50n4kWd&(MDK!_ef7~C!(X{r*!8QA@(QkSpZG^ZrN-hnt}r5$OCWFt6ewZk z*#UxoFf`)*Gcb*(v78d6-^KrrQE?uA_4`8J0z=q5p~{{CAl;9t{X||r>K>p$+84|R zj`Ly3#g|biP+%iG>wNOjB8|Gq{4kMz((54EjZx2_Q| zA(^^5yRmD_Xsl%J($JD%YPfWt8k{W^9B~sAAOT3Jp$p+)g4}r8oF8$EDbm0{?t{o9 zDB^7{O(>pk4w$TmMY<`E6fSj!6rOpdKupw=uwFN{i+uDr4Id(o=c!wsImNyIOz{C7 zetr2NTef_;zeo7u{a$LVtrKm-`nGGPZ#D5?kGqAbP@*kQk38~NTU%RuBlqkGWaS!0 zZQQWYdb>MyUF*G#Ude2*?^{;S%8M0(Fzf}IH<2?QF46D>h8BY%s2EJe z491^$#c|?3F@6k85wDmcKF=cmAixCiEWpS$*^f}hIE3Eg73#|^e!i~eaR3zgj-~A% z?(wiHn;!967pe_Sz=x&z_%(TQO3IvV7TC;LbCqY6p7q#3|FG58<*u1LvG#=prU&kS zw5_jquo33)+A>!*$^k4k^jBol!X}c7w_~xbICykuq}vk+yY~$l_U;Mn700M{CL!rJmm;UewZ~FpN z;v`nlp$Nv&)fnZpPc6q+H#XXoDN}9ww5>G!Z}jvwboE+SFR!eZS-nPb91Lrj!D}Yg zRlTslbla_WwP_^VNDqw$gHhgSG70%)JHX-@py0{`=Sblz-+Vil@PG|sI9zB?_a_dG z&+#;XiN@wPVB$W0$9*vcbIG$9NYHpNMHcb16#A|tht&7 z|2_-x@uOWUvcoStFkODx)ol|eOl^$yw;*pkA5nz(Pp=K7Mocrc00p20qd7NnaF|!X z6C(-F)nAC@pi+U8cnpd0BVI7X87Vs@%8-W5s3-k^u}X_a0S2U@f0IS&`ACys`lG2( zJ$&K3cutH9M+%~PAo60w29Zu7suS_N6Ud{YEFI862db&9Nkx@QT5-bK2mFG9i=IYE=qlSZ`cfwr2K~F>t64oV~KsAu>8?`@3GkqB#z3WdhZc~WH z(l0O*kYprf%9*y{EnG%b3ajU7G?f5@oklrefP=b15=P}=L>AAZyyTA`fC6Nc0qK*g zsE}!NGWj+(;?n`}ge>f6!H} zB!p}`3}wJfdK{cVI@AMl){@C^I=PMvN1rJ?`BEM}!jr465}5T&Vdyk`;-i*>Daxrk z;6b%g&!iGbrntSh$3K1-6Mo_CS567e*)=V>iWe4`&O7hCwq17Gr?I0W9iU%aVHyA? z(V!3vDJFjNoN$BzAkbKYDZHc$&vAs0dyc(fDk6+);&4r1BRy;sfkeHTIUD@)1M#M< z($_!EL2#9(YowE_tF<1fRMc+}Oy`ms9O3MH-1Wx?n^DoIJ5GfIWgLlEp)&Xu z9Xg5f1+>Ja9%YK}TmfG^E2wDN0muD#igp}NG}ma8K>|}vP3D@$s`8S6Dd~a|5F@mT zEImWLxh#F|0fq&rkP-ooVxR>u@S~CNkA@tJk7%L+VVao5Mx?@hQ{x1`4(0*Lh<`L0 zu#EVzBjrh@Np%1!K%nHTx`uD&mRW6m*0MEXbbY1ebYE5_$sku=Eh*)afd&6Hj-A zGNiIaogj)>4Ei*Z4aq}!qTDHdD&yuHw5cCP{(pi>1}46YqZ`MIx;zlV82eYIt1$!gvNo*r0e8Wo63< zOGE&Pdd0%DLXNuP^dNrwuG0eWpp->~rwqvvCP}xka4Al5MMc|$@OGD?m4r$LCMu3< zV8lXYqmgLzU3Ihd$36EcKnnB~k6jS(djdF2KOiK5}k1~WG z6zSrM<3ofk{+-fGfK7%k;r)^O>7U{tZIj(cT+$Dh!j8hgU5XdK6Q%GeVXpeQ2~h=) zA{zf}OHv8JG-5ry-DysUT{WsrFco3tTVrX&f&>ZXZ0bg=wl-(qJ@EvAif|aW0-Rh; zP0s4-`S6WY1!E+Qm`EN5(zxTnQk*V+!8m?LxgyS(9L6~`y1%sfmijFl#T7F23g#2FUL(0HVmQ?t>RuGL&Pv%25{5o|E^(7xg5=8BvO4tddP%! z#uskW{0q`2&0D43%N2a00#A9(HkN6$wg)~fI0W2LN)tUN5=LrXS`3iAT zJony&R6?J!$o`8D9sN60QZVrmzfdDViRmd@!T^Nv*9b$y*4EbeeQMN1{6?yemm(0L5MO6Jb@#n zNB$`uQZ=3zC0R&6QcUS{9dpIB>F>ykjy*82X`5_GDjAp{n3ftm8exn9UR{5*X)l9l zI8+$JWkxHsBOlh8IB|mUZCj)X_b?fC3IKzdi6L2kM+|AQIYP?u4jNhV_D94GqAW0= zxLhiQU&*r=P{hUI@4xj&9ImPC$+3Haau&A*Qa8o(hHyV-!Bc(wr)cb1B0!$*(zW<` z+!ubU9H`pLET7@$J29(m-MS6wSqZ45l4)pA>ZqL6aztxXSUp9zENl+ZGYd=#8fA)F zs=TUN>P}Lorq(XF@Gth`AOFN|y6Gl+?6JrE!#M15BA-cB<%7 z_0Nd>aO2DRY?Kk^a}^`DXyL>DRR{($Pd>T0@N~=5|E?DQ4|Mj~XSYeqG#-4=p|)W? z^G)>F)PpnZMb;G+7`;500Y!rmmXX(k4?bXzKk|_ENv#1SzA=YHLRw)!ha|#}jr5Ba zEwY!t{1Dq=`(308d!GS}iIZCG;~)R1z4fhc_0OL6_oZ*8IM51Voyq>ysPv3&w*H=9 zAxwk|sTlDGRmXVFGtxor4(74_lCfVLpLoPierY#CTC*EVGl<_ogkiEX-KX>-tr*#r zX9m@ohwSRcGthY0p|7^~w!Tp?dBYXJ1P}sD zP*QD4jlcx%am*`KV6{ta@J(HqLoZvihL1w`_(zlZA`@R?;*($8A9KtbZRS>UrP9XK z7+2EeGpAqt;^*y6Z+er>nKO5EKT|P7JgjUCjA-ryOz}Lz7c-lC;_#e%%E`TtIyJ(` z<;K2INBl9OdbH*e9$UYz z-8OFMvUO|Q)OzJsThnOUZM&nr?4<|U(MKI)pZe6N>>JzUFi~L}} zmo0S~I+Ikg+Dfp~?|#3stvKZ&;Aj+9oh!F&xdt?uZd>x?16Er->>bR@sCLR~2w7jP zGFy+HKWNLBK4Jg3`Z~M*`kQR}^hvh$yjiw>{kly$@0O;Lfr&<^14ZL|ql_aAVV)N= zkb4@R_v@KptF5VawZ;y{^zp#-aX`d;TF*k&r2W*qQnhyNI{)SxBfZTr+!-r>jQF5n z`ZGw;0XASO23&Ev#rLBU!~a)Zq*^E!X|RWTY?z;(2T2C{|2Y3EghRRvj|`~u_38J3 zee)aNw0rNp&u+g%lBT-S8tSuFRmqo~NU+aN|MBVeg)e-`{{Hui?XgD}`kpe{h`ebt zUPPEZyJSaNmJUovmg?#n>+MUgDit$>dzi=XVu=)#dTdfjs43J%vLnVAM)*hv=l*hO z;WVj|2ovEUm7|6^f-vdqe5d$8k0=) zV6HTT{}#g%uy~WCPa`iectnlCFh!30FzVgbP!^~y)F1o2`4vQ%aNv^n%JPGJlXvq{ zDaynEfcYrC3EWg)V=WD}*44h=?!Mzzd+@%yt);QnrN>Y~J!PbBM$0JUJtxMW^P98n zj$3cB8mVklQjJvBp()UaPJwxAT7g zNBiN)r`Sb*yF{beUsz`+OG|Z9UpLxz+s(87e3#pfeZBoQXZBpT8)*nS)zw#DWyHS|)!cx#UoKgG0Q<(l3u^f{8FN0sp)2zT3X~)vwwQzW+T9 zuQPV>-!HNgjz8XR7dXy2>$mpQ;zcS~wK`6v0L_lfers&36Vuzo>l}DcIjny#;?z`TW`5j`CMxE-E+U)eB({Z zx59SaWoN0hoCBg)z(M7&Ub9kCXn$*IX;G)6-Wh+JmoGgrs{Q=uKVxrr!|ODHo8*9F z2gJIyYYMg8@>DV~!4Q~@N^u4jfC9m!09f4P2!n)Sn2#y}h=_a`d%PI=-te$zjEm^X}dNi8jIcjyngjSm}Wr}~ek90_zJfH-$lqXV>aB))t?dm^pK%edQ}(c8RrU(UU6Mx9wZsI$qZk{QkrfPqH8W@JA}|i7sVH zi+QoM|9aRixZnc+1pPbT`A&PyYhLZo_t|G}JLHf9Y~kYzWhk%rc&s2$#={RkR3L2d zQ7WB=wgE7-6Xl@;@gCiF+ih#FfBkE1`|TIli(a&+I$oaBzkT-4tByLD{-PB2w?HgbHvJI*O?6v#ucGT-$tI;CTGo9F$ zR%YlpWp>bk2aT40>#gSrXzfZ9$z1M6@-DmVWFP9ug-LI)9kQ>RXKP%*#7@A|rWm06?CT(vbz#q{^|*{m5eW$$Rvpuc6yR(csGPo8S! zWtFla`>ZOLlT>=UpAFE})nikqOqZIw->$#z77gR4+h6~Bk=sZ80@lk9dAU{R>aAtM zWIO5m-?4YU=k0dDK?g_@HQQ@n`x@JRhaIiESLVdPkoC#Y0r*5d@9C}7wZ5^QA*>Ck zt?M-y=;>o*SQ;uBnEZ?&7%BeHvl#Bu_{9`V3*t9+5sX93<46O?Og3tdSEsQTaM%G% z8^kmK>gb?@4w9&Uy{jVpgJ|Rc7JH>gn_UATfgsWdgP*XJn>;bX3ByTj3l=PJHT0z~ zecAn3!XXa8BRqLB6mM*7cFEV$(&WrV4G#{cH&AZB?M}PsqKoZ_BVO%mjHssl_kXGF zz4z|wB%igDPCCI(IN=+9I0es|np#wEUXQ0u8Cue4XZ;!y9oG|G)P-l*R%_hE4`KR^b-eEcE8_{dI_Ms$e)3d|;K zrAADbU3RIMx3?Rtu~#ZU6=_HMfV5Ti*wh)*ZSLH;`aRhu2#BwG)vIh<*(nXOXI{4d z%QX6|vVC5(k4>L3!%rvK`$hW-ER!TnUo1OjJD&#wkOxV!?Dyh*ZPu(g^6ORFlWhJr z^OdnANPk{ssvEVLkevDakVdlQk~Ucl1WvK-x0`Qw-*u;e++w%hdYet2GSSYL9d_jv zSK5jdE7jf&ZZ|zFJLzRF+s{_6SfviI(RSWpTU)ha*`l+4tKnq{sB~&hjPT?23cVH} zrNbAp8WvBmMj4Q0jJyhKMj;i_NGbOJUda(Z_E?^=ft+uuffr8JT_DQOCS=&a1>BjiSjv2Ntb%GIJ3Nbt7 zlvC}TbAE4s``h2_AOE;cHdnP(Wy|fV%dVD69kzaftfQmL=FFKT!@SWRedtkpx$Lm5 zrp>UI2&Al80zy8u`tbb^Ta#4rfiK-pc4(v8y}o3UsbpY+5tJIfz(iCFqo1Gs?C18G z&m8Lw)!Er0pw#;)$+zVy!Wd{0NKkn!k)Un>h^H$D0UX@Ab!#~&!+!9CAK0fq{b`B+ zzxXV8NE)a(URQUQ$3qPP8~g)65cdHr+%?x+V}JbPAML*T?sK)#A&L3tKmVEaM@g10 z2QgcK|MaIniTVF~x6eMi+cuI` zt5>g48!&sF7l2lm#bCh_U$<( z<9SKJM8gFG*&p56*`-m+$L-i-KVx;WL(croZv~W3+wmG!Uvu@<&KQhiW{Lwie4S|B zI)=)5_ebSSojS$moqqe<-^zCRlKn>MJo@OP-nanogcH7FTWz(~s3antaDbyup!S2Y z3N~4kv6!6c^6%{Gu*lV?Y1JFYScye8;}>m9GiVgO(K#m;<6? zoqO&d1oRrI`)dT=DoM3=?^GP7F`z4;q{vJ)aJ&v5Jff`ZI2e|sL-jH<+tSi(Q>RTe znQ0!Lo})J5VDOSq$-p$MkxQxo%u2llm4XOnD*Gh|9$;Vo##iloC!b_*d(#`NW8*qI z_qS&XXrFWA8bg)Y?7BMj-sTBDI$dI~Be0SQnAV7Tv-^aD&B92%pv0A4Y1yvMA0<}T*II>4h?g9=zwNy19&&qGTgQlPztiqgp^{c*SsN6%*bbeykryDC zoPkNbVMI%DcyA9$fT2u}YnLs7nt0PO$Jp1t_En8!PIO=-ns$7Ycf7+z`wSVpEF&=DgArjWkq<7^6^{JFE(6$XF$pRL6!(PX6t{i$ z*+(kweo2w9_(%@*i2X+$P+?1#F0~mN(lcX^`oT7$9B+Bco9un>dykI>4>;gJNz}<6 zo_aH1MtPuIE^X-R>tld1C|hW@{r>mo`&7u@d+(`dvGv7#W?T5RgEeaX$VWclBf@?6 zd8v&IOO4jFs7`sMlggfE#mOP5aBh{y*lRvpm`VmFh{ahptRa!2_rqK!@c_xPWl#Gv zYzOrI%9X2JrJ>?r6b%T|ks{m7-^Nwst6%+UZ&1KPm_$kX(31nKafP_w#OaT8<5^II z=ZZtc0#x#R+gso25`yI$2;c%_z_HCX+t|}jFZIK_01?A|;!mGG!vTVk&J6YP&ANT4UuL~M19tS$NBiC=PR}*V zsto`S0|n~KC^p%8sVb?y(Yc`Vii#KBw^Pc?s=Ptb@icm>AT!4`cEx3v*pGg2lAU$N zukFO|q~(VV8`itcgKA@|FEhn31}VThZjDWi_WkdFpHJL-BjXPsaB+G_F))J26TpUZ zTTK1{(PySpt9x9^2;s-?I*rCI|NF&u)3w*zpZ<8B=f!Y*yB&A1-<*54{rrqyS@Wa` zHgEfFY_U4Vm%jcr|D43!xwE|kUGCmcCtK+)@l=gGCW+NI2;%zkYsaGdwhXl)7c%$9d&Z{ z%7!W?fj5l~NXUwyH-V{;2o__i%yYPYw?9-q4xQl;A zUANtKt6g{9^}bd$Z|en;S{>dfA5e~nD8S^b#;|}?BgHtbv{Oq^mOvWML6yO4{Gh{r=QlSYPC-X_>fyF?vA_f z@&UoN+ivTAs7~g1nwzk7Sc_XP_03BU<^GI(kVvGxbm`NQtm}PvfBPMG+2_9adHt3x zBq@gxO?=AE20q>oOl3n&2fN0~3Z+~AOLJ)uX>d;*`begH#5la}q5JOr(~I`p{f!=I z3)5JMwlMwf+&{IIl@B&HHcpW7x~SmVhSMP8XD`R zGC$%HufD!PM)c;J0fr$}gK?C{fhLA?PQrM97&tNvAjXbm#viann8aZ7=?0c&cG-1T z4OWu$;CWn0o8=cy(T(4vw>gSugyR~&;~spKWd)`xN#w51_e^STJfjeGi_+#xw*@E~ zj-kHy8QBF4W06E#&z&d6^M%YxHF8EO0sAOx?|t9-q)-N5*a?-Nf=>fqs4;hB`=iYlX4!(|orio=hvop;;Yditb#^8j7a z#`j_gyt0MT8$AgiK~a~e5A6~z!g1wyG4V4-)K!(a^hwMTP)WfAv)L6$Jz*r@MB(ba zU0H`??@@kW&>9<>-1xlr-n$isUY;7LxUm2gz(K|EcF9LR@)1`>Ojy#}Ip~5pAQ~?y z;zFcFxhRKzJ)_}^NySRrqNFPPzTgLUyxfJdB zg27C#sHwg7+FPTXYh@hQdLux@jYce%RIK`A(0}GLpYdse+ittfzV@}R*dO=u8-8V1WuhpW!be9{E7U@690*A)ZG(uCz(Ik2XnRXs7f% z(jd*4=1676Z|phg6hK_K57J}#r~4>JDX3&%LQN$`2{5WW84YWw&03rudIO9n8lM?p zR@r0KI~ppbl^6g>JUZ)I`C)6@*kSYMEwHbA`Ku19TW`J9)ggI9#Etkc1J#x!<)&qb ze1hSLDJf2*;r`UAD9z%qLHsW8&+o?=4)J6xesMj=D1{jdOBn+E&*l;pr;Fn!Yk){l zc72wLN(LrB(+E;c5aBWx9866bj`JmJB*%E7>WuKxGDl(pOs8?iH}r^Xt+d*owq>yT z&dm3$S+o2cf?~W6Tsu2_VP1|lt7q!SD+rU>K9HKJq_J(Gg*hwm<(8+Cfr(1dSbRH# zGqtJOko>maaeKQ)HWA1AaZo$Q2U2lt1U@9gq#uj9EJ^rBZDh1#`gmg$7+BmO_>)(n zWK#rS#{9mZLiEvCt5{9K7eiwrP!Y_d|{f_4WAfCniQ(|6moUuIf8m(ni zh7olPW-7Qx)n}AmMrq;HpY%Jg#0P9-u-~dHGgiyj5_09%P@A=;`mD7yR@sUbPpb22 zG|Z>vecEGFBHt)OlnDT(w}@$dI^~dc_mpgApmbnLm4XpTG)Dz}#J1<2t~x&Z*<NJvAr)Sh zx0*TurZH#D%?;kMT3eg!vdb>B6HolUAHH$L6<6D*KmB?8+uts=(@*=UmzPeEi26L! zrPs|1ZBn?VHA_7&+?R?^v%k1i_ zul7Aa7{%;CVj+`#)$FB)DM*hmfBDO{^Ugc_+TENvbF8Jg)tcmL#8?2tA~DMqyus1X zP-`Fh&*z``zz!8|~VE{KHx& zw%SWywx3;d%|Gmkg-`ey3hdYVRG}VITU}$R#iG)I2iE-(lo43J)DO5_{TqH%a$#7 zdx{;JOj5G?j&x&B()8)m1foU<8;y!I1B~VMRX*_J}p@jZFM42G3(?~XrbXERxske2jR#<&?r7d2#$R~5BPnqmt zOF^4&(Jer!myC^OI5~}3?PW`sxs!9f6k+9)J9Cb-Mk0S1Ic4d*Az^!gM9DhgDy2v@0J*E5uYK)n?QL&+n{VS~E3G$r z0YJrIa=S*i00vbOc21C&vmn7JD-w=bcECW{xIXmILq5d;z$wE*frModfXbV?0EPTm zJ^>so{Q9140f)D4-~Nub+s8ikVYN-CO`S4T@ha3|nygKAq7BYI`y4+C=bCG-waJns z?EU`02i~jl)}=y9#j2$4ko?P+FI8t;?qx13&r8Mj+uirv=AD%ClO|G|sTta{RJ8fY zm@Pm@zu~CkBmr{e73ygdrnt?-C)1x;yvUAu)6p88EVZkyy3+pgmka%b4x|9P7co|U z{_|hh%U<>}mr@wJTrZNk*=eVpoOy(WaY=d%8Q-fN%%^KtXSenC@%<7?L4zkS6-yyD ztX+BK6;dUyv)&#KuNaer#bE&(Y8UmoOg0DGP&iDCGGWh9md7-3m@G95f7fr^V6Q#u zNW1j%%d9+GVF$hZV7unJYwd2Ss#m=7P;2Yxw98fJ>#o1SLC2W^t&*T~XU`LW2W_9d z_pv>8-^*V9@|W9-_j|GJv)_ws!S>r)M|ZE)OZxivXdsycWdL4d{WfrY}!=WOiQ1Z?KD+oZa)9J-#-4Kl+c!?(t+vd1g47e zN{vz`TYsKYLYM-mw5?{$u@*)vKqnk$*jM8oKxj6wA(#Iml@!^pO&vDI2z zCaR%orPurYSiz3=ZaZNAgB)ww3PythADi7Ybcaba8t=t%{oxOP==osJa2^tqavJM+ zzA2A!;+$D*IjqDtzNT2%w4R`l(puTdP$CY%jv$mr^6?4D+Q#d z7CmVf|LtNM9_Y1m&pO+#lO46+K6@&BGU(^cpY1OyRLGpzcfWn?h$CL9PPpD~y6IMH zY;LfI)&}2vC+u3c)M{7f*eml}no0^LCdk~r@f`q(U<|$dvdb=)ZS+goLVs5;9g>0A zDkd;B&}|?2$Vb&68^k2yr8Pa?)2D~Sq&K|b4K{DyJm15_WGC}IY~pWjW_qC6jZN~| zlu&h`JAHf^5VH+}F>G2JJrbTd{Jfop#!(J~#H*V~X&=a(qofMM+)!VLdFG-}IY=hLGbI1bZ+_zqibMcJ)2Gd(-F!hYiL(fRYYaodVL;~3F5UVEK` zK#AGszwkLbPN3X<_ubs~;&rAQZ@k%F{pwd~Aab>z!35pN;a-wR)Riw*F&akwQ%A~! zqjS-zIFIUzE3UL%cHYf*OML$G$7)oWR55$XrwGV*-F2_*z8!7d`t`Q;+}YNv&RQxe znE`&(QAZtDUS5{VR_1I%>lF3Gepd&)wfm22uCcFu<14n;K6}eBe3=?zrd@i;C6Y#K zZO^^-&?twa3pMN&mjM<_0qinh(v68h*<&&~FSYHr-`+m>fe+fNk9dv1wXeTaFoAOn z1k(B2%(H%t>H-)nEdYkFVQ#rrK?{+~!93?RVZODR-QJ$0>NV ze&qCvU%a1Pd+qh=NQe1>TomW=#~1l&ECok^FpndBYFFTB++4qzrxzPJ8k9KRkl(?*@+Wd?JHmXl14=9)HAPF zL$d%&4;&DP(&3=D+;X$;qGW#RfCCQjmoSk&ETe4P&@P;m*^KEkeRQ@c z_IjBN+47v#NnNxt))@AwcKG0(&$K)^mq`LRzroo|VHL=pud=>ja|8)A zpJ!f}YhpOh#*wlz0Fk#p{^3u4ln!lj{{s)$+ur#$d)dog;^qDAZ_jmG?nN5qEnT+C zjyn2KyWxi0thITvq+72`#rCH#K@i?U}o2goim}0&8 zUMsIGw?`g(#CG0kC(CP?imj26T|hCw1uBaZ(Vlo>p`Z0g!=VPwI_oSK{pDr6>7qC; zPz4~@PN_d6FmWAwUQE8p4uFZ+V~*|h%2&QpOh+AV8kTTK7l6xXi#0)Pm_7I0(?^j9 z9&)g~Na|*iK*LP;fd?OCThHIx=196!RH_rOvM&%!MFloA`5|Du(!~O-PfV)5NEqtf z+skbIh#1}M^G7phZY5Ci`uJUT=C9ARR~~+_egC8%+RG0)P?GBS(lec|)=)o*>%_B-HZw&=-4_Vl8~Rw0$zC`s`6gAdtSjoQBZt>Xov zT6=owBKzg9erC&8EV1AJ;cVG3ueE*mdy&oEdbZ7;GuDpd+xKZz5MXQZ04N#R;K40JNhgu z@G$3#Va}#J-k_d3Wu{G@G__E>El(u_6KhJSH%4==$^S_!#1$j>6G%0Us;;+y_wxo+Is$4m{%?zwtzxsCA9aTGRRu<1Z+zp?J~4@kW~9da8j=(hMV%-k zohBp&_9D`ZPg7ie`IUaiJhbbsJG->{@|VA%!OQtBU0J*p*~l!Qt{ZwNz{bG%PH@w@h-eP85@ zyR5l!e!y>kdzLerurxU0oGAcCJpm2?5Fm=*;pp9{P$;R;O~XLM#kdE+nh@9XvL zD7(oRe|pJMm;9xol7WfOio%p&h}%#iD&EuAZyP$gtxwq6VVB+Pi(mVSo$&pW?2T`E zvm3`qCu|zxv&|JIGW$%Uht$B2=fQZcJmZ>{8YYM-G__PHtDHq|YT&A>&;fuu0i1Zn z1VaG@ODSv>Zjw>oQr~E`l{xPi?LA#qQC(&2y3x3hpZDK;&U4Q9e3;V_>#TsC-qBTdT}-te1?I@prJI%(ns}i(v46AiKY5@- zK_Ts=^xRNH$53EGRV5y_ZM`XpW=c9wl%WoLO1%_Wljb*Pn2A5gSh>#lICH_rFbe~v z;&)cU$AdVF9ciAMTJ6j>3AaZ_M@_&$@q6*NMf_{l-^87C^0N=A97g`XSOAIKzlac@ zQZkS0`R(-EFMRI-Z-)Ud8xHVrvym%3gO;gwo!Lp2O$5bK$}pineq{Bls|1-l_WED% z=01z8?8)QUre(MCcf$=dpyaLz{3~02RzxG={kP$kmaWOQnd*P9VfG9B^axg%w6Z{#FX&4d{HA*(nq8(U6oVSu z&afYdX)cQ8t!Vrz+!juj*Nh!2tvu=hxGQRYfH>Xp96B6lL;}AC2=HMB!me~&{Okbn z&dQZecsI69rs4~s+{wKTX`5dczo9-wj+<0;iDp};Wu|y+`g@L9xlaimo;+0FAGCG? z-o3wF7{6LRA8kX?j8KdHTag-~i&e;VEXFa50kCFx`c0fK2z0hVR^~sqF}-pj$zLFu zR%V8=3$ovSd!5?dhr9S&j0C)9y7wb7JdzN_KnhH(E+0A%MTz%COvRrwWaY=xd{itJ zNzL#n8_WV5+cRQhgeZ@ZALak35>d`YTOrxv`%9-_5jl{6kC_#6X=ETjI+hy zo7jK;#H1t@4_pQZ8do+}NyHmc;l_1&D z?$>+aSK%&mbG#ATo=I)?s)qxJh>LOtGiNy@4I*u#*wozmNxHOxcBewjeTkde(DuodUFJn^2Sk-bOX>m=rO zf_F+<;|HQ3a=;{#Gp*fdv3ke-iN)1A1_e%@XFIN&$4=zd z)ns5NSfa~dhlyg&F*yKV^<394x;&35|;NBFEQoYzg})|u=F8w-G_&lb1PSV^$O zUh0DeN6v{-DynmxlWdWufO8%3^zIyE@5z0S{9~u=Tb7U}ndQ0wcXM%z?dUw8-x$yH zc}5SA_ZaKG{Y0>WyGpli*Vy~^?+^ump#7u$jNyelShtGQh;y-gWKg@G!ZK}DGD(@=iW$ri2>7q`_YnY=^D=0T27jBN-I}T zj$uaSQkC{9f*s{n?fqG^+?RyuZ1LqIox7yX500%Z-Jl2VdZxJM2FgdAB=~Z-+gXQ8 zhulkQdNg?veP-Dk?Afl_an#}HB+ z_FkBeIgd{J{8xx0r;4>+lQst58t4d`$Ccg=#XPFk4Kevhlj3IS)l&>pQsQg93XMEF z(t_aJa{@X)??aY^_jSI?kw1C!=K<+%^A#%E*bl$&0a0_mxJBP*dJVWLN(hPJbNqkK zEG=faV%}Dsf8d1Q=`l-)17(Fzrd}psX2It7`hMb-`_d-&-*`}8ta7w zHchsmR7KC`UuW=Iw20pR8fb}@c=-=XKrPgt9$ z*+nrqq_eYN%so|4!jI1?iB$=hfGKiJhKWj?csLt}`wZ|6Z(s(NHh3gOFa0iZW0Xo@ z;Hw)dq^vo=F^DBmE|4mPwaxvyy#y18r{X?Fd8nv-zKOcrWqM+`#Ox6ueQ3LH`4n6B zHUjt_($11|pR&3%%*}(`u5XF%zt#G#ioIOLulk5xie++`H+0D+nRmhCH}Vz;>8e|{ zcHK7(7`-a^tV$wSt7g=z_}+83l**c}pEo6=Rj_J*FgCL#-D_qOLUt?Mt=s5J!tOv@ znc7$$Nm5+GXZP;+cRo43pLu=I?^;7*l76M|yG2@mA9~hJ<@>%+F`?a_DCTjR0lkx8 zTeGTQT&yj({qWmET(=C+56l4)!9YRWbnFRqWL1dc%?}*z%}%oM*0pr*e17aOPoBDP z7E^)c1nnWKjxWqBpUUM3#&2EY17gsnsgtzpHIe&soiDjyq~8+&2}=;ji&HXUGK@B8 zhnyrq1aTybkfKoRAf3PDiK$#K?%1Rv^fo;)e1SdXYi_@5dxdH2IUv6LCR-D~@?FQs zj^eSm<2CBbn$yU+uPIJom2MxuS7mi^yS({u)33)p=0jgD-k`l*?%Phq)^=}uCSbz~ zjB_EQYXqB`%%{OGpy+7_^~H=G#dc=GH&X3D;S)#MfEnk^6+pbaIna=NY$zDbjW8ZI zD>d{v?-uy4K8U%4k5eAqrwp|(R~P}8=24n&)>||(M8|jFMOmVy&W@2YpT>o8nV^X3 zUs)3B*_BR_P>rj#aB2iX@Qp7$Pm>wyr50;|siflC@q=49>uki;<8F_=%fUnn*-~B; zl;ZFrjm#_16*%^Gy&P@(x9gz+c&jR`*X3*6uTs7J@Y68M&XvCGg?Xqn{3mJ*&-4HB zUshr68_Wh!)6r^g{-Bw<>e2noD*U#-mB8~;Qr3d_dOmvV^}@r4{p%{MA%!};yyNvK zLkHA&5xE33CSf7rE(iXwj4mOnOFqaM%F9|%(AfQ43dQqd*VHzW{mo=N*4cKi0Q zlHK~-)<&DH5y|vyG0o6~;Pr`}Z)N^)1a;GYSJ{0Ha3!_&+_UPpe<^>xXth{pV({DQ zzKL~MMRG2EyX48_b7Sc^8ME;tXWCDe*jzBMs1>-S)KRuss&e5d*kPm~3mX`;%monm ziPmOET_R&1h`selwtLfbz_CDOnqR2U{&z0fT!5B}{~a(begCHmV|_-V7R_cxnq;=7 zxB$CCP@a^Ri<&@9X`m0xcXad0x5>S${}W6@h$7L}ec^VzFHhQ&$kCbIe-s%h(oH`q z2%9C<|AG^)x8XQ|CKid5FALHE7g1g#P^M4?YN3)d29Dr4LVZPj?RkIwn?&5x;(d3L z!PW0|l{|X_*rm4%$G*k0r~GRlV_@+b4fHq@d)db5XrilD@jFR2a;N7hzuELTKX;=E zkj*~Keqf+@lH6OK?KAjHJoI*3+S35Uz4t$Ovwm)xF0b@EE&!UOAll3rYj`#t&^IazXy(+eZYrn)ojapH*r zPh#`_YD_ zB-80)UF&(yTX{=OvGByRIa}_J2aB^D{AajagC7^LDLk zQmZVdYy6LQ-{m^zE;>)O*Z&UrJi{_7irXUey$PQDGNZjZ`1fyvbA;6FKRxr^hwPr2 zg+VHkPMwwgIIf1=mopcCGh3J8u!@SR=F+sPrjEbfGd&6NehHq$6rbt!zs9qFwiP~W z3b*TmbO)f8X#&o*Clfqq1#tL|n&xA@Ux*t^oXtTOw-GGl97XG+r$HHuw>UN&Z{UD- zl!jxXQD<>qH_Z;TRBzx4kq;DA5Ui9n6_ZmYO~0CK@XhG_f5^>!q>As{=b;UtmtfxL z`N#4a#k*&Y-^I7v&#i45Mav z&0BI?L_}d^H@sN6kUwQ25~hO#3sAW*G;9)iScys>h|P4V+xsoUrRGBSkR%$F(;MNt zuVNj*W7T(tFp@){XwSiXgOq_Zr=lOk=9fDJ6CohLH(4J-xoYXF{NgQ6cwgL-mVPRI zFO?%Q^0CW|BWUg5{BXJR01@Ff3UB;er{`bu^7bn+>dVP;&n1DjAoSH#2L*Q9nqME$ zF<=Wo@ETe7_d!=z%uZaMbm660S~CbxVoUZi$(~MW8BEn{p+3ZMF(*Qgk(i7u=b8Yd z+NK=T_>LwLk5?qUeML94P`YCf8)XTt0NANTJBuy@SnV0rB+$-qvwLIBQKm9{V z4%pf~$?A)MfzarGdoD$Shz}ufyH(FYrDrlN;&5MDY!_~}?UovmKF)#-E#4$frWfC| z6(kW_PFTL8ll#1JNa}j#3j1L&s4bj&5`>Q~@h56JE;wqu7xOhm#p_91;RG>7m*`Qgci|UzqnxTECu$%=18>jFGk%NTiUSe(I z(~bFI8NYK5P6z(nI(w&t>V9p~O}25%b?1$tLo?w0Go&=8K^i)gnzOl1_?hsI(V>V? ztR5`?lho&%5m^EL0hPB`J{D*;Fy?^p00%yBW~Gmklo_6*{y5g+_7Mbw7RLFBFl>k8 z4Djmjm$_0a@mON^nD~O}$MlpQVT8ue0_z9B6r;aL@sqHu1{L9z6gl=Rc*c-AQK?tf zCnLVUDrLQlOPY{IO|xiN(dyV7GLu_pimEHwR2g>6o_=ZvVI`-gWd8%v@`11)Gday4z0MpY^DV8x9RAW}thh#(l#LyGW`EwANs zqw=nY&2>3Q);^jGVdQoKGzeZEly2!tIF?_=(VA|_F^8ZTy32#L^k_O|*DtqDLp}tdEWClkmCR{bM19whoukuM#7Wi|!q!(B(Eu&xUbpr$>u^-&qF168^|85|O;2My zF03=#;|*@9#M{mFZe>L5P2T4nLHw+yHQ?91-<6`<_rateW+ce!0b_f|Nt#txNHV@< zB@&t=!mY*ppA`U;Dh>r+=%_8#H?K0$O*TJ;fiGIqP$4UFyq8imT|WxH9A%eDc$=RX zhKM2HRaB;vBEnH)psJqX+$$Cu@yXq)k9|v_@%KI_K29+Jb6>}bv|A8aUhRBT*CVMa z&3skZzh9xj&?}VHj2F2~`0EvL+5LR}2AoD-E(f1`V$P~Gk6!vk|9s=Kw{f2VFHTJr|bYYYfa0P2_GcSJ+c6m~#=di=K$sBu0W9EDaDg95X$lW5X+ zs}Idifz5u$6(w4#HU<0()}F&I&Pxhn($xB-RLFI_SWqub6YPn90(-#4Wp=P4r;HpQ z8r)tk$)}~iO#myf>J<3{DrRW9J&cyx5HUe!EmM)8R}xS~A)CQQsKqEqjn&!VTX_O@ zq_*>sH@B8YuJFNe^uduS(=hM&-yRRwCgFZZ(iGQRkmoCH6r8rR=zlu|Jx63wtM;4B zCUHp32x{722bpx3MQJ`R)B~-1t0GsnXI|=_#Xx9pq*1TE9Pw|Kv%7q1GvG)dQUCb8o%#8ZL5#|6;rK>Tqg182`E*&)8FlR)!1LU9J{?-D8IO%67 z@Yn5# z)D*Nh$54E|*cDvgl)co^Nhx;>1pyah+3VwonE6QO6{|n&AA+8LZqEluTg|`}I{sGf zjsJP;?ZRV~Wb5D8OzwajyR);)-6RXkbg?oP2_o{O&)*Bl1ZeUaLuv)fUx-%IoS#hG znu19_*y@whZH;AxJy-=imo&9|OEsam5s{DStH`CfHFtq}vXemd<^ClNpdgRo#~k9W zoJ0cLSc!DXIgpHqnS0g~ZP>x!J`oLxCY(C_T_nv1G$OV+R(e{3xX0acfdEi=(O~xg zXE`$H34(q_B+oS==LdC>P|-;n^wW$CSeYuVIEGH>PE7MSpE0o$gC>UF@Lhhka^aog z#~1of)(-d+L}e+@%#vni$5X^Bu1V%7b0qO%CvBTS+Z)>YldckFqc3K>EIKuH)rV8F zj_=yJ_7J6(&FJ%!-HhZz1da zMmItCi8Fr<1nc8-zwXeZ#)OXwt2pE|%uS?2Kiu2?h&CjOP9L^+CmAtfK1Nl1>f{KQ z)O9uy|CmX0a7r!Kqu%z5+l_ch{ zO&y<1z#7UnqLjH{khGry1)0N37mB+`F4QTYKP8?n&{*}#Z|~TtKEpsLwixaz)4Opw(lD#zyxVMh zK*WW%p5g%=$c}F$gP=9@5}Wf;aQiu1_3~&}uqttoGWFx>Opp>Hr(eqTL*gMlq)vla z-50~;l$yA)u#MB=@4m*h(BKJ0&fLKUI2ZY%kkEdr3{^Li&}551#tRb}gM5fT<}uty zQqs4pn639H5hF?Ok1u)DodO@p-$e|m>oqmC2+fxmvt0>)35*&O>gNN~HgAI!>m|Qvw z&9ReYq!U9ueshE|epDINxyaDz@9&hv;|a#=!WcEN{<_$Z!%Q<~|5+l}pkeY=|e&tH_b{6?zp zD|25L)|MO~YjboWNfCNJYarHMU#*%JqtTR@-=E$)w4VaT8C% z-L1obdd>|+#&lyPFlRp(S6USrng(f)?wpf9y^G=_mV0NR;Y$KixyS`l8q4(03X5LJ zk$wz0k~-<+jK{wL@3^hvK%Rt(&r!Y{U;}fnS7d9Cad^?oM7?;v2Ar_2s%U z=Fe=#2B!2sV%-UMJNe*rY5r1Phh7;#F<7}6D-AN;M>{*CMSeben2ylt`h`JoCmBVp zT<*X;p8judO?>9BdKx#>N{(tnZo0i~MdQD)AHlIn zz2VVKS0ohdbLLAKg}ys7kP92@%Cl=0w)y}ApYIc(qNxa8{w2LnUgj%bvxqPm$6yD= zo@dKTSCsjU9r(9=Llo({UtHJiJUr!0;&CW}s;*ek?j!lkRtO0Tfy50A&64WYSqC4{ zm%1b6)#YkK8kkOUpMi1h|K9banBPVlA(|UBc+ea#UwshPmHsb>xf+^|CL&h~Nd!f( zxO`esKkMC#Vc?s{KLC+h5#aQwRhJ3P(fM;?Mnziqjz2JnKh?hijCdW1ecR?hKX`7N z+%Xyb0Zcsik!)6yk)m|-dJLOnTYw-CNd`Y!Sa{vAAc0r?@PwtdPWqiq$l{pa z|6X00yNeOr7d7>3=@=Q7ZU5hMw5c)#QMlCxVNV3MShjL)Oke2x|9V*vVG?G0I`8K#}>0i@?yL*ryF|MaQu zf2*>>V3?s?+9lb?!%V0Sg9MwNUOmiVu`(S>-?$FqOh=wAQ=)*l)E6efXdsOXyZTPU z%J$M;uaJHdKTdR?kc?%h*UdnBp*ikF+{yR$iY+VQvuIZ57k^(>Im_v|Xe!My__A!^ zRxJ9`8*+bmGu>*HT)KjnX7trYySnAwYq`VjJ*{(vzNKX)r{nL}Wt3YLk+(MGRJ(y6 zEE6T%+n>aqaLW&^i~>M0u4Xmoe*=1ChVL=V!GAvl-md}UeU+zjcX)S4>-1xt$~(ln z7zJrWhbN8A(6my!woX1-enzP zyb~ES9Y^^bgae62N`=@6Vbn;79&1*mPeu$2gzEyHoH$4klKQAZ8wZFG2E0UcI^{0^ zd3s1I3_^0TA;t&!FMcio`p>dDoYDBAYz$KVF;jq31Ij_TPVp z`nMyLGdO1db@-gkMZepJ14@6N(eCG!&#UYNFIOt=mv0EV*|vly3U4dEwi#aPy?Z&= zAlilHj;%X#pHux!d;Q6DyKr*vHivKdXGw+bea37}OY%4`C`bkZm`A|2M5H*-D-3id7 zH)+HxX>pog;!vQg_Cm;hxf2pj{3Em5@I8C$H*r9DtGE&)mHr0R?lp^J{T~M?TF&dA#bUEO z;b$2&k!AZ`W3*{u(Ii5oc-W>Pllsj|YQxy*~-TRQ%fiL0N{i$1UM z_gL!~`o&gCy4xkO-<4FiAENw7GxYv8nRey>n^%YQCL5>cbCUeHGC@fTB^fX(jWmBs zPuU$bWR@+qv@Aka+UBS1(=O->Ip*QfHzPWL;d=q3QF73n{rSsRo1*M=p+CN8XDx?1 zDsk7vNRX1^>VSItu=l3>F!rWJWzs=7{u{fD{OB_<%yDpgh>~MbuqWTew;v~6#*{O_ znLK(sCV~+`!$cNY+inBmQ1RdPxzdydhv;Jp(N~o@1Kvd3DC62bxtT10eG>WHzWg(d zlNj=X2U{5-e>CL|_IarvIU5~{=E-Xx)2=l*H)hi9Jc_)j?b$vdSQy)_j6ns-xcJ?6xq60h-uXr8FcOgU~s1#c5ti)Pm^Hx zl$bXgB8w?srUiDF?WM(l2Yf^0nJG24P`@?_%Yb*PXMEG#RSl{jAFp%b-x zMsEl~_iN`>vDLEDW2BggaI9Z={Sb7Zy;a+6{e*0j0@Z!~0@o5E>-_q}cY3^@z^n@m z++0V^eMP1S5voue(OWSImZ}k#kB!~%p!V=%+aNmhE;f4TCtYr4v>6kNJO$_`s2`@( zwUiQ?2Hli9@K+x+86@b$HBrr<*FO??Fp z5u#k7O4J2JK8i@6P<|u4<7B<8kN2B6OiypyC5kQxj3%`S3mI;J?rDY4!bPr-4CyP(qX{gbw+}{!=Uh}b? zB=Y^)VD82VXC0iCI`jQgiMSG0COTI%h3TY=x>;w^W%%;Y!%{6*bYXl3G5<>-C(~n@ zOYk%Wg{~@m)Cl*4tW1sGKM3A~}{0OZGNhCon*W+&JQ^uab4s9KNV=<_7?7wGSg zNMDfd;&2*8@YsBRdsvkdzn9#q@gC0TsRM@1Vy)#bST71*AF3(mP%hO|L72Ga1*j>J zFH*sMGX2mW=#KnDsnBdG0@O6I3;Aog(&S^~zu3OHudnVe8<>kf?N3)1wysaxt$lqy zud1$`=Z7{u#0mhY8*7x7Rkhx=O|k39_-8?dr$nm#Eeo=9QRrsWr|lRI=BWwTiGcU< zt+OQ(hg5IBnSVch?AE<*$^$XL2~wo%jqiO3YivGe7Y@^?7F?xW7h2&ZyT=MZ6mfDc zoF)hc9e$f~;qwQwUWpuO4pCd8bU+Y!frJ9%c-voNj}FK3AichI-_p7U2)0?*caVxT zwjpdKfFjG$7?q3hx;K|)m~SE|Qpp5lIfk0x^@#}RYAX;^`sM!1e%&u#^b3M=z3BbM zywStI<#j6JA+q;#hjmS~S7YG!Qwo9xtdfN)f|y(1aOYe1?LRGXYh&{=^|hb%$gz)v zcT~Xr8m*wu$~$JkDo~y7(yQjDW8hvq&B-~6e95#G*ehNnTlp*XoprIn_5WFcsTyrz zFqF5Dr6qw_zYPeFzQZ_ND@+1w)*?HSGz1#0v!^=XVWcOzKww@es+ zWU3qa#oQxJZ&bxlt#fWjC=-YMpU+SIQ4#Cbb9|j6=guCS$yhNton4NZ3RuhIg_a=n z+y+10QlJ5bY+^=gNU8KH-DZ2;i3hci=ZthJyr}PZpNB67kz*$;3NaCN+b2Q?ajBcf9Y>DfuNGp6+FRs$#l7zL_XzwFFhzJi z0my0{pJpGQS$`$VIeQ1dfL>+313SLh&@B5wOBfZ6*>1NpEM~#MYe+*er-og#_6zW* z*WcrNhXL)0ePCO1Tlj8#`PzeZ2QZ7QbWAWr3S4>BB-rB`sx-WutEzbGi=p$2pA^(35WKnOew9Gx3^pr=l^<#O;dAkG*}i-GE6LILGcox+27>o&Upj+nRA`(t z;DUO3A+`y{Q!ulXshIPCrHoYgNh_beT{AyP2Eb23~sfa_@-D zUq7IR>nW*nNfm5oNar(1O*juA$_P!M9S5W2Z3piN=7vL_f;=ukMBF1oS0+5;oPnV< zsM1jqP;51Oie4*K2s9K|%?%1Vlc2;|x?@Mg7n*p{6ZPPXXK{dZ7R&BE<88bH8=okA zR${G-jIS#*b%(EGKW@?gd&w(aL^qEKW|nnk_d8b96iam~X&*d*#giE1LXjvsd#g6P z`+NclEa$dyn+WA@oGNg1aL`$ZOF2E%4z@Suus>qo7L+Ymz!(MA7{a2%O7JJgS>lQd#J68NEinI? zE@Mq-?L1E!y~S+vg?@`+_UG|Yi~djZxi;6h>a8Ya4-wo z1K>+2ndA0=IM7BRj2TN?Z%Wa(5x|7nV|_Vp{5nz7bz!aFVgDVp?$AW`+*E19Tuhzz z3=TI$iVRaH`3gpn;I!TY)$<|PtgvG4$21J%`M`4Y7|}E^X)vt+ytDD0CmnD}kH>`t zWy#F0(c-z!Zk^>n|HV=KUfJ98chhHeee0V3^zU)Yx_!R?dgdR8{*7Hvw`05^&j!nX zi*$&hgtyy!YbzryVZX^>R=pM~o^QI%J0GgKA(~7a_d%2-hFaA^v*I zZaaLNA%@s{$x1&aFHnLHf_EXeE`~lYMkLHQI?ECjxwKdO=L-H@3L3O@bU$NWq?BvbQTdt3+r-PW|Y_ zc8^Y>Uw*z^v%D4x9Iw;J55W%vC*YSU9e8*;1vv&1%q%S~+JvTz5s&kiS=NTzwx=gW z+(ykS?|)CsV)DKJE_XsX^yCuj9sA(oJj&DZk7C+WIg0>0A#_4gE7hX9CN*fV0Bw28 z^E{s|R z0?7ul8(>;-MiPeGV&XFmiw^h_hJBH2PNLucL&QC$*3u?5w7=sgg(xm-Foa7_NxAWHvTXxbtI2%?VCm9X=g0imUf{}}y8*O433G>Kor z9%VwB&i^`@1FswGUY2y?Nh%@083id=ig-2+lbnWUexb3wx@jw|r=DQsml0wAL=h$M z7#{$Cb*w$Uw`i6@PuN%;HNS)WCqax!g%@w&FIG80s~)nt%mnemv?Jy*Cc_vMoCJ05 zJ4^kHFb_btIWW=8AyYP9#UUBn_9uXuzvW=8U*oByx%xAeslKwRD3uf+JTK$MlAw{X zG5RA&MFS|uAxRR*SZr)lw3pS#Ok*~jtJ1KPVmK*#IFQG! z8OxObHQKRVb7qAA7xNb#w_U3!@;URH+p}X#rgENQ)mvdRJZKCX&kr@ri#mG70pY)$ zmM6u8w`OPgR<@RPuFn~OtjF8I{%>N6u~6f`5DRv8=~N!=;ym$D_lQMX9>suNG%Y)1 zqK1@+z|-w3>9mAv;zcgY#z-~Q^Ff1ZGG(|i?IyPwLGwkVys2T949VB@to!+I9ZPMu zuKV0P@$V;GSqEW_ooOgwkp{fPLe@$)lfGL{*?1}s5t?FDh|^`3q&qpWeg$)&N7X%U zQ~KkGaay8czDGsy4<~4*?sNvfm@9t$!Ru|-mqOKgSYGD^6}*qG{hkND(Hp1k`BnKr zUs|TrUFS-OX~2A1S1B7|q|P3+Hq%H``i%)2pO^dDwDk6}|c;&9|{`w_nzu zZ#4eku6^j!k>mBp3kmoPOuYwsGWlj~(9qnhuc=P)(&4ZDOefNRW250yBJt-$4dBf; zetXy9Ni|{~`8p3$LT99%)+Ov4`kmkpQ$;!F+j9LUMBD^C%g=#p;PluQe;uoqGGKPv zK8Ky|sZX%p^f?=ls8KWq<&XzyPKPaw!t?f%5EJGIL4y7yve0$N;|jdy|qQneCO>MoGio;2Z@9x2}#(SF2je{S0@ zQ_jZ~)2J3NzUxk8b~9+jcMZ}Py~?UF^Rp8hw&u-EzEzcDU#Np$34vp21p7;+ZNgz@u$g3p5Ep5BlQotL4t>?m>i=Lfs*T_*dPyrMUJEG7gR zT-D7@utTy@ksxAiK&&dGb8yC4Vlviyf-ap!4W;e*vG>84P*8lk> z(a`v#5f$?`7_-YxeXb^1rBCKU8Gtt7UcZZanH-~vDRFm9TMvFk^F`@@7 z2bU+AE<_xw88%zG{4R2z7n6=Z{adT7t%ephOKcj{U}qzDaBb*ElKGso7)nvGUxoK) zOkdQTnaR>=r?Ack)YWX;&0WVLoyt1&8ZGo{gi0+U-dv~nDW$!yx=CbWfSIeDR2foa)URXw#KVt4A8|lxo4X`_VY)cUH#=3Agea<*dy9z zD{)d#0orkbO`CCqOZ0I}u&y6n7DsEa+ z%;S|Wm2dzFkaT|2RBg~bfiHGn1_VNZrJvmwL$Dlk(Z+E9oGRg23%j!w-OlrZKKi@r zUOf9eSJmfl58nW-DbCYvgFH*>`sw~}(evx@@bJV~JxT`JUj+@t4;_Y=_<28P&|d-BA#2B#LSeVhf+q*?4AN=mg zAzs)?S#SgN31B3v3#~8>yftTYs=`uIQ(&+l3G7WMPfMH22}X?*bO>EZf7kGDd8pCr zSX;!kzuwbsmv1p0Qh<`rR{SWj$X%Q?S>h~_D3;Qab(!>$*%(~jx#n;`k?~jjg;(xv z4ki`IYAxXoxQXWDjSGpC9oOEYE%Eun(2T64j84xrjj>lPi+Y4#rW!u?R`Y;$M=Cn- zg$iWqLi~qDG(r|l0&ez*rvyfJsz<2&5L=-;_!G>HNMYC^D@K_Tq|g@ADJnx#JGFak z5R+twNQs0drKy)H&V?C?9dcim75J^o^07W?+JWv|?n>3F2niv_iTL7Vv2uZp1jT(j zfdXP&8poSJQCHLQNq+uTNHmO>#&8S-Da?Y}NEwM}g*rd{`^=QfluS?Izk*fUGZC$C z%FL9mIVM|%TdUO6+6)?X-R2eX>_9KKTDDi!iwVn#fG7R zW_Dp*MOf(j1?N>g@e1A6N#N6%v;Eu)3=$9MUgbVWkeCh z=)Le>8O1JodBtLjz7y?k1sGDP?D}8*4DGtj!<&jzeXT-Uj!#e3_h1vs*mbV+S<5MU zm~=L9;F&P;zHqL@Sj}Vneoq*vxeQMEFD!Q<%Uh1-go$wAUfWwq3$Kg4OSZ{-l9^Y+ zdlIQ+MwP8(@d#YPNNIJMWkmSUw?RqFMa)Z_<@=;e+K1++DCbhN?{GH1SUimCOg_j%h2?Ir|vxY z?(T6=eE-~uT14iyi##N{AK~j516p+!nVGk_Ik10?5`FMH{!X4h2mlDLw-%)>NMLk& zVoc1dVffg&`4CCH1IXG+i=@9iuY{L8o;QRr-K{=%hkQKp!=aO6FCOun6blN z5D9epIm*gv*nBxFL~I%lO4#8z#>mdjuj`6}WF)ybS?7L-EF4&7UnuvcjPaGEI_<&C zqJtv&4spyHGK}iiH=n!e`drtJ8CuKLh>!imTK8n_PpS>9AjCa(yF#&JkG|GIs=?ZWzXAdnH?#BB_ zd9cDoVJ)A0eFuruJ?AV&3zT}Gu)dju>3wTNUJP>VJo|-^O@)v}+9M|kCPm{kX$vvx zVNlB0?mhl$-qSc~EJOJ+QGHOht0f%B$a2MRyOH;7BwG4`IpoBU#)Znr8SZVtxRtNK z-S)eo!e=yIpvPpz^~nF3;w7uBeF2(|G7x%prTlQF?#TCnoQ_toZIM1PQ3_52!+p6Z&RQPf=vFzd;=EbCO zlS29P^88T-9lCX8_>aoPMIX&Gj_b|Cil=yzNQsVS!JXrV-K`o06(g^Mtl|jer5)q7 zA<{sT_I}@InmehV^;!9Glq27*5_PF}M8y-LizKC>QQxtH-x|LAu7}R=>Y6Iln$5Cx z;`XMoSGtf2rwCz_fu32n#PghK`O73@)?K}akzAm7YVv#CFA$uv^5}) zem4oJUf69+Tg-HK27wr5bT8~WQ1g>mmlW*x)19vBKp}5>hz#Dr(1(j%!3P; zieC6G&1YMR} zyFiSj3lE`aDAq(L97@$^>|r^NB=wppOH|&3$D9Zs-l(lHP%#5Ha)AZT<}PClx9*f3 z5?WzKCuvIkm}mz&Q7Vn(HFC0MUbfwJrv*mq(+oZkoq!T`!W~S4-Jgln7it*pHpE@SbJEXO10IBU0 zt9fN86<^$;Dcj=-R$X;JOL%80_wC207FzCibz?^CX1qYtG&pR+#Yh-%e^Wee#sD_j^1_1uYip0F z51x1q3UkIJZOFgH^K&wtKCpxYdpwoBi=yHWBpnPHYpSk|I$Su&W#KlJ|89crrkUFi z6h0|#4^_=xh-5s9njUW(7aJ-kS(k>5w z#j?oQQ&iw}cTsbXetL1#)Lgmj`3*{`J?0aI(CH?cE3ukC;zf)tl><%7WChGzg5<`? z-!_j98LOF)-`MKY4~b$l;&iY$8&pF)LOUBpLET0cBId3Mc|t|#1Nn1=?UAQR0uAPF zlSi#p?8T8kWhN1i4DLt*Jj%$8xl@8z11X&ZDzW{kn=d?k^g|O%;jRy ze74NASy6;3*X>_AgOoe^FYD>4A{ipHOQy z+Ax`(!zw0y+kHS&mZN&oOGaSRbP=aGH1S#KGUh!tY|qERTtL*+G%-@e_-K(LR@vxG zwhXh>5l)ihM=H$6>G46wESMrt-Uo26ER#3+cKfx!3vZ6|JFbz{kzn-9Xn?B8_m)5z z!t0VZP_RPio(Wa@M}{faq=W)zIDTyh39tdYkn0$824;x*mfvqt{(zn25w^R)X)FM0 zno*PME|)88)!EVy7(h@?ANRUrOJa`G0pIMA(#iBO~(6HqCft<`d#+bDUr>@ zS6GQEI~|8w{45@@NfGzJ6p@GDejIuj3N;QL`q+LI0>=4T+LpP5BEAMY8lkzvf4&Rf zvvVU%io0xC%gApxENb-HEY)VqP2D67bi@ZFoHc1r-+0t zL&MRK^hg?tM#mwwXl(8Y$BDOTzG|#-aSn=tLq(Qnbr0hdR{?y@jWlTR(Re%)Sg}ze zE@9Y1jh|0C%8&USWS+}Cj~if2pl~Puc-vAKlmfp-rjELt!{0?%4=(hv0=swg4_a592gHU*> zR(73?KGzSPr*J7pJIZ+ke9zuF0KJ&2fUuSuRmA~aK-G|v&%R~h?g{( zFOenc3`7+%rxYrQwI%%+WgNW`$2)kugb+R18&P3s*kTG$1f#g(ih-qz1XS8V;0wJ1 z)adI=BdEtQP(~bo6k$YhA7u#_VJR2Cp#U2liMoW^=Q&cauDR9tsI$i@OH&%GVUF5v z3K#hSD1K8u+Cu4V6kLz~;Kx4woE%g!o=P^)v^m;)@4cUDXlUqG;~lKVEMsbb&wMhv zqCv2qd~T`0cqRk+gSkG3^Z&JXZlQ4%VI0pU*<`b+CMncQ@u3QZSV$TX`cM%;`clyc zpA>vj#Dbz&iI+AhHP%aMP^k!3ibBzcpoM@Myike+w1^n!gFZz^G=$cdW;f~l!f@uyedqh1Idf*tZq#9PJZn$v<+%xa1QT=8b>K!5ZG#z+_u z!?AtA?I)S^Zzj5MIl|mNVuMeI0Ei>6IV;QjEA@Er$3;eaXdh*f$L59{*`wpN5q=Mx z#a%Brm8H+ZXsLqSf+yQSE~Yj!BtuX)>TX+BO`Tt_uPG0FuLHm=nDnJqtU2>6w&CR zqx(H0`Ij`h5$3;@E2HY%y+Nrw^$D(Qza3(AmfbQ0ao%7i2s>g((wmShulY%5VK~HM z;$a(!Hwt=^X&coP`k^9`u&lvn=fdJCjx?mDAGqa5b&aWM`=32{_&3+c zD&c#u3JeVmJ=WRT*_+EPbYGg9RDajI)#6H#m1=J+GY%ccBR@~X_~VeqSQcAkPz%Fv z`7lP@;P|Nvzgw`Bm{<|#9LH7f+NLndi08vkoC$%WIfP>KBb?Pk81cY45NB8%Si60^ z>Qa;~dJ-e}_dVm|w!=1;dSs-qB-bzt0R zZl6GY;>{Ewgje>TqvxI-k+NjU>#U*dkHKoAC^OK+6om>ny5mTHCqvyA3vieYNG4tfy-0VG*lamSN3S8Ydwnx~rS`FRL z+mTLiG7e(mXrq7`=xUfTbyK4N=cf$HibEJ9kY+|vh-bM@CD&a3G6=WwNoV3QI0swM z&15ptQ}OIVHrxN^iFd|bWQ|gjVluw@>ht=Jj*dsw*^fv}`(|cl(tM|mQAtx?XBdnv znYi>Aht*;m$xLwGSQyZqu8Dg!LZUMhe4+FOH{Tx5;2@+oT^32TQQuMg-kx+k}gy?1tcrj>0O z%#}#`5etK092|ZVh8gTicoFy`dE)|zB z(>K?O4Jjt$^m~K#jZMkDtvB9qS8F=mqbIR;8EU889WqY3Tv|#XCX8nSa|U+K8ygMq zW~K`hCJLqWX@#WXj?9lpCzdTYG!^os~lAVHxihjaa*6z}+%t5^=GrUR>Vil2~}`5*XbChu<(! z#X%&92S{s<@TiQU+!snStR&;QJ^!P)zn(bo%;l@Dn}|&*rq!GnIGkv1Zr+|srMBzV zx3f?xb~Q95x5(JHYlOKi*_dLRzDWk(s;~x)WJ?+~5)y|~i$su<Ey<5t z(D@&l&;6o&C5d)IVL!?HXYZjSzmxxZ;kpph)p)h<<%GndyJSO)M0B%+x6szs)+|x9 zNGN*9tNg2ENgX@nQo2QDHNwqk)ImsSsC4x8<10g1AP@)y0)apv5C{YUfj}S-2m}Iw sKp+qZ1OkCTAP@)y0)apv5TmZ{Kix*oUV>S&asU7T07*qoM6N<$f&l>h&Hw-a diff --git a/diyhrt.market/meds/groups/bicalutamide.html b/diyhrt.market/meds/groups/bicalutamide.html index 1d8e909e8..04a510c80 100644 --- a/diyhrt.market/meds/groups/bicalutamide.html +++ b/diyhrt.market/meds/groups/bicalutamide.html @@ -402,7 +402,7 @@ - 71 days ago + 78 days ago @@ -701,7 +701,7 @@ - 306 days ago + 313 days ago @@ -789,7 +789,7 @@ - 42 days ago + 49 days ago @@ -892,5 +892,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/combination-minoxidil.html b/diyhrt.market/meds/groups/combination-minoxidil.html index 7364cca18..5ca78a00a 100644 --- a/diyhrt.market/meds/groups/combination-minoxidil.html +++ b/diyhrt.market/meds/groups/combination-minoxidil.html @@ -278,7 +278,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi + style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -306,15 +306,9 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + - - - - 8 days ago - - - + In Stock @@ -481,7 +475,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -537,5 +531,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/cyproterone.html b/diyhrt.market/meds/groups/cyproterone.html index 8bbfd2efd..3d6c74dbe 100644 --- a/diyhrt.market/meds/groups/cyproterone.html +++ b/diyhrt.market/meds/groups/cyproterone.html @@ -503,7 +503,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 306 days ago + 313 days ago @@ -517,12 +517,12 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels + style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
Cyproterone (Procur) 50mg
- 4NRX Pharmacy UK + United Pharmacies UK
@@ -564,12 +564,12 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels + style="border-left-width: 0.2rem; border-left-color: #31D4FF; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
Cyproterone (Procur) 50mg
- United Pharmacies UK + 4NRX Pharmacy UK
@@ -740,7 +740,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -768,15 +768,9 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
- + - - - - 214 days ago - - - + In Stock @@ -820,7 +814,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 42 days ago + 49 days ago @@ -875,7 +869,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels - 31 days ago + 3 days ago @@ -933,5 +927,5 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/dutasteride.html b/diyhrt.market/meds/groups/dutasteride.html index fffc47e0f..4025dc2ee 100644 --- a/diyhrt.market/meds/groups/dutasteride.html +++ b/diyhrt.market/meds/groups/dutasteride.html @@ -557,7 +557,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 306 days ago + 313 days ago @@ -727,7 +727,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 306 days ago + 313 days ago @@ -815,7 +815,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 306 days ago + 313 days ago @@ -909,7 +909,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 148 days ago + 155 days ago @@ -956,7 +956,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 42 days ago + 49 days ago @@ -1050,7 +1050,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 42 days ago + 49 days ago @@ -1097,7 +1097,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 42 days ago + 49 days ago @@ -1144,7 +1144,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 67 days ago + 74 days ago @@ -1232,7 +1232,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 92 days ago + 99 days ago @@ -1279,7 +1279,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar - 92 days ago + 99 days ago @@ -1293,7 +1293,7 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -1321,15 +1321,9 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar
- + - - - - 4 days ago - - - + In Stock @@ -1552,5 +1546,5 @@ Though the exact mechanism is unknown 5-Alpha Reductase Inhibitors as a class ar const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-droppers.html b/diyhrt.market/meds/groups/estradiol-droppers.html index 527df470c..cf513f306 100644 --- a/diyhrt.market/meds/groups/estradiol-droppers.html +++ b/diyhrt.market/meds/groups/estradiol-droppers.html @@ -275,7 +275,7 @@ + style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -303,15 +303,9 @@
- + - - - - 8 days ago - - - + In Stock @@ -405,5 +399,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-gels.html b/diyhrt.market/meds/groups/estradiol-gels.html index f3973fb7f..fb874da1c 100644 --- a/diyhrt.market/meds/groups/estradiol-gels.html +++ b/diyhrt.market/meds/groups/estradiol-gels.html @@ -405,54 +405,7 @@ The main downsides of transdermal gel are that some users may have issues with a - 49 days ago - - - - - - -
-
- - - -
-
- - Estreva (Estradiol 0.1%) Gel
- Inhouse Pharmacy - -
- -
- - 50mg - -
- -
- - $21.50
- - $0.43 - per mg - - -
- -
- - - - - - - - 119 days ago + 56 days ago @@ -539,6 +492,53 @@ The main downsides of transdermal gel are that some users may have issues with a In Stock + + +
+
+ + + +
+
+ + Estreva (Estradiol 0.1%) Gel
+ Inhouse Pharmacy + +
+ +
+ + 50mg + +
+ +
+ + $43.50
+ + $0.87 + per mg + + +
+ +
+ + + + + + + + 126 days ago + + + +
@@ -631,5 +631,5 @@ The main downsides of transdermal gel are that some users may have issues with a const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-injections.html b/diyhrt.market/meds/groups/estradiol-injections.html index f054bf930..bfa8858a4 100644 --- a/diyhrt.market/meds/groups/estradiol-injections.html +++ b/diyhrt.market/meds/groups/estradiol-injections.html @@ -359,6 +359,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+ + + +
+
+ + TeaHRT Estradiol Cypionate 10mL
+ TeaHRT + +
+ +
+ + 400mg + +
+ +
+ + $85.00
+ + $0.21 + per mg + + +
+ +
+ + + + + Delisted from store +
@@ -401,52 +442,11 @@ The main downside to Injections besides practical difficulties with injecting an - 12 days ago + 19 days ago - - -
-
- - - -
-
- - TeaHRT Estradiol Cypionate 10mL
- TeaHRT - -
- -
- - 400mg - -
- -
- - $85.00
- - $0.21 - per mg - - -
- -
- - - - - Delisted from store -
@@ -503,13 +503,13 @@ The main downside to Injections besides practical difficulties with injecting an
- Voix Céleste Estradiol Enanthate in Grapeseed Oil
+ Voix Céleste Estradiol Enanthate in MCT Oil
Voix Céleste
@@ -544,13 +544,13 @@ The main downside to Injections besides practical difficulties with injecting an
- Voix Céleste Estradiol Enanthate in MCT Oil
+ Voix Céleste Estradiol Enanthate in Grapeseed Oil
Voix Céleste
@@ -615,47 +615,6 @@ The main downside to Injections besides practical difficulties with injecting an
- - - In Stock - - - -
-
- - - -
-
- - Fiolelabs Estradiol Enanthate
- Fiolelabs - -
- -
- - 500mg - -
- -
- - €64.99
- - €0.13 - per mg - - -
- -
- - In Stock @@ -748,47 +707,6 @@ The main downside to Injections besides practical difficulties with injecting an In Stock - - -
-
- - - -
-
- - TeaHRT Estradiol Enanthate 10mL
- TeaHRT - -
- -
- - 400mg - -
- -
- - $75.00
- - $0.19 - per mg - - -
- -
- - - - - Delisted from store -
@@ -831,7 +749,7 @@ The main downside to Injections besides practical difficulties with injecting an - 15 days ago + 22 days ago @@ -877,6 +795,47 @@ The main downside to Injections besides practical difficulties with injecting an In Stock + + +
+
+ + + +
+
+ + TeaHRT Estradiol Enanthate 10mL
+ TeaHRT + +
+ +
+ + 400mg + +
+ +
+ + $75.00
+ + $0.19 + per mg + + +
+ +
+ + + + + Delisted from store +
@@ -894,7 +853,7 @@ The main downside to Injections besides practical difficulties with injecting an + style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -922,15 +881,9 @@ The main downside to Injections besides practical difficulties with injecting an
- + - - - - 8 days ago - - - + In Stock @@ -939,13 +892,13 @@ The main downside to Injections besides practical difficulties with injecting an
- Voix Céleste Estradiol Undecylate 500mg/5mL
+ Voix Céleste Estradiol Undecylate 500mg/10mL
Voix Céleste
@@ -980,13 +933,13 @@ The main downside to Injections besides practical difficulties with injecting an
- Voix Céleste Estradiol Undecylate 500mg/10mL
+ Voix Céleste Estradiol Undecylate 500mg/5mL
Voix Céleste
@@ -1055,47 +1008,6 @@ The main downside to Injections besides practical difficulties with injecting an Delisted from store - - -
-
- - - -
-
- - Fiolelabs Estradiol Undecylate
- Fiolelabs - -
- -
- - 500mg - -
- -
- - €94.99
- - €0.19 - per mg - - -
- -
- - - - - In Stock -
@@ -1270,47 +1182,6 @@ The main downside to Injections besides practical difficulties with injecting an
- - - In Stock - - - -
-
- - - -
-
- - Fiolelabs Estradiol Valerate
- Fiolelabs - -
- -
- - 500mg - -
- -
- - €59.99
- - €0.12 - per mg - - -
- -
- - In Stock @@ -1445,7 +1316,7 @@ The main downside to Injections besides practical difficulties with injecting an - 16 days ago + 23 days ago @@ -1585,5 +1456,5 @@ The main downside to Injections besides practical difficulties with injecting an const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-patches.html b/diyhrt.market/meds/groups/estradiol-patches.html index 8cadd3228..b080fa32c 100644 --- a/diyhrt.market/meds/groups/estradiol-patches.html +++ b/diyhrt.market/meds/groups/estradiol-patches.html @@ -1315,5 +1315,5 @@ The main downsides with transdermal patches can be difficulty maintaining higher const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-pills.html b/diyhrt.market/meds/groups/estradiol-pills.html index ccff5ec3f..a09af378c 100644 --- a/diyhrt.market/meds/groups/estradiol-pills.html +++ b/diyhrt.market/meds/groups/estradiol-pills.html @@ -436,7 +436,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 306 days ago + 313 days ago @@ -483,7 +483,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 42 days ago + 49 days ago @@ -661,7 +661,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 42 days ago + 49 days ago @@ -708,7 +708,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 42 days ago + 49 days ago @@ -1218,7 +1218,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 232 days ago + 239 days ago @@ -1265,7 +1265,7 @@ The main downside to oral pills is that much of the Estradiol is metabolised in - 42 days ago + 49 days ago @@ -1364,5 +1364,5 @@ The main downside to oral pills is that much of the Estradiol is metabolised in const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/estradiol-sprays.html b/diyhrt.market/meds/groups/estradiol-sprays.html index d04634297..452967fa6 100644 --- a/diyhrt.market/meds/groups/estradiol-sprays.html +++ b/diyhrt.market/meds/groups/estradiol-sprays.html @@ -311,7 +311,7 @@ The main downsides of transdermal sprays are that some users may have issues wit - 8 days ago + 2 days ago @@ -408,5 +408,5 @@ The main downsides of transdermal sprays are that some users may have issues wit const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/finasteride.html b/diyhrt.market/meds/groups/finasteride.html index 92b6cfc7d..389130060 100644 --- a/diyhrt.market/meds/groups/finasteride.html +++ b/diyhrt.market/meds/groups/finasteride.html @@ -518,7 +518,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 306 days ago + 313 days ago @@ -647,7 +647,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 362 days ago + Over a year ago @@ -735,7 +735,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 357 days ago + 364 days ago @@ -782,7 +782,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 42 days ago + 49 days ago @@ -870,7 +870,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 306 days ago + 313 days ago @@ -958,7 +958,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 42 days ago + 49 days ago @@ -1218,7 +1218,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 306 days ago + 313 days ago @@ -1306,7 +1306,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 42 days ago + 49 days ago @@ -1476,7 +1476,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 306 days ago + 313 days ago @@ -1564,7 +1564,7 @@ Though the exact mechanism is unknown Finasteride is also associated with signif - 42 days ago + 49 days ago @@ -1745,5 +1745,5 @@ Though the exact mechanism is unknown Finasteride is also associated with signif const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/gnrh-agonists.html b/diyhrt.market/meds/groups/gnrh-agonists.html index d06950d0d..605c32078 100644 --- a/diyhrt.market/meds/groups/gnrh-agonists.html +++ b/diyhrt.market/meds/groups/gnrh-agonists.html @@ -317,7 +317,7 @@ Recently we've seen cheaper formulations come to market such as Buserelin i - 5 days ago + 12 days ago @@ -373,5 +373,5 @@ Recently we've seen cheaper formulations come to market such as Buserelin i const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-10.html b/diyhrt.market/meds/groups/minoxidil-10.html index 369636708..5a28f7212 100644 --- a/diyhrt.market/meds/groups/minoxidil-10.html +++ b/diyhrt.market/meds/groups/minoxidil-10.html @@ -475,7 +475,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -522,7 +522,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -660,5 +660,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-2.html b/diyhrt.market/meds/groups/minoxidil-2.html index f8b8dbf30..ba25f3298 100644 --- a/diyhrt.market/meds/groups/minoxidil-2.html +++ b/diyhrt.market/meds/groups/minoxidil-2.html @@ -311,7 +311,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 4 days ago + 11 days ago @@ -358,7 +358,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 4 days ago + 11 days ago @@ -405,7 +405,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -452,7 +452,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 130 days ago + 137 days ago @@ -499,7 +499,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 130 days ago + 137 days ago @@ -546,7 +546,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -602,5 +602,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/minoxidil-5.html b/diyhrt.market/meds/groups/minoxidil-5.html index b5621a637..f994261fa 100644 --- a/diyhrt.market/meds/groups/minoxidil-5.html +++ b/diyhrt.market/meds/groups/minoxidil-5.html @@ -557,7 +557,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 306 days ago + 313 days ago @@ -604,7 +604,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -651,7 +651,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -698,7 +698,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -1024,5 +1024,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/progesterone.html b/diyhrt.market/meds/groups/progesterone.html index 8c6e0c30d..8bddf8551 100644 --- a/diyhrt.market/meds/groups/progesterone.html +++ b/diyhrt.market/meds/groups/progesterone.html @@ -398,7 +398,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 306 days ago + 313 days ago @@ -445,7 +445,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 42 days ago + 49 days ago @@ -533,7 +533,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 46 days ago + 53 days ago @@ -752,7 +752,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 78 days ago + 85 days ago @@ -947,9 +947,9 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li
- €34.00
+ €35.00
- €1.13 + €1.17 per pill @@ -1004,7 +1004,7 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li - 42 days ago + 49 days ago @@ -1193,5 +1193,5 @@ Progesterone is best taken as a rectal suppository to avoid processing in the li const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/groups/spironolactone.html b/diyhrt.market/meds/groups/spironolactone.html index 0ede70312..e1562a537 100644 --- a/diyhrt.market/meds/groups/spironolactone.html +++ b/diyhrt.market/meds/groups/spironolactone.html @@ -395,7 +395,7 @@ Spironolactone has been widely used particularly in the United States in transfe - 42 days ago + 49 days ago @@ -565,7 +565,7 @@ Spironolactone has been widely used particularly in the United States in transfe - 42 days ago + 49 days ago @@ -833,7 +833,7 @@ Spironolactone has been widely used particularly in the United States in transfe - 42 days ago + 49 days ago @@ -1085,7 +1085,7 @@ Spironolactone has been widely used particularly in the United States in transfe - 42 days ago + 49 days ago @@ -1184,5 +1184,5 @@ Spironolactone has been widely used particularly in the United States in transfe const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html b/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html index b44824f61..47a9ef08b 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-enanthate.html @@ -428,7 +428,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -471,55 +471,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1798,7 +1798,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1809,5 +1809,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html b/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html index 2750bdd12..bd1949082 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-undecylate.html @@ -343,7 +343,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -386,55 +386,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1465,7 +1465,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1476,5 +1476,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/astrovials-estradiol-valerate.html b/diyhrt.market/meds/products/astrovials-estradiol-valerate.html index 71c7252e4..f16e901dc 100644 --- a/diyhrt.market/meds/products/astrovials-estradiol-valerate.html +++ b/diyhrt.market/meds/products/astrovials-estradiol-valerate.html @@ -343,7 +343,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -386,55 +386,6 @@ Unlike many other medications on this site, these products are produced by priva - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1625,7 +1625,7 @@ Unlike many other medications on this site, these products are produced by priva - + @@ -1636,5 +1636,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html index 2deab9979..6dce8c234 100644 --- a/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-binarex-50mg-x28.html @@ -318,7 +318,7 @@
- + @@ -361,55 +361,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1776,7 +1776,7 @@ - + @@ -1787,5 +1787,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html b/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html index 867d3514d..25efae48d 100644 --- a/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html +++ b/diyhrt.market/meds/products/bicalutamide-calutide-50mg-x10.html @@ -362,7 +362,7 @@
- + @@ -405,55 +405,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1611,7 +1611,7 @@
- + @@ -1654,55 +1654,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2876,7 +2876,7 @@
- + @@ -2895,7 +2895,7 @@ - 306 days ago + 313 days ago @@ -2925,55 +2925,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4059,7 +4059,7 @@
- + @@ -4102,55 +4102,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5852,7 +5852,7 @@
- + @@ -5871,7 +5871,7 @@ - 42 days ago + 49 days ago @@ -5901,55 +5901,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6844,7 +6844,7 @@ - + @@ -6855,5 +6855,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html index 4a3a4f4bc..78f277177 100644 --- a/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-casodex-50mg-x28.html @@ -318,7 +318,7 @@
- + @@ -367,55 +367,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1313,5 +1313,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html b/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html index 174ea12c2..dcdb0ff3c 100644 --- a/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html +++ b/diyhrt.market/meds/products/bicalutamide-castramid-50mg-x10.html @@ -318,7 +318,7 @@
- + @@ -361,55 +361,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1280,7 +1280,7 @@ - + @@ -1291,5 +1291,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html b/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html index 4fd86f1d2..de2082676 100644 --- a/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html +++ b/diyhrt.market/meds/products/bicalutamide-procalut-50mg-x28.html @@ -340,7 +340,7 @@
- + @@ -389,55 +389,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1299,7 +1299,7 @@
- + @@ -1348,55 +1348,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2242,7 +2242,7 @@
- + @@ -2291,55 +2291,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3226,7 +3226,7 @@ - + @@ -3237,5 +3237,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/climara-100mcg-x4.html b/diyhrt.market/meds/products/climara-100mcg-x4.html index e97cd8b2d..9c87abce0 100644 --- a/diyhrt.market/meds/products/climara-100mcg-x4.html +++ b/diyhrt.market/meds/products/climara-100mcg-x4.html @@ -386,7 +386,7 @@
- + @@ -435,55 +435,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1345,7 +1345,7 @@
- + @@ -1394,55 +1394,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3160,7 +3160,7 @@
- + @@ -3203,55 +3203,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4105,7 +4105,7 @@
- + @@ -4154,55 +4154,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5048,7 +5048,7 @@
- + @@ -5097,55 +5097,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5991,7 +5991,7 @@
- + @@ -6040,55 +6040,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6975,7 +6975,7 @@ - + @@ -6986,5 +6986,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/climara-50mcg-x4.html b/diyhrt.market/meds/products/climara-50mcg-x4.html index a37347130..899c6f368 100644 --- a/diyhrt.market/meds/products/climara-50mcg-x4.html +++ b/diyhrt.market/meds/products/climara-50mcg-x4.html @@ -386,7 +386,7 @@
- + @@ -435,55 +435,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1345,7 +1345,7 @@
- + @@ -1394,55 +1394,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2936,7 +2936,7 @@
- + @@ -2979,55 +2979,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3873,7 +3873,7 @@
- + @@ -3922,55 +3922,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4816,7 +4816,7 @@
- + @@ -4865,55 +4865,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5759,7 +5759,7 @@
- + @@ -5808,55 +5808,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -6743,7 +6743,7 @@ - + @@ -6754,5 +6754,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html b/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html index 30b7c5702..3edb67e77 100644 --- a/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html +++ b/diyhrt.market/meds/products/combination-minoxidil-finasteride-3-solution-morr-f-60ml.html @@ -343,7 +343,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -386,55 +386,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1440,7 +1440,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1483,55 +1483,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2513,7 +2513,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2532,7 +2532,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -2562,55 +2562,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3513,7 +3513,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -3524,5 +3524,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html b/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html index 821ea1085..5c45c2e01 100644 --- a/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html +++ b/diyhrt.market/meds/products/combination-minoxidil-finasteride-brintop-f-solution-100ml.html @@ -330,7 +330,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -373,55 +373,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1452,7 +1452,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -1463,5 +1463,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html index 76edab950..fea5b4efd 100644 --- a/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-androcur-50mg-x50.html @@ -343,7 +343,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -392,55 +392,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1302,7 +1302,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1351,55 +1351,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2245,7 +2245,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -2294,55 +2294,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3229,7 +3229,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -3240,5 +3240,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html index 04260f1fb..3d201a6f9 100644 --- a/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-procur-50mg-x50.html @@ -343,7 +343,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -392,55 +392,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1302,7 +1302,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1351,55 +1351,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2245,7 +2245,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -2294,55 +2294,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3229,7 +3229,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -3240,5 +3240,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html b/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html index ee943be19..90f5c3187 100644 --- a/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-siterone-100mg-x50.html @@ -321,7 +321,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -340,7 +340,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - 31 days ago + 3 days ago @@ -370,55 +370,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1234,6 +1234,22 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If + + June 7, 2025, 6:57 a.m. + $105.00 + + Out of Stock + + + + + June 3, 2025, 9:11 p.m. + $52.50 + + In Stock + + + May 3, 2025, 8:04 p.m. $105.00 @@ -2209,7 +2225,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - + @@ -2220,5 +2236,5 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html b/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html index 58ce279e4..13e8974aa 100644 --- a/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html +++ b/diyhrt.market/meds/products/cyproterone-siterone-50mg-x50.html @@ -154,7 +154,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If + style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);"> Inhouse Pharmacy @@ -365,7 +365,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -408,55 +408,6 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1811,7 +1811,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
+ style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -1822,7 +1822,7 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- + @@ -1830,21 +1830,15 @@ Cyproterone has been shown to be fully effective at doses as low as 10mg/day. If
- - - - - -
- -
-
-
- -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- -
- -
-

- -

-
-
-
- - - - - - - - - - - - - - - - -
First SeenPriceState
Oct. 12, 2024, 1:48 p.m.€64.99 - In Stock -
-
-
-
-
-
-
- -
-
-
-
- - - -
- -
- - - - - - - - - - - - - - - - - - diff --git a/diyhrt.market/meds/products/fiolelabs-estradiol-undecylate.html b/diyhrt.market/meds/products/fiolelabs-estradiol-undecylate.html deleted file mode 100644 index ec928f737..000000000 --- a/diyhrt.market/meds/products/fiolelabs-estradiol-undecylate.html +++ /dev/null @@ -1,1346 +0,0 @@ - - - - - - - - - - - - - - - - - - - - - - - - - Fiolelabs Estradiol Undecylate - DIYHRT.Market - - - - - - - - - - - - - - - - - - - - - - - - - - - -
-
-
-
- - - - - - - - - -
- - Login - Register - -
-
-
-
- -
- - - -
- - -
-
-
-

Fiolelabs Estradiol Undecylate

-
-
- -
-
-
- - -
- - - - - Fiolelabs - - - - €94.99 - - - -
-
- -
-
    - - -
  • - Group: -
    - - Estradiol Injections - -
    -
    • - - - -
  • - Dosage form: -
    - - Injection - -
    -
    • - - - -
  • - Manufacturer: -
    - - Fiolelabs - -
    -
    • - - - - - -
  • - Active ingredient: -
    - - Estradiol Undecylate - -
    -
    • - - - -
  • - Excipients: -
    - - -
    - Castor OIl (Supension Oil) -
    - -
    - Benzyl Benzoate (Solvent) -
    - -
    - Benzyl Alcohol (Preservative) -
    - - -
    -
    • - - - - - -
  • - Volume: -
    - - 10 ml - -
    -
    • - - - -
  • - Total active ingredient: -
    - - 500 mg - -
    -
    • - - - -
  • - Concentration: -
    - - 50.0 mg/ml - -
    -
    • - - - - - - - - - - - - - - - - -
-
- - -
- -
-

- - - - - - -

Estradiol Undecylate is an estered form of bioidentical estradiol suspended in an oil solution making it suitable for subcutaneous and intramuscular injections. Esterification is the process of combining Estradiol with an acid which the human body will then slowly break down over time, creating a slow-release form of the medication so that it can be delivered as larger injections at lower frequencies, typically around weekly. Estradiol has been delivered in this form for almost a century and it's a well-studied, safe and convenient process. Estradiol Undecylate has a biological half-life of ~30 days.

- - - - - -

Unlike many other medications on this site, these products are produced by private individuals, not pharmaceutical companies, and thus do not have the associated safety guarantees. While we only list providers with a positive reputation within the DIY community it's important to understand these risks so that you can make an informed decision.

- - - - - -

- This product is 10ml of liquid, at a concentration of - 50mg per ml, for a total of a 500mg per vial. -

- - - - - - -

- -
- - - -
- -
- -
-
-
-
-
- - Fiolelabs - -
- -
-
- - - - - - - -
- - - -
-
-
-
-
- -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- -
- -
-

- -

-
-
-
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
First SeenPriceState
July 19, 2024, 12:10 a.m.€94.99 - In Stock -
May 3, 2024, 7:02 p.m.€69.99 - -
Feb. 24, 2024, 10:53 p.m.€94.99 - -
Feb. 24, 2024, 10:50 p.m. - Out of Stock -
Feb. 24, 2024, 6:48 a.m. - In Stock -
-
-
-
-
-
-
- -
-
-
-
- -
- -
- -
- - - - - - - - - - - - - - - - - - diff --git a/diyhrt.market/meds/products/gynokadin-dosiergel.html b/diyhrt.market/meds/products/gynokadin-dosiergel.html index 470022be7..17831cebd 100644 --- a/diyhrt.market/meds/products/gynokadin-dosiergel.html +++ b/diyhrt.market/meds/products/gynokadin-dosiergel.html @@ -331,7 +331,7 @@
- + @@ -374,55 +374,6 @@ - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1445,7 +1445,7 @@ - + @@ -1456,5 +1456,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-10-solution-hair4u-10-60ml.html b/diyhrt.market/meds/products/minoxidil-10-solution-hair4u-10-60ml.html index bad4e01b5..c41acd53e 100644 --- a/diyhrt.market/meds/products/minoxidil-10-solution-hair4u-10-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-10-solution-hair4u-10-60ml.html @@ -337,7 +337,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -380,55 +380,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1450,7 +1450,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1493,55 +1493,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2531,7 +2531,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2550,7 +2550,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -2580,55 +2580,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3539,7 +3539,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -3550,5 +3550,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-10-solution-tugain-10-60ml.html b/diyhrt.market/meds/products/minoxidil-10-solution-tugain-10-60ml.html index e18a12d88..68cc95e5e 100644 --- a/diyhrt.market/meds/products/minoxidil-10-solution-tugain-10-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-10-solution-tugain-10-60ml.html @@ -368,7 +368,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -411,55 +411,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1401,7 +1401,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1444,55 +1444,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2354,7 +2354,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2397,55 +2397,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3363,7 +3363,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -3406,55 +3406,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4380,7 +4380,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -4399,7 +4399,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -4429,55 +4429,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5372,7 +5372,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -5383,5 +5383,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-2-solution-hair4u-2-60ml.html b/diyhrt.market/meds/products/minoxidil-2-solution-hair4u-2-60ml.html index a6f02082e..917012859 100644 --- a/diyhrt.market/meds/products/minoxidil-2-solution-hair4u-2-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-2-solution-hair4u-2-60ml.html @@ -337,7 +337,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -356,7 +356,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 4 days ago + 11 days ago @@ -386,55 +386,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1328,7 +1328,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1347,7 +1347,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 4 days ago + 11 days ago @@ -1377,55 +1377,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2295,7 +2295,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2314,7 +2314,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -2344,55 +2344,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3287,7 +3287,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -3298,5 +3298,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-2-solution-regaine-2-60ml.html b/diyhrt.market/meds/products/minoxidil-2-solution-regaine-2-60ml.html index 298415545..dc4d59510 100644 --- a/diyhrt.market/meds/products/minoxidil-2-solution-regaine-2-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-2-solution-regaine-2-60ml.html @@ -337,7 +337,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -356,7 +356,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 130 days ago + 137 days ago @@ -386,55 +386,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1440,7 +1440,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1459,7 +1459,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 130 days ago + 137 days ago @@ -1489,55 +1489,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2487,7 +2487,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2506,7 +2506,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -2536,55 +2536,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3511,7 +3511,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -3522,5 +3522,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-5-solution-hair4u-5-60ml.html b/diyhrt.market/meds/products/minoxidil-5-solution-hair4u-5-60ml.html index 01699ebcf..734e762de 100644 --- a/diyhrt.market/meds/products/minoxidil-5-solution-hair4u-5-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-5-solution-hair4u-5-60ml.html @@ -337,7 +337,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -380,55 +380,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1338,7 +1338,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1381,55 +1381,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2323,7 +2323,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2342,7 +2342,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -2372,55 +2372,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3315,7 +3315,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -3326,5 +3326,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-5-solution-mintop-forte-5-60ml.html b/diyhrt.market/meds/products/minoxidil-5-solution-mintop-forte-5-60ml.html index 3c3d60801..dfd0ac77b 100644 --- a/diyhrt.market/meds/products/minoxidil-5-solution-mintop-forte-5-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-5-solution-mintop-forte-5-60ml.html @@ -348,7 +348,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -391,55 +391,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1333,7 +1333,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1352,7 +1352,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 306 days ago + 313 days ago @@ -1382,55 +1382,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2284,7 +2284,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2327,55 +2327,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3253,7 +3253,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -3272,7 +3272,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -3302,55 +3302,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4261,7 +4261,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -4272,5 +4272,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-5-solution-regaine-5-60ml.html b/diyhrt.market/meds/products/minoxidil-5-solution-regaine-5-60ml.html index aeaf34f37..e6bc37309 100644 --- a/diyhrt.market/meds/products/minoxidil-5-solution-regaine-5-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-5-solution-regaine-5-60ml.html @@ -346,7 +346,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -395,55 +395,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1305,7 +1305,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1354,55 +1354,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2248,7 +2248,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2297,55 +2297,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3207,7 +3207,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -3256,55 +3256,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4191,7 +4191,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -4202,5 +4202,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html b/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html index a7720c703..ee2f7c213 100644 --- a/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html +++ b/diyhrt.market/meds/products/minoxidil-5-solution-tugain-5-60ml.html @@ -368,7 +368,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -411,55 +411,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -1321,7 +1321,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -1364,55 +1364,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -2274,7 +2274,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -2317,55 +2317,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -3243,7 +3243,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -3286,55 +3286,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -4180,7 +4180,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi
- + @@ -4199,7 +4199,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - 42 days ago + 49 days ago @@ -4229,55 +4229,6 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - - - - - - - - - - - - - - + + + + + + + + + + + + + +
- - - - - - - + + + + + + +
@@ -5172,7 +5172,7 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi - + @@ -5183,5 +5183,5 @@ Applied as a topical solution it is regarded safe, though it has known hypotensi const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html b/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html index 1f30b58d9..12e462a97 100644 --- a/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html +++ b/diyhrt.market/meds/products/open-gate-labs-bicalutamide-x100.html @@ -307,7 +307,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -326,7 +326,7 @@ Unlike many other medications on this site, these products are produced by priva - 71 days ago + 78 days ago @@ -1042,6 +1042,55 @@ Unlike many other medications on this site, these products are produced by priva data-bs-title="June 2, 2025"> + + + + + + + + + + + + + + + + + + + + + @@ -1284,5 +1333,5 @@ Unlike many other medications on this site, these products are produced by priva const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html b/diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html index ab5541d4d..137bba20d 100644 --- a/diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html +++ b/diyhrt.market/meds/products/open-gate-labs-combination-minoxidil-finasteride-5.html @@ -139,7 +139,7 @@ Unlike many other medications on this site, these products are produced by priva + style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-success);"> Open Gate Labs @@ -314,7 +314,7 @@ Unlike many other medications on this site, these products are produced by priva
+ style="border-left-width: 0.2rem; border-left-color: #233D87; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
@@ -325,7 +325,7 @@ Unlike many other medications on this site, these products are produced by priva
- + @@ -333,21 +333,15 @@ Unlike many other medications on this site, these products are produced by priva
- - - - @@ -146,5 +146,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/qr-codes.html b/diyhrt.market/qr-codes.html index 95e1e8597..e1251ba23 100644 --- a/diyhrt.market/qr-codes.html +++ b/diyhrt.market/qr-codes.html @@ -174,5 +174,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/register.html b/diyhrt.market/register.html index 7f6d59cc3..9ffe102c1 100644 --- a/diyhrt.market/register.html +++ b/diyhrt.market/register.html @@ -95,7 +95,7 @@ - +
Enter the same password again
@@ -143,5 +143,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/resources.html b/diyhrt.market/resources.html index 7d9908f18..deae25de6 100644 --- a/diyhrt.market/resources.html +++ b/diyhrt.market/resources.html @@ -155,5 +155,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/stores/4nrx-pharmacy-uk.html b/diyhrt.market/stores/4nrx-pharmacy-uk.html index e71cda408..46fa00273 100644 --- a/diyhrt.market/stores/4nrx-pharmacy-uk.html +++ b/diyhrt.market/stores/4nrx-pharmacy-uk.html @@ -1370,7 +1370,7 @@ - 4 days ago + 11 days ago @@ -1417,7 +1417,7 @@ - 130 days ago + 137 days ago @@ -1743,5 +1743,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html b/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html index 682b0c7d9..bfbfb5c26 100644 --- a/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html +++ b/diyhrt.market/stores/4nrx-pharmacy-uk/reviews.html @@ -179,7 +179,7 @@

Leave a Review

- +
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
+
Your Name (Optional)
- - -
- - Login - Register - -
-
-
- - -
- - - -
- - -
-
-
-

Fiolelabs

-
-
- -
-
- - -
- - - https://fiolelabs.org/ - - - - - Active - - - - - - - - - - - - 3.4/5 - - - 22 reviews - - -
  • - Category: - Homebrewers -
    • - -
  • - Ships From: - United Kingdom -
    • - -
  • - Ships To: - UK + EU -
    • - -
  • - Payment Methods: - - - - - - - - - - - - - - - - - - - -
    • -
    - - - - - -
    - -
    - - -
    - -
    -

    Fiolelabs is a homebrew provider run by 2 trans women based in the UK. They have been operating since July 2023. They follow strict, transparent safety procedures.

    -
    Payments
    -

    They currently only accept payments via Cryptocurrency.

    -
    Postage
    -

    All packages are shipped from the UK to elsewhere in the UK or the EU. All packages are shipped via Royal Mail. Shipping to the EU can take up to 10 business days whereas shipping domestically usually takes 1-3 business days.

    -
    -
    - -
    -
    - -
    - -
    -
    - - - - -
    Estradiol Injections
    - - - -
    - - -
    -
    - - Fiolelabs Estradiol Enanthate
    - Fiolelabs -     -
    - -
    - - 500mg - -
    - -
    - - €64.99
    - - €0.13 - per mg - -     -
    - -
    - - - - - In Stock - - - -
    -
    -     - - -
    -
    - - Fiolelabs Estradiol Undecylate
    - Fiolelabs -     -
    - -
    - - 500mg - -
    - -
    - - €94.99
    - - €0.19 - per mg - -     -
    - -
    - - - - - In Stock - - - -
    -
    -     - - -
    -
    - - Fiolelabs Estradiol Valerate
    - Fiolelabs -     -
    - -
    - - 500mg - -
    - -
    - - €59.99
    - - €0.12 - per mg - -     -
    - -
    - - - - - In Stock - - - -
    -
    -     - -
    - - - -
    -
    -
    - - - -
    - -
    - - - - - - - - - - diff --git a/diyhrt.market/stores/fiolelabs/reviews.html b/diyhrt.market/stores/fiolelabs/reviews.html deleted file mode 100644 index 04524d240..000000000 --- a/diyhrt.market/stores/fiolelabs/reviews.html +++ /dev/null @@ -1,1575 +0,0 @@ - - - - - - - - - - - - - - - - - - - - - - - - - Fiolelabs - DIYHRT.Market - - - - - - - - - - - - -
    -
    -
    -
    - - - - - - - - - -
    - - Login - Register - -
    -
    -
    -
    - -
    - - - -
    - - -
    -
    -
    -

    Fiolelabs Reviews

    -
    -
    - -
    -
    - - -
    - - - https://fiolelabs.org/ - - - - - Active - - - - - - - - - - - - 3.4/5 - - - 22 reviews - - -
  • - Category: - Homebrewers -
    • - -
  • - Ships From: - United Kingdom -
    • - -
  • - Ships To: - UK + EU -
    • - -
  • - Payment Methods: - - - - - - - - - - - - - - - - - - - -
    • -
    - -
    - -
    -

    Leave a Review

    -
    - -
    Your Name (Optional)
    -
    Country your delivery was ordered to. (Optional)
    -
    Rate your experience on a scale of 1 to 5.
    -
    Share your experience! (Optional)
    -
    - - -
    -
    - -

    Reviews

    - -
    -
    -
    -
    - -
    - - - Anonymous - - - - 1/5 - -
    -     - - May 25, 2025 -
    -
    - - -
    -
    - Didn't respond to messages. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Leah - - - - 1/5 - -
    -     - - May 20, 2025 -
    -
    - - -
    -
    - Ordered on 2 vials on the 11th of March, still not received anything. Communication is terrible, pretty sure they are a scam at this point. Avoid -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - hazel - - - - 4/5 - -
    -     - - April 1, 2025 -
    -
    - - -
    -
    - bought around 1st of jan, took about a 3 weeks to a month to ship, but it did get here eventually. Communication was iffy but as kat has said, they're a small operation. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Kat - - - - 5/5 - -
    -     - - March 6, 2025 -
    -
    - - -
    -
    - Super easy to contact, were very friendly and quick to respond considering the type of service. Product arrived in 4 days. Spoke briefly to them about the delays on other packages: due to the small operation size, just one person being ill can cause a whole hell of delays, so please be considerate that these are real people with real lives. Big reccomend. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Rebecca - - - - 4/5 - -
    -     - - March 2, 2025 -
    -
    - - -
    -
    - Update - Vial arrived after 1 month! Looks like they did reship in the end judging by date on the parcel. Vial arrived in good condition, seal still on. I really wish they had communicated better, but from what it seems that's all I can fault them for now as reships and occasional lost mail are to be expected imo - -I hope everything is okay with them, the UK needs more suppliers with Vanna no longer selling. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Anonymous - - - - 1/5 - -
    -     - - Feb. 23, 2025 -
    -
    - - -
    -
    - Took payment and then stopped replying, several weeks now with no contact. Avoid -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Rebecca - - - - 2/5 - -
    -     - - Feb. 18, 2025 -
    -
    - - -
    -
    - Great communication to start, took payment and confirmed shipment, but it never arrived and they've not responded to either messages sent. I don't know what's up at the moment, but I'm missing dosages without the product or any communication to sort a refund. Something seems to be up, but until there's some more communications I can only tell people to hold off for the time. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Isabel - - - - 1/5 - -
    -     - - Feb. 18, 2025 -
    -
    - - -
    -
    - Multiple promised to send but never has. Even supplied a tracking reference that when checked has never been shipped. -Con artists who take money but do not ship. -A V O I D -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - F - - - - 3/5 - -
    -     - - Feb. 9, 2025 -
    -
    - - -
    -
    - Echoing H’s review. I ordered on the 3rd of jan and havent received anything. After a long time with no communication they said they were having issues with their local postoffice. Id recommend buying elsewhere until they have ironed out the kinks in their operation :( -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - H (Update) - - - - 1/5 - -
    -     - - Feb. 6, 2025 -
    -
    - - -
    -
    - 4+ weeks, spotty communication and still nothing. Maybe im just really unlucky with postage but :/ -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - H - - - - 1/5 - -
    -     - - Jan. 21, 2025 -
    -
    - - -
    -
    - Ordered and paid 2+ weeks ago, good customer service at first but no response after an entire week. Will update if resolved -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Gwen - - - - 5/5 - -
    -     - - Jan. 15, 2025 -
    -
    - - -
    -
    - Very good communication and excelent quality. - -Had to reship a couple times due to royal mail being a pain but this was not at extra cost to me. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - Ally - - - - 5/5 - -
    -     - - Dec. 4, 2024 -
    -
    - - -
    -
    - Arrived in 3 days, good customer service :) -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Anonymous - - - - 4/5 - -
    -     - - Nov. 16, 2024 -
    -
    - - -
    -
    - Took 2 reshipments but did (eventually) arrive. Took preferred crypto and seems to be in good condition. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Emma - - - - 5/5 - -
    -     - - Nov. 8, 2024 -
    -
    - - -
    -
    - Great customer service, the order arrived in 2 days with no problems -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Val - - - - 5/5 - -
    -     - - Oct. 26, 2024 -
    -
    - - -
    -
    - First vial got lost in post somehow, but was reshipped a week later then arrived within a week of the reship. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Suppy - - - - 5/5 - -
    -     - - Oct. 16, 2024 -
    -
    - - -
    -
    - Fast replies and great service. At first the vial got lost in postage but it was reshipped and arrived in perfect condition! -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Rain - - - - 5/5 - -
    -     - - Aug. 15, 2024 -
    -
    - - -
    -
    - Easy to contact, sent with no problems, arrived quickly. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Bella - - - - 5/5 - -
    -     - - April 24, 2024 -
    -
    - - -
    -
    - Arrived in 2 days, easy ordering process -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Grace - - - - 2/5 - -
    -     - - April 18, 2024 -
    -
    - - -
    -
    - It arrived on time but the lid was not put onto the vial very securely. I think it had been bashed about a bit in the post but it seemed so flimsy that it damaged that easily. Very hard to take the plastic stopper off without seeming like I was pulling off the whole top and exposing the vial, and I've honestly no idea if I managed that or not. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Anonymous - - - - 5/5 - -
    -     - - March 24, 2024 -
    -
    - - -
    -
    - Easy to contact, took my preferred crypto, uses fast tracked post in UK. -
    -
    - -
    -
    - -
    -
    -
    -
    - -
    - - - - - Anonymous - - - - 5/5 - -
    -     - - March 17, 2024 -
    -
    - - -
    -
    - -
    -
    -
    - -
    - -
    - -
    - - - - - - - - - - diff --git a/diyhrt.market/stores/girlpotion.html b/diyhrt.market/stores/girlpotion.html index e79e70b3c..8ffe3abcb 100644 --- a/diyhrt.market/stores/girlpotion.html +++ b/diyhrt.market/stores/girlpotion.html @@ -282,5 +282,5 @@ const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]') const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl)) - + diff --git a/diyhrt.market/stores/girlpotion/reviews.html b/diyhrt.market/stores/girlpotion/reviews.html index 9b72c0e07..d3f568d42 100644 --- a/diyhrt.market/stores/girlpotion/reviews.html +++ b/diyhrt.market/stores/girlpotion/reviews.html @@ -205,7 +205,7 @@

    Leave a Review

    - +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)
    +
    Your Name (Optional)